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Regulation of Skeletal Muscle Metabolism 
— Supply and Demand 
This thesis examines the regulation of skeletal muscle metabolism under 
resting conditions. Previous studies have shown that vasoconstrictors stimulate [type 
A] or inhibit [type B] metabolism of the constant flow perfused rat hindlimb. There is 
evidence that this may be due to redistribution of blood flow between the two vascular 
pathways in skeletal muscle, either increasing [type A] or decreasing [type B] the 
extent of nutritive perfusion. It is not clear if enhanced nutritive perfusion and 
therefore enhanced oxygen delivery is enough to account for the observed increase in 
metabolism with type A vasoconstrictors. It has been proposed that a cellular 
thermogenic mechanism is activated in addition to redistribution. The identity of this 
mechanism is not clear. A number of possibilities are explored. 
The effects of varied oxygen delivery on hindlimb oxygen uptake were 
examined. Flow was maintained at a constant level while arterial oxygen content was 
varied. Three independent methods (1-MX metabolism, microdialysis and laser 
doppler flowmetry) were utilized to rigorously monitor redistribution. A positive 
relationship between oxygen delivery and hindlimb oxygen uptake was detected, 
independent of redistribution. Cellular ATP levels were maintained, though PCr 
stores were depleted at low oxygen delivery. Lactate efflux increased, but was not 
considered great enough to fully compensate for diminished ATP production from 
aerobic sources. In this regard, the perfused rat hindlimb may be considered as an 
oxygen conforming tissue. Thus oxygen delivery is a key determinant of skeletal 
muscle metabolic rate, and type A vasoconstrictors may effectively enhance oxygen 
delivery by improving nutritive perfusion. 
Mechanisms accounting for increased oxygen consumption during enhanced 
delivery were explored. The roles of sodium cycling and accompanying Na ÷/K+- 
ATPase pump activity were assessed. Comparisons were made between type A 
vasoconstrictors and the sodium channel labilizer veratridine in both skeletal and 
cardiac muscle. In perfused skeletal muscle both vasoconstrictor- and veratridine-
mediated metabolism were blocked by the sodium pump inhibitor ouabain, however 
vasoconstrictor-mediated metabolism was resistant to sodium channel inhibition with 
tetrodotoxin (TTX). The same TTX-resistant vasoconstrictor-thermogenic effect was 
absent from perfused arrested rat heart, possibly due to differences in vascular 
anatomy. Intracellular recording techniques failed to detect any change in skeletal 
fiber membrane potential during type A vasoconstrictor infusion, but did detect 
changes with veratridine. In summary the data supports the notion that metabolic 
demand (sodium load with veratridine) can stimulate hindlimb metabolism. However, 
there was no evidence for type A vasoconstrictor mediated changes in muscle sodium 
cycling, Na+/K+-ATPase activity, or membrane depolarization. 
Oxygen consumption of resting skeletal muscle is largely controlled by 
oxygen delivery, whether this is by changes in bulk flow or flow redistribution. 
Cellular thermogenic mechanisms may well be activated in response to increased 
oxygen delivery, though sodium cycling/pumping is no longer a candidate. 
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The contribution of skeletal muscle to non-shivering thermogenesis has been 
debated for many years (171). While many researchers favour brown adipose tissue 
as the primary source of non-shivering heat in small mammals (42; 43; 217), a 
considerable body of evidence also implicates skeletal muscle as an important source 
of non-shivering thermogenesis (NST) in species with and without brown adipose 
tissue (171). Typically, NST stimulated by catecholamines, cold and diet, is ascribed 
to thermogenic mechanisms in brown adipocytes. However, evidence of NST 
• induced by catecholamines, cold and diet has also been demonstrated in skeletal 
muscle, though the biochemical mechanisms responsible are less clear. 
The stimulatory effects of type A vasoconstrictors (including catecholamines) on 
perfused hindlimb metabolism (59), in species with and without brown adipose tissue, 
is considered firm evidence in favour of non shivering thermogenesis of muscular 
origin (131; 183; 208). Blood flow is thought to play a significant role in 
vasoconstrictor-stimulated metabolism, though it is not clear if changes in oxygen 
delivery are the primary stimulus for increased metabolism, or if additional 
thermogenic mechanisms are activated in response to enhanced blood flow. The 
thermogenic mechanisms available in skeletal muscle are discussed herein, with 
particular reference to those that may be recruited during vasoconstrictor-mediated 
metabolism. 
1.2 Non shivering thermogenesis 
1.2.1 Brown adipose tissue versus skeletal muscle 
Non-shivering thermogenesis (NST) is defined as the heat produced in response 
to cold that is not dependent on muscular shivering. This was first noted in cold 
exposed (5°C) rats treated with curare to prevent muscular contraction (shivering), 
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where animals survived exposure, while maintaining normal body temperatures (84). 
In rats and mice, long term cold exposure results in a gradual shift from shivering to 
non-shivering thermogenesis as the primary heat producing mechanism (123; 147; 
170; 170). The finding that norepinephrine induced metabolism is enhanced by cold 
acclimation, led to the hypothesis that norepinephrine (NE) is the hormonal mediator 
of NST (163). Heat is produced as a consequence of increased metabolic rate, 
however the source tissue, and biochemical mechanism of non-shivering 
thermogenesis is controversial. 
Microsphere studies in rodents demonstrate significantly elevated blood flow in 
brown adipose tissue (BAT) during cold exposure and norepinephrine infusion (117; 
118). BAT thermogenesis in rats is also elevated in response to overeating at 
thermoneutrality (257), and during cold exposure (148). BAT mass increases 
significantly during cold exposure (119; 173), while bilateral removal of BAT 
attenuates the cold induced metabolic response (275). Furthermore, the oxidative 
capacity of BAT was shown to increase with cold acclimation (173). Thus, active 
BAT metabolism contributes to thermoregulation and dissipation of excess caloric 
energy, an effect that may be artificially stimulated by the application of 
catecholamines. 
However, several lines of evidence argue that BAT alone, may only be able to 
account for a portion of total NST induced by cold, diet or catecholamines. 
Measurements of cytochrome oxidase activity in BAT from cold adapted rats suggest 
that BAT may account for an absolute maximum of 76% of the additional heat 
produced (173). The remaining portion of NST must be attributed to tissues other 
than BAT. Comparisons of cytochrome oxidase activity in cold acclimated gerbil and 
mouse tissues (liver, BAT and skeletal muscle) were carried out after 4 and 8 weeks 
of cold acclimation (4°C) (34). After 4 weeks of cold acclimation BAT mass was 
increased, but muscle mass was decreased by comparison with controls. Cold 
acclimation led to an increase in the resting metabolic rate, and enhanced the response 
to injected NE. Combined, these results indicate reduced reliance in shivering, in 
favour of non-shivering thermogenic mechanisms. Cytochrome oxidase activity of all 
tissues was elevated following cold acclimation, however BAT alone could not 
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account for the total increase in metabolic rate. It was calculated that the oxidative 
capacity of cold adapted muscle exceeded shivering thermogenesis, therefore an 
energy-consuming pathway other than shivering had been activated in muscle (34). 
This data supports the idea that muscle non-shivering thermogenic mechanisms may 
also be up-regulated in response to cold-adaptation. 
In the partly isolated curarized leg muscles of the cold acclimated rat, skeletal 
muscle metabolic rate (A-V oxygen extraction) was shown to increase to a similar 
extent in response to cold and norepinephrine infusion (172). These changes in leg 
oxygen consumption after cold and norepinephrine infusion (132% & 134%) almost 
equaled the whole body oxygen response (126% & 126%). It was suggested that 
skeletal muscle might account for a large fraction of the total increase in metabolic 
response to cold. Measurements of cytochrome oxidase activity in skeletal muscle 
combined with blood flow figures led Jansk (168) to the conclusion that skeletal 
muscle may account for up to 57% of NST in cold acclimated rats. It is however 
stressed that the metabolic capacity of skeletal muscle is not large enough to account 
for all heat production by both shivering and non-shivering thermogenic mechanisms. 
Thus, NST is probably the combined result of increased metabolism is several tissues. 
In the absence of BAT, skeletal muscle may assume a more significant role in 
non-shivering heat production. A comparison of the oxidative capacity of tissues 
from species with and without BAT (rat versus duckling) appears to support this. In 
cold acclimated rats, gastrocnemius muscle showed a decrease of 22%, while BAT 
showed an increase of 544% in oxidative capacity. In contrast, muscles from the cold 
acclimated duckling, gastrocnemius & pectoralis showed remarkable increases in their 
oxidative capacities (33% & 195% respectively) (19). Furthermore, evidence for' 
cold, and norepinephrine induced NST has been obtained in the Australian marsupial 
Bettongia gaiinaridii, a species devoid of brown adipose tissue. Cold acclimation (4- 
5°C for 2 weeks) increased resting oxygen consumption by 15%, while the response 
to norepinephrine was enhanced by cold adaptation (255). 
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Catecholamine induced NST has also been demonstrated in humans, where 
BAT is thought to be restricted to small, scattered deposits. In a study by Astrup, 
Billow, et al. (12) the thermogenic effects of ephedrine were examined in humans. A 
minor increase in pen-renal BAT blood flow and temperature was noted in response 
to ephedrine, however these effects were trivial when compared with the 60% 
increase in leg oxygen extraction. Extrapolation led to the conclusion that whole 
body skeletal muscle may account for up to 50% of the ephedrine induced oxygen 
uptake in humans, while the contribution of BAT was negligible (12). Similarly, 
Simonsen, Stallknecht, et al. (279) estimate that in humans 40% of the thermogenic 
epinephrine response is localized to skeletal muscle, while another 5% is attributed to 
white adipose tissue. Some evidence of cold-adaptation has also been found in 
humans, since the epinephrine response appears to be potentiated in cold-acclimated 
subjects [polar swimmers] (188). There is also some evidence to suggest that skeletal 
muscle may also participate in carbohydrate induced thermogenesis in humans (10; 
11). 
NST is probably the combined result of increased metabolism in a variety of 
tissues, with BAT and skeletal muscle as the primary contributors. However, skeletal 
muscle may assume a more significant role in the absence of BAT. By virtue of its 
large mass [up to 38% of the total human body mass (174), and 48% of rat body mass 
(172)] muscle has great potential as a source of non-shivering heat in species with and 
without brown adipose tissue. While the biochemical mechanism of NST in BAT is 
relatively well known, it is not clear if the same mechanism operates in skeletal 
muscle. 
1.2.2 Mechanisms of non-shivering thermo genesis 
The biochemical mechanism of NST in BAT is well documented (43; 190; 
222), and is addressed only briefly here. Mitochondria of BAT are specialized to 
allow uncoupled respiration, whereby substrate oxidation occurs independently of 
ATP production. Respiration is uncoupled when the potential energy found in the 
proton gradient across the inner mitochondrial membrane is dissipated ("wasted") in 
the form of heat. Protons leak across the inner membrane back into the mitochondrial 
matrix, by-passing the FLED ATP-synthase (222). Proton leak leads to a dramatic 
increase in cellular respiration rate, most likely fuelled by the large multilocular lipid 
deposits found in BAT. BAT thermogenesis is under tight sympathetic control, and 
may be pharmacologically activated by the application of [33-adrenergic agonists and 
norepinephrine (222). 
The discovery in the 1970s of an uncoupling protein in mitochondria of brown 
adipocytes [later named UCP-1, reviewed in (223)] enabled researchers to examine 
more closely the role of brown adipose tissue in energy expenditure and heat 
production. The protein was shown to be located exclusively on mitochondria of 
brown adipocytes. Uncoupling activity of the protein was stimulated by 
norepinephrine and free fatty acids (205), while purine nucleotides [especially GDP] 
inhibited UCP-1 activity (212). The uncoupling capacity of UCP-1 is widely 
acknowledged, but the precise mechanism of ion transport is unknown, though several 
theories exist [for reviews see (41; 186; 218)]. Consistent with previous suggestion, 
mouse brown adipose UCP-1 mRNA levels were shown to increase during cold 
exposure and overeating, while fasting and obesity were associated with decreased 
UCP-1 expression (216). The advent of transgenic technology allowed the creation of 
mice over-expressing UCP-1, and as expected UCP-1 over-expression led to reduced 
adiposity despite hyperphagia in both genetic (185) and dietary (184) models of 
obesity. Based upon these findings, it was predicted that UCP-1 knockout mice 
would be cold sensitive, obese and diabetic at an early age. 
UCP-1 ablated mice displayed a number of characteristics confirming 
successful removal of UCP-1 from the genotype. Firstly, no UCP-1 could be detected 
in the brown adipocytes with polyclonal antibodies (107). Secondly, mitochondria of 
UCP-1 ablated mice did not possess GDP binding sites (206), nor did GDP have any 
effect on UCP-1 deficient cells (212). Interestingly, the resting metabolic rate was 
identical in knockout and wild type brown adipocytes, as were the rates of 
norepinephrine-induced cAMP accumulation and lipolysis, though the metabolic 
response to norepinephrine was greatly reduced [only 3% of control (205)]. The 
response to the 13 3-adrenergic agonist CL 316,243 was also abnormally low (107). 
Knockout cells were shown to be in a more "energized" state, indicating greater 
metabolic efficiency brought about by enhanced coupling efficiency (206). 
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Alterations in UCP-2 and UCP-3 [UCP-1 homologues] expression were detected in 
BAT, though no inherent uncoupling was associated with either of these proteins 
(218). Curiously, mitochondria from UCP-1 ablated were equally as sensitive to the 
uncoupling effect of free fatty acids as wild type mitochondria, leading the authors the 
conclusion that free fatty acid stimulated uncoupling was not entirely UCP-1 
dependent (206). It was speculated that the residual GDP-insensitive, free fatty acid 
stimulated proton leak was an intrinsic property of lipids in the mitochondrial 
membrane. This basal proton leak has since been described in a variety of other cell 
types that do not express UCP-1 (286). 
Creation of the UCP-1 knockout mouse had been a success, but it was quite 
unexpected that knockout mice maintained a lean phenotype on both standard and 
high fat diets (107). The importance of UCP-1 in energy expenditure had apparently 
been overestimated, and it was hypothesized that "other" compensatory thermogenic 
mechanisms had been activated. These compensatory mechanisms did not however, 
protect animals during cold exposure, as UCP-1 ablated mice presented with a cold-
sensitive phenotype (107). 
Generally it is accepted that UCP-1 deficient mice are cold sensitive, however 
exceptions have been noted. Comparative studies of UCP-1 deficient mice from 
different genetic backgrounds [F1 hybrids and congenic C57BL/6J and 129/SvImJ 
mice] highlight an important issue. Hofmann, Loiselle, et al. (154) found that only 
the congenic animals were cold sensitive, while the hybrids were cold resistant. It 
was proposed that the hybrids were able to tolerate cold due some compensatory 
mechanism enabled by heterosis. Thus, the absence of UCP-1 alone does not 
necessarily dictate a cold sensitive phenotype, and the genetic background of the 
animals must be stated specifically in these types of studies. 
A study by Golozoubova et al. (123), demonstrates that following acclimation 
[3 weeks at 18°C] UCP-1 deficient mice could withstand cold exposure. Upon 
exposure to 4°C, the pre-acclimated UCP-1 knockout mice maintained the same basal 
body temperatures as wild-type controls, while producing heat at four times the 
resting rate. Measurements of muscular shivering intensity indicate that wild-type 
7 
controls gradually replaced shivering with non-shivering thermogenic mechanisms 
according to conventional understanding, however the UCP-1 ablated animals were 
still heavily dependent on shivering thermogenesis even after several weeks at 4°C. 
Curiously, the response to injected norepinephrine and epinephrine was greatly 
diminished in knockout mice when compared to wild-type controls. It was concluded 
by the authors that no form of non-shivering thermogenesis other than UCP-1 
dependent mechanisms (including adrenergically induced thermogenesis) were 
recruitable in UCP-1 knockout mice (41; 123). These findings do not however rule 
out entirely a potential role for skeletal muscle in thermoregulatory NST in UCP-1 
ablated mice. It may have been useful to examine the effects of curare in these UCP-
1 ablated mice, since it is still possible that shivering and non-shivering 
thermogenesis may occur simultaneously in skeletal muscle upon cold exposure. The 
possibility must also be considered that the physical act of shivering increases tissue 
blood flow, stimulating additional mechanisms of non-shivering thermogenesis in 
muscle which are effectively masked by shivering. The effects of blood flow on 
tissue metabolic rate will be discussed further. 
Based upon the findings of Enerback et al. (107) that UCP-1 deficient mice 
were cold sensitive but not obese, it was hypothesized that adaptive thermogenesis in 
other tissues might compensate for the loss of UCP-1. Skeletal muscle has long been 
considered a candidate, owing to the large mass as a proportion of total body weight. 
Though unlikely that skeletal muscle alone can compensate fully for the loss of UCP-
1 during cold exposure, non-shivering thermogenesis in skeletal muscle may still 
contribute to energy balance and maintenance of body weight at thermoneutrality. In 
a study by Monemdjou, Hofmann, et al. (211), basal 'proton leak was compared in 
muscles from control and UCP-1 deficient mice. Indeed, the residual rate of GDP-
insensitive proton leak was shown to be greater in muscles of UCP-1 deficient 
animals than in wild type controls. Thus, in the absence of UCP-1, other thermogenic 
mechanisms in skeletal muscle may be activated, perhaps assuming a more important 
role in whole body metabolic regulation. 
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1.2.3 Skeletal Muscle NST is not UCP-1 dependent 
Uncoupled respiration via UCP-1 expression is an effective means of 
increasing heat production and dissipation of excess calories in BAT, however UCP-1 
expression is restricted to brown adipose tissue (205). How then does skeletal muscle 
produce heat? Cold induced NST has been noted previously in bettongs, though 
UCP-1 expression was not detected before or after cold acclimation (256). The 
source and mechanism of vasoconstrictor-mediated thermogenesis in the perfused 
bettong hindlimb was the subject of investigation by Ye, Edwards et al. (311). 
Vasoconstrictors, norepinephrine and vasopressin induced significantly elevated rates 
of oxygen consumption (V02), lactate and glycerol efflux, concomitant with elevated 
perfusion pressures. These metabolic effects were rapidly reversed by the addition of 
the vasodilator nitroprusside. Since the bulk of the hindlimb mass is skeletal muscle 
and the development of pressure was critical to the thermogenic effect, it was 
proposed that skeletal muscle thermogenesis may be under vascular control (312). 
Similarly, vasoconstrictor-mediated thermogenesis was observed in the perfused 
hindquarter of the rat (59; 79), a region predominantly composed of skeletal muscle. 
Thus, vasoconstrictor mediated thermogenesis is observed in skeletal muscle of 
species with and without BAT. 
Measurement of electrical activity in the pectoral muscles of cold exposed 
pigeons [1°C for several weeks] suggests that birds depend largely on shivering 
thermogenesis for thermoregulation (157): However, there is evidence that birds may 
also utilize non-shivering thermogenesis of muscular origin (21). Histological studies 
of avian tissue failed to detect BAT (21), or UCP-1 (260) despite the presence of 
mutilocular adipocytes resembling brown adipose deposits (21; 259). More recent 
studies describe the discovery of an UCP homolog in hummingbird muscle 
[HmUCP], however uncoupling activity of novel protein has so far only been 
demonstrated in yeast (297). Barre et al. (21) were able to demonstrate NST in 
muscovy ducklings [cold acclimated for 5 weeks], where heat production was 
increased without muscular shivering. The effects of cold acclimation were mimicked 
by twice daily glucagon injections at thermoneutrality (20), while increasing rates of 
oxygen consumption (99). The conclusion of these experiments was that NST did 
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occur in birds, and may be triggered by cold exposure or artificially stimulated by 
hormones at thermoneutrality. 
By monitoring changes in blood flow during cold acclimation and glucagon 
treatment, Duchamp & Barre (98) determined that a major proportion of avian NST 
occurred in skeletal muscle. Though the cellular mechanism of avian NST is likely to 
differ from mammalian NST [catecholamines do not have the same stimulatory effect 
in birds as in mammals (22; 150)], the effect of increased blood flow on skeletal 
muscle thermogenesis aroused interest. It was later demonstrated in the perfused 
chicken hindlimb, that vasoconstrictors norepinephrine and epinephrine also 
stimulated resting muscle thermogenesis (106), and that these effects were abolished 
by the vasodilator nitroprusside. It was concluded that vasoconstrictor-stimulated 
metabolism existed in birds as in marsupials and mammals, and that vascular control 
of skeletal muscle thermogenesis may be a widespread biological phenomenon. 
Skeletal muscle is known to be metabolically responsive to a number of 
treatments. Skeletal muscle metabolic rate is acutely stimulated by adrenergic agonist 
infusion [in rats(172), dogs (263) and humans (13; 199; 279)], membrane labilizers 
veratridine (291), and monensin (unpublished observations from this lab), and hyper-
osmotic media (49; 85). Exogenously applied thyroid hormone has also been shown 
to stimulate skeletal muscle metabolism (26; 88; 278; 294). It is not known if one 
single biochemical mechanism accounts for increased metabolism by all of these 
treatments, however it is clear that skeletal muscle thermogenesis is not dependent on 
UCP-1 expression. Alternative mechanisms are discussed, with particular reference 
to the regulatory influence of vasoconstrictors on perfused rat hindlimb metabolism. 
1.3 Modulation of perfused muscle metabolism by vasoconstrictors 
1.3.1 Type A vasoconstrictors stimulate skeletal muscle thermogenesis 
Previous reports from this laboratory (79), and others (83; 132; 207; 248) have 
detailed the stimulatory effects of catecholamines and other vasoconstrictors on 
perfused rat hindlimb metabolism. The stimulatory (Type A) vasoconstrictors include 
low dose norepinephrine (<11.1M), epinephrine, norephedrine, phenylephrine, 
methoxamine, amidephrine, angiotensin II, vasopressin, vanilloids (low dose 
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capsaicin, gingerol, shogoal), and low frequency electrical stimulation of the 
sympathetic trunk (0.5-4.0 Hz) [reviewed in (59)]. 
Treatment of the perfused hindlimb with type A vasoconstrictors, leads to 
increased perfusion pressure (PP), and an increase in the rate of oxygen extraction 
(902) (79). Total flow to the hindlimb is constant, but oxygen extraction remains 
elevated for the duration of treatment. Concomitant with increased oxygen extraction, 
efflux rates of lactate (144), glycerol (58), uracil, and uric acid (63; 241) are all 
significantly elevated above basal. Comparison of high-energy phosphate content of 
freeze-clamped muscles collected in vivo, and after prolonged (3 hour) hindlimb 
perfusion with vasopressin, revealed no differences in cellular energy status (78). 
Therefore stimulation of perfused hindlimb metabolism by type A vasoconstrictors 
does not compromise muscle energy status, in fact there is some evidence to suggest 
that type A vasoconstrictors (angiotensin II) may improve cellular PCr/ATP ratios 
[shown in Figure 1 Appendix, data from (300)]. In addition to the observed metabolic 
effects, type A vasoconstriction was shown to markedly " enhance aerobic muscle 
contractility in the blood-perfused hindlimb. Angiotensin II caused an 80% 
improvement in aerobic tetanic tension development, and enhanced contraction-
induced oxygen uptake during sciatic nerve stimulation of the calf muscle group 
(gastrocnemius-soleus-plantaris). Curiously, angiotensin II had no effect on tension 
development during anaerobic contraction (237). Findings from these experiments 
led to the combined conclusion that type A vasoconstrictors had a potent regulatory 
effect on aerobic muscle metabolism, and contractility. 
1.3.2 Type B vasoconstrictors inhibit skeletal muscle metabolism 
In the early 90s, routine testing of different vasoconstrictors in the perfused 
hindlimb led to the surprise finding that serotonin caused a decrease in metabolic rate 
(94). High doses of norepinephrine (>1[1,M), capsaicin (>11_1M), and high frequency 
electrical stimulation of the sympathetic trunk (5-10 Hz) were found to have similar 
effects [reviewed in (59)]. Ascribed the title type B, the metabolic properties of type 
B vasoconstrictors were outlined as follows. 902 was suppressed below the basal 
level (94), along with efflux rates of glycerol, uracil, uric acid (59) and lactate efflux 
(311). Interestingly, insulin-mediated glucose uptake, and 2-deoxyglucose uptake by 
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the perfused rat hindlimb were both significantly blunted by serotonin infusion (235). 
In addition to the inhibitory metabolic effects, serotonin was also shown to decrease 
aerobic (tetanic) contraction-induced tension and oxygen uptake in sciatic nerve 
stimulated perfused muscle (95). While vasoconstriction is a feature common to both 
type A and B vasoconstrictors, the metabolic effects are virtual opposites. 
1.3.3 Vascular delivery is essential for the effects of type A and B vasoconstrictors 
The inclusion of vasodilators nitroprusside, nifedipine, or isoprenaline 
completely abolished the pressor effects of type A vasoconstrictors in the perfused 
hindlimb, along with the changes in V0 2 (78; 79), and lactate efflux (145). 
Furthermore, the inhibitory effects of serotonin on hindlimb V0 2 , and insulin-
mediated glucose uptake were partially reversed by the inclusion the vasodilator 
carbachol (235). Thus development of pressure is essential for the effects of both 
type A and B vasoconstrictors. In addition to this, type A vasoconstrictors do not 
have the same thermogenic effects when applied to isolated incubated muscle 
preparations (69; 104; 139; 145). Similarly, the inhibitory effects of serotonin on 
insulin mediated glucose uptake (235), and muscle contractility (95) observed during 
perfusion, were notably absent in isolated incubated rat soleus, and extensor 
digitorum longus muscles. 
Dubois-Ferriere & Chinet (97) made a direct comparison between the 
thermogenic effects of norepinephrine (NE, 10 -6M) in perifused mouse soleii (from 
cold adapted animals with varied thyroid status), and in the perfused rat hindlimb. 
Perifused muscles showed only a transitory stimulation of thermogenesis with NE, not 
exceeding more than 5% of the basal rate. In contrast, the effects of NE in perfused 
muscle were far more pronounced. It was concluded that NE did not have any direct 
thermogenic effects upon the muscle, but the indirect haemodynamic effects (only 
apparent during perfusion) may be important in regulating metabolic rate. It was 
suggested that NE may participate in the removal of hypoxic or acidotic restriction on 
metabolism (97). Thus delivery of the vasoconstrictor via the vascular route, and the 
development of perfusion pressure is essential to the respective metabolic effects of 
type A and B vasoconstrictors. 
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1.3.3.1 Hot pipes- an unlikely theory 
The interdependence between vasoconstriction and oxygen consumption led to 
the development of the "hot pipes" theory, where the stimulated rate of oxygen 
consumption was attributed to work performed by vascular smooth muscle as it 
constricted (57; 77). However, this was difficult to reconcile with the serotonin 
effect, where vasoconstriction was associated with inhibition of hindlimb metabolism. 
Dora et al. (96) highlight key differences between type A and B vasoconstrictors. The 
effects of oxygen availability on vasoconstriction were investigated by perfusing 
under conditions of hypoxia, or in the presence of cyanide or azide. While type B 
vasoconstriction (serotonin) was unaffected by these treatments, type A 
vasoconstriction (low dose NE) was completely abolished by hypoxia, cyanide, and 
azide addition. Type B vasoconstriction induced by high dose NE responded 
similarly to serotonin, showing no signs of oxygen dependence. It was concluded that 
vasoconstriction induced by type A was biochemically distinguishable from type B 
vasoconstriction, and most likely reflected different sites of vasoconstriction on the 
vascular tree. 
Further evidence against the hot-pipes theory comes from later findings in the 
dual perfused hindlimb of the small rat, where high membrane stabilizing doses 
(100uM) of the 13-adrenergic blocker propranolol blocked the oxygen uptake effect 
without interfering with vasoconstriction (292). Although vascular delivery and 
vasoconstriction appear to be essential pre-cursors, increased oxygen uptake with 
type-A vasoconstrictors could not be wholly attributed to work performed by vascular 
smooth muscle during constriction (59). The idea once touted by this laboratory that 
vasoconstrictor mediated thermogenesis derived from vascular tissue is now 
considered unlikely. 
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1.3.4 Skeletal muscle has two vascular pathways 
Investigation of V02 in the perfused dog hindlimb led Pappenheimer (229) to 
the observation that alterations in muscle blood flow (caused by either epinephrine, or 
stimulation of the vasoconstrictor nerves) resulted in distinct changes in arterio-
venous oxygen extraction. While epinephrine applied in small doses increased the 
rate of oxygen extraction, stimulation of the vasoconstrictor nerve decreased V02. It 
was suggested that nerve stimulation caused diversion of blood flow away from the 
capillary beds, through regions of low metabolic activity. This theory was supported 
by the observation that the arterio-venous loss of heat was greater following 
epinephrine application than nerve stimulation, implying that during nerve stimulation 
blood flow was shunted through a faster transit route, with a smaller surface area, and 
less heat loss. Similar results were noted by Grieb et al. (129), with the use of 
isotopic oxygen and chromium in the perfused dog hindlinib. Both fast and slow 
blood flow channels were identified. It was noted that the fast channel (so called 
"shunt") had a short transit time, with minimal nutrient exchange. The slow channel 
("sink") had a much longer transit time (thought to be due to the trapping of red blood 
cells in the capillaries), with a much greater rate of nutrient extraction. These results 
imply the existence of two vascular pathways through skeletal muscle, with different 
transit times, and differential rates of nutrient exchange. 
Injection of 24Na+ into various sites on the cat sartorius muscle, allowed 
Barlow et al. (15) to characterize differential clearance rates, dependent upon the site 
of injection. The fastest clearing regions were closely associated with muscle fibers 
(the regions of high nutritive exchange), while the slowest clearing regions were 
localized to the intermuscular septa, and tendons. The metabolic activity of this 
region was quite low, with little nutrient exchange (15). Clearance experiments with 
radioactive ions 131 1 (16), and 42K+ (239), and other diffusible substances antipyrine, 
urea and sucrose (239; 240) confirmed these findings. 
In a study of the rabbit tenuissimus muscle, Lindbom & Arfors (191) noted 
that the main feed arterioles (transverse arterioles) supplied two distinct vascular areas 
in parallel, the muscle capillaries (terminal arterioles), and the adjacent connective 
tissues. Application of various adrenergic agonists affected the fractional distribution 
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of microvascular flow between the muscle proper, and the connective tissue (30). 
Characterization of these two distinct vascular areas provides an explanation for the 
previously observed differences in muscle oxygen extraction, transit times, and 
clearance rates. The terms "nutritive and non-nutritive" blood flow were coined to 
describe these two vascular pathways (59). 
1.3.5 Type A and B vasoconstrictors redistribute between the two vascular pathways 
The effects of type A and B vasoconstrictors may also be explained in terms of 
nutritive and non-nutritive flow. Sites of type A and B vasoconstriction are 
biochemically distinguishable (96), with the serotonin vasoconstrictor sites located on 
large vessels (158; 187), and adrenergic vasoconstrictor sites restricted to smaller 
vessels (149). It has been proposed that type A vasoconstrictors enable capillary 
recruitment (and thus greater nutrient exchange) by constricting at particular sites on 
the vasculature. A paper from Lindbom & Arfors (192) suggests that the presence of 
yield shear stress within the capillaries must be overcome by perfusion pressure, 
before flow can occur. Therefore the number of capillaries perfused is a function of 
the pressure gradient over the capillary bed (192). Type A vasoconstrictors appear to 
provide the necessary pressure gradient. Conversely, Type B vasoconstrictors appear 
to cause shunting of blood flow via the non-nutritive pathway, thereby restricting 
access of oxygen and nutrients to the muscle fibers. It is therefore conceivable that 
site-specific vasoconstriction is responsible for flow redistribution, exerting control 
over perfusate delivery, muscle metabolism and tension development. 
Physical evidence has been obtained in support of the view that type A and B 
vasoconstrictors affect distribution of flow between the two vascular pathways. 
Perfusion with cell free media enabled detection of trapped red cell washout post 
equilibration. Red cell efflux with type B vasoconstriction (serotonin) was not 
different from vehicle, but infusion of a type A vasoconstrictor (low dose NE) led to a 
marked increase in red cell efflux (219). Similarly, experiments with fluorescein-
labeled dextran demonstrate that low dose NE recruited a new vascular space, that 
was re-accessed only by a second exposure to the same vasoconstrictor. Furthermore, 
vascular corrosion-casting with a 30i.tm microsphere acrylate preparation provided a 
3D model of the arterial vasculature during control, type A, and type B 
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vasoconstriction (219). Low dose NE did not change cast weight when compared 
with control, but did increase the total number of small vessels filled. In contrast, 
type B (serotonin and high dose NE) decreased the number of vessels filled along 
with cast weight, apparently restricting flow to fewer vessels of the muscle bed. In 
separate experiments, the inclusion of fluorescent dextran in the perfusion medium 
allowed visualization of tendon vessels thought to carry the flow diverted from the 
muscle bed during type B vasoconstriction. Positioning of a surface fluorimetry 
probe over the exposed tibial tendon of the perfused limb confirmed an increased 
fluorescence signal during serotonin infusion (220). Conversely, low dose NE 
decreased the tendon signal. The tendon vessels are thought to provide the physical 
basis for at least part of the "functional shunt". However, microsphere embolism 
studies demonstrate that only some of the non-nutritive (shunt) vessels are found in 
the tendon regions, while the remainder are homogeneously distributed throughout the 
muscle (301). 
The enzyme xanthine oxidase (located on capillary endothelial cells) converts 
the substrate 1-methylxanthine (1-MX) to 1-methylurate (1-MU) (175; 230). 
Inclusion of 1-MX in perfusion media and measurement of 1-MU production enables 
the extent of capillary endothelial exposure to be monitored. Serotonin was shown to 
decrease 1-MX metabolism below basal (234). Since no changes were detected in 
xanthine oxidase activity or flow to individual muscles (61), it was concluded that 
serotonin had decreased access to capillary xanthine oxidase by shunting flow through 
the non-nutritive vessels, effectively reducing the available capillary surface area. 
The next logical prediction, was that type A vasoconstrictors would enhance 1-MX 
metabolism via capillary recruitment. However, this was not the case, as type A did 
not substantially increase the rate of 1-MX conversion above basal. It was later 
speculated that release of endogenous metabolites (xanthine and hypoxanthine) during 
type A vasoconstriction may competitively inhibit 1-MX metabolism by the enzyme. 
Exercise-induced capillary recruitment (during sciatic nerve stimulation of the blood 
perfused constant flow rat hindlimb) did however successfully demonstrate a positive 
correlation between capillary surface area, and 1-MX metabolism (317). 
Further evidence for this compartmentalized model comes from laser Doppler 
(LDF) monitoring of red cell flux in the blood perfused hindlimb with the use of 
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implantable microprobes (55). Randomly impaled micro-probes (2601.IM diameter 
impaled — 90 times across four muscles of the perfused limb) identified heterogeneous 
sites of microvascular perfusion, with varied responses to infused vasoconstrictors. In 
the majority of sites (56.7%), LDF signal was increased by NE, and decreased by 
serotonin (identified as nutritive sites). However, some of the sites (16.5%) gave a 
decreased LDF signal with NE infusion, and a greater signal with serotonin (non-
nutritive sites). The remaining sites (24.7%) showed no net response to either 
vasoconstrictor (mixed site). This data provides direct evidence for the existence of 
discrete regions of nutritive and non-nutritive flow within the perfused muscle, and 
redistribution of flow between these two regions under the influence of type A and B 
vasoconstrictors. More recently, the effects of type A and B vasoconstrictors on 
nutritive and non-nutritive flow were demonstrated by monitoring the microdialysis 
out to in ratios for 14C-ethanol and 3 H20 during varied flow rate (221). The out to in 
ratio was decreased as a function of flow rate, however type A (NE) further decreased 
this ratio, while type B (serotonin) impeded the decrease at each flow rate (Appendix, 
Figure 2). Thus, type A vasoconstrictors augment capillary access, while type B 
vasoconstrictors decrease the extent of capillary perfusion. 
Taken together, these findings provide evidence for dual circuitry of perfused 
muscle, and vascular recruitment/derecruitment by type A and B vasoconstrictors 
respectively (60; 62). Following cannulation and equilibration, the perfused rat 
hindlimb appears to assume a dynamic position somewhere between nutritive and 
non-nutritive flow, which is fully dilated, yet regulatable by applied neural input or 
infused vasoconstrictors. 
1.3.6 Bloodflow regulation of skeletal muscle metabolism 
The relationship between perfusion flow rate and resting muscle V02 has been 
noted in many different preparations (55; 103; 133; 221; 228; 285; 305; 310). In 
addition to enhancing muscle V02, increased perfusion flow rate is also noted to 
improve cellular energy status (209). These observations imply that under resting 
conditions muscle metabolism is limited. Though total flow is sufficient for the entire 
mass of perfused muscle, heterogeneous blood flow distribution may restrict blood 
flow at the microvascular level (48; 97). Data from our own laboratory supports the 
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view that resting muscle blood flow is heterogeneous (61; 219). Increased flow rates 
may stimulate muscle V02 simply by removing the physiological hypoxia imposed by 
heterogeneous flow (167), thereby removing the micro-scale heterogeneity in 02 and 
substrate supply (48). Conceivably, type A vasoconstrictors may also participate in 
the removal of flow heterogeneity via capillary recruitment. Though total flow 
remains constant, the fractional distribution is altered in favour of the nutritive 
capillaries, enhancing microvascular perfusion. 
The state of the microcirculation therefore has an important role in the 
regulation of resting muscle metabolic rate. Exercise is known to recruit a large 
number of capillaries (178) through vasodilation, increased cardiac output and cell to 
cell signalling (266). However the regulation of capillary density at rest is less clear. 
In resting muscle, capillary blood flow appears to be regulated by both active and 
passive factors (160). Interestingly, no pre-capillary sphincters have been reported in 
striated muscle (193), and control over capillary blood flow appears to be mediated by 
closure of the terminal arterioles (126). It is likely that vasoconstrictors exert control 
over capillary perfusion in the same way. 
The increase in V02 with type A vasoconstrictors, may be the result of 
increased tissue perfusion. Measurements of muscle oxygen extraction and blood 
flow in response to norepinephrine strongly support this idea (172). This point is also 
elegantly demonstrated in the human forearm (280), where adrenaline infused into the 
human forearm caused a significant increase in muscle blood flow and oxygen 
extraction. However, restriction of blood flow on the contra-lateral forearm (by 
external compression of the brachial artery) severely blunted the response to 
adrenaline (280). These findings support the hypothesis that the vascular system 
plays a key role in the thermogenic effects. of catecholamines in skeletal muscle. 
Alterations in blood flow distribution, whether through changes in fractional 
distribution or bulk flow, therefore have an important role in the regulation of skeletal 
muscle metabolism. 
The effects of type A and B vasoconstrictors are typically described as either 
stimulatory or inhibitory on metabolism, and this may be the result of simple changes 
in perfusate delivery. While the metabolic effects are apparent opposites, an 
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interesting aside is now touched upon. Infusion of type B vasoconstrictors is 
associated with increased perfusion pressure, and depressed metabolism. However, 
upon removal of the vasoconstrictor, metabolism returns to basal values. This return 
has been questioned as a "stimulation" of metabolism, admittedly from a lower 
plateau. The question is now posed, is the stimulation of metabolism noted upon 
serotonin removal, due to the same mechanism as type A vasoconstriction? This 
question will be addressed in more detail later. 
1.3.7 Is vasoconstrictor-mediated metabolism the result of enhanced oxygen delivery? 
Increased flow rates have the net effect of increasing microvascular perfusion, 
and oxygen and substrate delivery. It is not clear if metabolism is stimulated in 
response to flow itself, or enhanced substrate delivery. Perfused liver metabolism is 
generally unresponsive to catecholamines (perhaps due to a reduced capacity for 
capillary recruitment), though elevated arterial oxygen and substrate deliveries (13- 
hydroxybutyrate and acetate) are effective stimulants of liver metabolism (169). 
Similarly, catecholamine effects were severely reduced in perifused mouse soleii, 
though an increase in muscle metabolism was noted in response to increased substrate 
delivery (acetate and octanoate) (97). Thus, increased oxygen/substrate delivery as a 
consequence of increased flow, or vasoconstrictor-mediated capillary recruitment may 
well exert a significant effect on muscle metabolic rate. 
A considerable body of evidence suggests that muscle oxygen uptake is 
dictated directly by oxygen delivery. By varying the haematocrit of the perfusing 
blood (at constant-flow), researchers were able to demonstrate delivery dependent 
V02  in dog gracilis muscle, but only below the value of 0.45 ml/min per 100g 
perfused muscle (181). Above critical values, oxygen uptake (V02) is delivery 
independent (2; 183). VO2mAx is thought to be oxygen limited not only under basal 
conditions (181; 262), but also during exercise (156; 161; 165; 166; 244; 246). The 
idea that vasoconstrictors might influence skeletal muscle metabolic rate by altering 
oxygen delivery raises some interesting issues. 
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Oxygen conformance has been defined as cellular suppression of metabolism 
in response to decreased P0 2 , without loss of cellular viability or activation of 
anaerobic energy supply pathways (153). In turtles, and brine shrimp the unique 
ability to withstand prolonged anoxia is attributed to a combination of events leading 
to stabilization of the plasma membrane, accompanied by metabolic suppression of up 
to 90% (151). Experimentally, hypoxic bouts have been shown to induce decreased 
rates of ion flux, decrease membrane permeability, and suppress sodium pump 
activity (90), in addition to decreasing urea synthesis and gluconeogenesis (38; 38). 
Membrane potential is maintained near normoxic levels despite these changes (93) 
and ATP levels are not depleted. By decreasing ion flux, the requirement for ATP-
dependent ion pumping is minimized, thus providing the basis for energy 
conservation during anoxia. The phenomena of anoxic "channel arrest" has been 
reported by many groups (38; 90; 91; 93; 151; 232). 
The only endothermic systems currently known to utilize channel arrest and 
metabolic arrest for extending hypoxia tolerance are hypo-perfused hypometabolic 
tissues and organs of diving animals (151). Perfused skeletal muscle may qualify as 
such a tissue, owing to heterogeneity of blood flow and micro-vascular perfusion 
under basal conditions. Type B vasoconstrictors decrease resting muscle metabolic 
rate by reducing the extent of nutritive perfusion, however, even after prolonged 
periods, muscle energy charge is not different from basal (300). This suggests that 
during oxygen limitation/ischemia, skeletal muscle also has the capacity to decrease 
ATP utilizing processes. 
Oxygen conformance has been described in a variety of mammalian cell types 
including cultured mouse C2C12 cells (8), primary cultures of rat hepatocytes (264), 
chick and neonatal rat cardiomyocytes (39; 44) and canine skeletal muscle (155). The 
major energy-consuming processes in mammalian cells include ATP dependent ion 
pumping, protein synthesis, mitochondrial proton leak, and gluconeogenesis, with 
minor contributions from urea synthesis, RNA/DNA turnover, and substrate cycling 
(254). It has been suggested that some, or all of these processes may be preferentially 
down-regulated during low oxygen limited conditions. 
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Assuming that under basal conditions, perfused skeletal muscle metabolic rate 
is oxygen limited owing to heterogeneous perfusion, then type A vasoconstrictors 
may conceivably relieve this limitation by enhancing microvascular perfusion. The 
resulting increase in V02 may be a reflection of the return from limited to non-limited 
metabolism. The observation that PCr and ATP content of perfused muscle samples 
are improved by type A vasoconstrictors (300) would appear to support this line of 
reasoning. If low oxygen delivery causes membrane stabilization and "channel 
arrest", then one must consider the possibility that increased oxygen delivery might 
increase membrane permeability. Hulbert & Else (164) present the view that the 
relative leakiness of the plasma membrane is a significant determinant of cellular 
metabolic rate. Thus, increased metabolism observed during type A vasoconstrictor 
infusion may the combined result of enhanced tissue perfusion, increased oxygen 
delivery and increased membrane permeability. This might explain the sensitivity of 
type A vasoconstrictors to membrane stabilizers (292), and low sodium media (291). 
1.3.8 Do type A vasoconstrictors activate cellular thermogenesis in addition to 
redistribution °Blow? 
The possibility that vasoconstrictors may influence metabolic rate through 
alterations in oxygen delivery is enticing. However, an alternative possibility must 
also be considered. Previous publications focus on the theory that cellular 
thermogenic mechanisms are activated in addition to vasoconstrictor-mediated 
redistribution of flow (291; 292). This idea is now investigated in more detail, with 
discussion of potential thermogenic mechanisms available in skeletal muscle that may 
be recruited during vasoconstrictor-mediated thermogenesis. 
1.3.9 Evidence of cellular thermogenesis 
In the examination of potential adrenergic-receptor involvement during type A 
vasoconstrictor-mediated thermogenesis, several different a- and 13-antagonists were 
trialled in the constant-pressure perfused rat hindlimb. A strong a-adrenergic 
component of type A mediated metabolism was demonstrated (309), though doses of 
propranolol sufficient to block (31 and I31-adrenergic receptors (10p.M), did not have 
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significant inhibitory effects on type A mediated metabolism (79). Quite by chance, it 
was noted that higher doses of propranolol (>50p,M), had significant inhibitory effects 
on type A vasoconstrictor mediated metabolism (292). Further investigation revealed 
that unlike other n-blockers, propranolol at this dose had membrane-stabilizing 
properties. Norepinephrine stimulated metabolism was blocked by both (+) and (-) 
propranolol at 5011M, when only the (-) enantiomer is an active P-blocker. Further 
studies showed that other P-blockers nadolol and atenolol also at very high 
concentrations were ineffectual. It was concluded that the inhibitory effects of 
propranolol on type A vasoconstrictor-mediated metabolism were due to the inherent 
membrane stabilizing properties of the compound at this dose, and not blockade of 13- 
adrenoreceptors. This was confirmed by the finding that another membrane stabilizer 
quinidine, was also an effective inhibitor of type A vasoconstrictors in the perfused rat 
hindlimb (292). 
The inhibitory effects of propranolol on vasoconstrictor-mediated metabolism 
were particularly interesting, because perfusion pressure remained elevated while the 
metabolic effects (V02, lactate efflux and glycerol efflux) were abolished (292). Prior 
to this, inhibitors of vasoconstrictor-mediated metabolism had also abolished 
perfusion pressure (78; 310), leading to the assumption that elevated metabolism was 
entirely dependent on vasoconstriction and the subsequent redistribution of flow. 
This was the first demonstration that the vasoconstrictor and metabolic effects may be 
separated. Even though propranolol did not appear to interfere with type A mediated 
vasoconstriction, it was not clear if redistribution still occurred as per usual. 
Examination of red cell washout during angiotensin infusion demonstrates no 
differences in the pattern of red cell washout in the absence or presence of propranolol 
(292), even though angiotensin mediated metabolism was suppressed in the presence 
of propranolol. These data were interpreted as evidence of activation of a cellular 
thermogenic mechanism in addition to redistribution of flow. The identity of the 
thermogenic mechanism is not immediately apparent, though several candidates are 
now explored. 
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1.4. Thermogenic mechanisms in skeletal muscle 
1.4.1 Vasoconstrictor-recruitable thermogenesis 
The stimulation of oxygen consumption by type A vasoconstrictors is 
characterized by a number of features. For a putative mechanism to be considered as 
a likely candidate, it must comply with the known features of type A vasoconstrictors. 
First, type A-vasoconstrictor mediated thermogenesis is not dependent on muscular 
contraction, as NE has been shown to elicit thermogenic effect in rat muscles treated 
with curare (172). No change in force development is detected during type A 
vasoconstrictor-mediated metabolism in the perfused rat hindlimb, thus the 
mechanism will not rely on contractility. Second, vasoconstrictor-stimulation occurs 
rapidly, corresponding with onset of vasoconstriction (59; 79). Further, the 
mechanism is readily deactivated upon removal of the vasoconstrictor or upon 
application of vasodilators (78). The mechanism is also sensitive to low oxygen 
tension and inhibitors of the electron transport chain (96). Finally, the mechanism 
appears to be inhibited directly by low sodium media and membrane stabilizers (291; 
292). Thermogenic mechanisms available in skeletal muscle are now discussed, with 
particular reference to those that may be recruited during type A vasoconstrictor-
mediated metabolism. 
1.4.2 #3-Adrenergic receptors and thermogenesis 
The thermogenic effects of intravenous norepinephrine infusion in cold 
acclimated rats are mediated by a combination of a- and p-adrenergic effects (116). 
Findings in the constant pressure perfused rat hindlimb are partly consistent with this, 
since a- and 13- agonists (phenylephrine and isoproterenol) each induced increased 
rates of oxygen consumption (309), though the latter was quite small, and only 
evident under conditions of constant-flow. During type A norepinephrine-mediated 
metabolism, a significant a-adrenergic (prazosin-inhibitable) component has been 
demonstrated, consistent with the findings of Grubb & Folk (132), and auto-
radiographic studies in rat hindquarter showing the prevalence of the al-subtype 
adrenoreceptors distributed on the small arteries (203). However the identity of P-
receptor responsible for the much smaller increase in muscle oxygen consumption in 
• 
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the absence of vasoconstriction is less clear. The thermogenic effects of the P-agonist 
isoproterenol were not blocked by the 131-, 132-antagonist propranolol (309), nor did 
propranolol significantly inhibit the effects of vasopressin or angiotensin in perfusion 
(79). It has been proposed that a P-adrenergic receptor (other than 131 or 132) may be 
responsible for the thermogenic effects of P-agonists, and possibly type A 
vasoconstrictors in perfused muscle (309). 
The atypical-13, or 133 receptor has since been described in BAT and skeletal 
muscle of the rat (276) and in human adipose tissue (108), displaying resistance to 
the conventional P-blocker propranolol (4; 46; 47; 196; 276). The discovery that the 
methyl ester BRL-26830A bound specifically with the 13 3 receptor gave researchers a 
tool to pharmacologically manipulate this new 13-receptor. Indeed it was shown that 
BRL 35135A [and a variety of similar compounds BRL 26830, CL 316,242 and 
SB2265521 caused a modest increase basal rates of oxygen consumption (309) and 
glucose uptake in rat muscle (29; 196; 210). In an 8-week human trial, CL 316, 243 
was also noted to enhance insulin sensitivity, lipolysis and fat oxidation (304). Thus, 
BRL 35135A was shown to have potential anti-obesity and anti-diabetic applications 
(6; 46; 47). 
Studies in mature rats suggest that BAT contributes no more than 8% of the 
thermogenic effect of BRL 26830 treatment (7), therefore the thermogenic effects of 
133-agoninsts are due primarily to other tissues, skeletal muscle in particular (4; 5; 
290). Catecholamine activation of 133-receptors is thought to increase mobilization of 
fatty acids from triglyceride stores in brown and white adipose tissue, thereby 
increasing the rate of 13-oxidation of fatty acids. The mechanism of increased heat 
production with 133-stimulation is currently thought to involve uncoupling, however 
the existence of functional uncoupling proteins in skeletal muscle remains unresolved 
(discussed later). 
While BRL 35135A was shown to be thermogenic in the perfused rat 
hindlimb, these effects were small by comparison with type A vasoconstrictors [18% 
increase in V02 versus 30%], and may only be evident during constant pressure 
experiments. Secondly, BRL 35135A was not vasoactive. It therefore seems unlikely 
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that the mechanism of type A mediated metabolism is dependent on 33- 
adrenoreceptor activation. 
1.4.3 Uncoupled Respiration 
1.4.3.1 Proton Leakage 
Basal proton leakage has been identified in the mitochondria of many cell 
types including brain, liver, kidney, thymus and skeletal muscle (225; 251). 
Demonstrated in both isolated mitochondria, and intact cells, proton leak is not an 
artifact of isolation (225). The proton conductance pathway is unknown, though it is 
not attributed to UCP-1 (35; 37; 211; 212; 286), nor is it a simple biophysical leak of 
the mitochondrial membrane (35). Proton leak decreases the mitochondrial 
membrane potential, thereby forcing electron transport to work harder in order to 
counter the leak. For this reason, proton leak is thought to make a substantial 
contribution to basal oxygen consumption. In perfused skeletal muscle, proton leak 
has been estimated (with the use of oligomycin) to account for half (52%) of resting 
respiration rate (251). Combined with data from isolated rat hepatocytes, where 26% 
of basal oxygen consumption is attributed to proton leak (36), the potential 
contribution of proton leak to standard metabolic rate (SMR) in the rat is considerable 
[-18-22%, (251)]. 
These figures have been queried as overestimates, since resting tissue may 
have lower ATP requirements than in vivo. In the absence of ATP demand, proton 
leak will increase proportionally with increased proton motive force (251). Thus 
similar experiments were conducted under working conditions. Collaborative studies 
with Brand et al. demonstrate that the contribution of proton leak in perfused skeletal 
muscle during maximal tetanic contraction was in the vicinity of 34% (251). Proton 
leak in isolated rat hepatocytes supplied with substrates for ureagenesis and 
gluconeogenesis to increase the workload at was shown to account for 22% of the 
metabolic rate (252). Even under working conditions, the contribution of proton leak 
to SMR was still considerable [-15%,(251)]. 
These reduced values imply that proton leak becomes less significant during 
work. However, an alternative explanation is also worthy of mention. The perfused 
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hindlimb preparation may not be ideal for these types of experiments, due to 
inhomogeneous perfusion under basal conditions. These results hinge upon adequate 
delivery of oligomycin to all regions of the per-fused hindlimb, in order to block the 
F I FO-ATP synthase. Exercise (tetanic contraction) in the perfused rat hindlimb may 
lead to enhanced tissue perfusion, and better delivery of oligomycin. The apparently 
lower value for proton leak during exercise may therefore be a more accurate 
reflection of the true contribution to total hindlimb respiration. Nonetheless, the 
contribution of proton leak to standard metabolic rate is still considerable. 
Proton leak has also been studied under conditions of metabolic suppression. 
In muscles from the cold submerged frog during normoxia and anoxia, data was 
obtained to suggest that total proton leak was reduced during metabolic depression 
(284). However, this decrease was shown to be secondary to decreased flux through 
the electron transport train. Estivation in snails is another example of metabolic 
suppression (135). Evidence was obtained to suggest that remodelling of the 
mitochondrial membrane composition occurred in hepatopancreas on the estivating 
snail, allowing a co-ordinated, reversible suppression of mitochondrial membrane-
associated processes (287), possibly including proton leak. Thus, proton leak appears 
to become less significant during periods of metabolic stress (exercise, hypoxia, or 
metabolic suppression). 
If proton leakage is dependent on oxygen delivery in mammals as it appears to 
be in ectotherms, then vasoconstrictor-mediated thermogenesis in perfused skeletal 
muscle may be explained in the following terms. Micro-scale heterogeneity of blood 
flow under basal conditions may limit oxygen delivery and thus the rate of oxygen 
consumption. The coupling efficiency of oxygen consumption and ATP production 
might be expected to increase under these conditions, while the rate of uncoupled 
respiration (proton leak) is reduced to a minimum (122). This situation may be 
exaggerated during type B vasoconstrictor infusion, where muscle energy status 
begins to show signs of energetic stress [decreased PCr, Appendix Figure 1(300)]. 
However, during type A mediated vasoconstriction, enhanced tissue blood flow may 
facilitate oxygen delivery, relieving the limitation on muscle V02. The rate of proton 
leak may increase proportionally to the change in oxygen delivery, accounting for a 
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much larger proportion of the total respiration rate. Thus, vasoconstrictors may affect 
the rate of uncoupled respiration by changing microvascular oxygen delivery. 
1.4.3.2 UCP-I homologues in skeletal muscle 
The discovery of novel UCP's in tissues outside BAT raises the interesting 
possibility that uncoupled respiration in other tissues may contribute significantly to 
energy expenditure. While structurally similar [UCP-2, and UCP-3 show 55% and 
56% amino acid identity with UCP-1 respectively], the actual function of these UCP 
homologues is unclear. It is thought that UCP's modulate the respiration rate by 
altering the potential difference across the mitochondrial membrane, perhaps affecting 
the quantity of ATP produced by respiration (249). UCP-2 is expressed in most 
tissues (31; 115), while UCP-3 expression is restricted to BAT, and skeletal muscle, 
with small amounts in heart and white adipose tissue (33; 124; 298). The function of 
UCP-3 in skeletal muscle is of particular interest owing to the thermogenic potential 
of this tissue. Skeletal muscle UCP-3 is postulated to be involved in the regulation of 
energy expenditure (54), body weight (101), and thermoregulation. UCP-3 has also 
been implicated in regulation of fatty acid metabolism (261), adaptive responses to 
acute exercise (82) starvation (101; 261), and the prevention of free radical formation 
(299). 
Interestingly, tissue UCP expression levels have been noted to increase in 
response to 133-agonist treatment. Data have recently been obtained demonstrating 
increased UCP-3 levels in rat white adipose tissue (124), UCP-1, UCP-2 and UCP-3 
in rat BAT (316), and UCP mRNA levels skeletal muscle and adipose tissue of obese 
mice (214; 215; 315) undergoing I33-agonist treatment. Thus uncoupled respiration 
has been suggested as the mechanism accounting for the stimulatory effects of 133- 
agonists. 
Over-expression of murine, or human UCP-3 in yeast (124) or C2C12 
myoblasts respectively (32), demonstrates reduced mitochondrial membrane potential, 
thought to reflect the capacity for uncoupling by this protein. However, in a separate 
study by Harper et al. (142), where human UCP-3 was overexpressed in yeast 
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mitochondria, uncoupling was not stimulated by palmitate or superoxide, nor was it 
inhibited by GDP. It was concluded that uncoupled respiration observed in yeast 
overexpressing UCP-3 was entirely artifactual, and not attributable to UCP-3 
expression (142). Overexpression studies have not resolved this issue. 
Mitochondria from UCP-3 knockout mice have been shown to be more 
coupled than controls (125), with greater rates of free radical generation (299). 
Comparison with control mice, reveals normal body temperature and weight, normal 
responses to cold, fasting, stress, and thyroid hormone, with no compensatory 
increase in UCP-2 levels (125). The resting metabolic rate and respiratory ratio were 
shown to be the same in control and knockout mice, leading the authors to the 
conclusion that skeletal muscle UCP-3 is not a major determinant of metabolic rate. 
In contrast, a paper from Clapham et al. (54), suggests that skeletal muscle 
UCP-3 does indeed have the potential to influence whole body metabolism. The 
authors describe the effects of over-expressing human mitochondrial UCP-3 in a 
transgenic mouse line [66-fold increase in UCP-3 expression in the inner 
mitochondrial membrane]. The authors report a decreased mitochondrial membrane 
potential, supporting a role for UCP-3 in mitochondrial uncoupling. The mice were 
hyperphagic, but remained lean, with less adipose tissue than wild type controls, 
strongly implying the involvement of UCP-3 in whole body energy expenditure (54). 
It must be stressed that genetic manipulation may not give a true indication of the 
physiological function of these proteins in vivo. The effects of more physiological 
(diet, exercise and cold exposure) manipulations on UCP-3 expression are currently 
being investigated. 
Regulation of UCP-2 and UCP-3 expression is tissue specific (32; 33; 124; 
316), resulting in tissue specific responses to the same physiological stimuli. Like 
UCP-1, UCP-3 expression is decreased by starvation. However, starvation has the 
curious effect of increasing skeletal muscle UCP-2 and UCP-3 mRNA levels (124). It 
seems paradoxical to increase the level of uncoupling (a somewhat wasteful 
mechanism), when substrate supply is severely limited. 
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An alternative explanation is that starvation leads to tissue wasting, and loss of 
insulation, hence increased skeletal muscle uncoupling is necessary to provide 
essential heat (124). There are however, several lines of evidence against this theory. 
Studies in rats have shown that skeletal muscle contributes significantly to energy 
conservation during starvation, by decreasing total blood flow through the tissue 
(200). The second, is that during re-feeding, rats showed an accelerated rate of fat 
deposition, while UCP-2 & UCP-3 levels rapidly return to control values, but energy 
expenditure remained low (100). The energy conserving mechanism persists 
independently of the-thermoregulatory needs of the rat. Third, the starvation induced 
increase in UCP-2 and UCP-3 levels occur even at thermoneutrality (40; 261). 
Finally, neither short term [48hrs at 6°C, (32)], nor longer-term [20 days at 6°C, (33)] 
cold exposure affected skeletal muscle UCP-3 expression. It therefore seems unlikely 
that skeletal muscle UCP's participate in thermoregulatory thermogenesis (261). 
A more likely explanation, is that skeletal muscle UCP's participate in 
metabolic fuel partitioning (101). Dulloo et al. (101) suggest that starvation induced 
UCP expression may reflect a switch from glucose to lipid as the primary fuel source. 
The starvation-induced change in UCP-3 is more pronounced in fast glycolytic white 
muscles than slow red muscles, consistent with the capacity of these muscles to 
readily shift between glucose and lipid as fuel substrates (261). Adding weight to this 
argument are the findings of Weigle et al. (302), demonstrating induction of skeletal 
muscle UCP-3 mRNA merely by infusing free fatty acids. Physiologic states 
associated with enhanced fat metabolism are positively correlated with increased 
UCP-3 mRNA levels in skeletal muscle (31). Conditions of fuel depletion [acute 
exercise, and hypoxia], and artificial metabolic stress [induced by AICAR incubation] 
have also been shown to induce muscle UCP-3 expression (318). Taken together, 
these results are more consistent with roles for UCP-2 and UCP-3 in the regulation of 
lipid as fuel substrates than as mediators of thermoregulatory thermogenesis (101; 
261; 318) . 
The definitive role of UCP-2 and UCP-3 in skeletal is unclear. Current 
literature tends away from roles in adaptive thermogenesis, in favour of alternative 
hypotheses, such as regulation of fuel metabolism. The likelihood that type A 
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vasoconstrictors induce expression of UCP in skeletal muscle is remote. However, 
the possibility still remains that type A vasoconstrictors may stimulate uncoupled 
respiration in muscle, through either endogenously expressed UCPs or proton leak. 
1.4.4 Ion cycling 
1.4.4.1 Calcium cycling 
Contribution of the Ca2+-ATPase to resting muscle metabolic rate is estimated 
in the vicinity of 5-10% of basal energy metabolism (52; 76; 254). Skeletal muscle 
has a large pool of calcium sequestered in the sarcoplasmic reticulum, an essential 
requirement for contraction, however raised intracellular Ca 2+ [subthreshold for 
contracture] has the capacity to stimulate metabolic rate and heat production 
independent of contraction. Cycling of calcium between the sarcoplasmic reticulum 
and the cytosol [via the Ca2+ release channel and the Ca 2+-ATPase] has been 
demonstrated as en effective heat producing mechanism in specialized eye-muscles of 
several different fish species (27; 28). Modified eye muscles contain large numbers of 
mitochondria with extensive networks of smooth endoplasmic reticulum, but lack 
contractile elements. A complex countercurrent heat exchanging vascular system 
enables transfer of heat to the eyes and brain (27), maintaining temperatures above 
ambient water. The mitochondria are fully coupled with no detectable expression of 
UCP (27). Examination of key metabolic enzymes reveals a large capacity for 
oxidative metabolism (293), with ATP being derived from either lipid or carbohydrate 
metabolism. 
In homeotherms also, evidence has been obtained for increased muscle 
calcium cycling during cold exposure. Muscles from cold acclimated ducklings show 
elevated rates of sarcoplasmic reticulum Ca2+-ATPase activity, and a 30-50% increase 
in the fraction of vesicles containing ryanodine sensitive calcium release channels 
(102). Elevated calcium cycling may also account for elevated metabolism observed 
• in hyperthyroid models (110; 213; 277; 295). Perhaps the most spectacular example 
of elevated metabolism through increased calcium cycling is during malignant 
hyperthermia. A genetic defect in the ryanodine receptor (calcium release channel) 
predisposes susceptible individuals to a life threatening hypermetabolic condition 
triggered by a combination of anaesthetics and muscle relaxants commonly 
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administered pre-operatively. The patient presents with a dangerously high fever (5- 
10°C above normal), increased V02, metabolic acidosis and muscle rigidity (130; 
201). The defective ryanodine receptor is hypersensitive, and fails to deactivate. The 
channel remains open for longer periods, resulting in calcium flooding. Other cellular 
processes that are sensitive to calcium levels (contraction, glycolysis etc.) are forced 
into overdrive causing muscle rigidity and massive efflux of lactic acid. Left 
untreated, tissue damage and death are likely outcomes. 
Is calcium cycling a likely mechanism to account for type A-vasoconstrictor 
mediated thermogenesis? Activation of intracellular calcium cycling by 
norepinephrine was examined by Cox & Gibbs (85) in small bundles of rat muscle. 
No evidence was found to suggest direct activation of intracellular calcium cycling or 
heat production by norepinephrine, however an alternate possibility still exists. 
Skeletal muscle calcium • cycling is triggered in response to a variety of stimuli, 
including K+-depolarization (18; 23; 52; 146; 294) and hyperosmolar media (49; 85). 
Redistribution of blood flow, and increased tissue perfusion may increase the 
extracellular concentrations of K+ and or the osmolarity of the perfusing media, 
thereby activating intracellular calcium cycling. Calcium cycling is therefore 
considered a potential candidate during type A-vasoconstrictor mediated 
thermogenesis. 
1.4.4.2 Sodium cycling 
The proposal that the Na+/K+-ATPase (sodium pump) plays a role in skeletal 
muscle NST has been brought forward a number of times (134; 162; 274; 289). The 
Na+/K+-ATPase is an integral membrane protein found primarily on the sarcolemma 
of all higher eukaryotes (195), and is particularly prevalent in skeletal muscle (66; 
68). The pump is an electrogenic (69), P-type ion proton motive ATPase (159). 
Three Na+ are transported out of the cell, for every two K + pumped in during each 
ATP-dependent cycle (281). The sodium pump participates in the maintenance and 
restoration of resting membrane potential, while assisting with osmotic balance, and 
cell volume (111). It has been suggested that skeletal muscle may derive non-
shivering heat through increased Na+/K+-ATPase pump activity and ATP turnover. 
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The contribution of the sodium pump during basal, cold- and norepinephrine-
stimulated metabolism is now explored. 
Cardiac glycosides ouabain (an alkaloid extracted from the ouabao tree, 
Strophanthus gratus), digoxin and digitoxin (derived from foxglove, Digitalis 
purpurea) bind specifically with the sodium pump (121), in a stoichiometric ratio of 1 
drug molecule per enzyme (140), inhibiting transport activity and ATP turnover 
(313). Ouabain is also known to cause a rapid depolarization, as demonstrated in 
mouse skeletal muscle myoballs (189), and in isolated incubated rat soleus muscle 
(69), reflecting the importance of the sodium pump in the maintenance of resting 
plasma membrane potential. Inhibition with the specific inhibitor ouabain enables the 
contribution of the sodium pump to basal metabolism to be assessed. Conservative 
estimates place the resting energetic cost of active Na +/K+ transport between 4-10 % 
of basal energy consumption (76). Similar figures are noted in human, rat, and mouse 
muscle preparations (26; 51; 112; 224). Higher values may be found in the literature, 
though these values should be regarded with caution especially in cut or non-intact 
muscle preparations, where the ouabain-inhibitable fraction of basal metabolism is 
artificially enhanced due to sodium leakage into the cytoplasm (51; 76). 
Tissue slices from cold exposed rats appear to display increased rates of 
oxygen consumption when compared with controls, an effect that was abolished in 
low sodium media (134). These findings support the idea of increased sodium pump 
activity during cold exposure. In young pigs exposed to cold, an overall upregulation 
in the number of ouabain binding sites was noted (87; 143), indicating an overall 
increase in the concentration of sodium pumps. However, the authors concede that 
this was probably due to increased muscular activity and tissue hypertrophy during 
shivering, rather than upregulation of muscle NST. Thus, ouabain binding studies 
alone are inadequate for estimation of cold induced NST in muscle. 
Dubois-Ferriere & Chinet (97) estimated the contribution of muscle sodium 
pumping during cold acclimation, by measuring the ouabain-suppressible fraction of 
basal heat production in incubated perifused mouse soleii. In cold acclimated soleii, 
the ouabain-suppressible fraction of basal heat production was shown to be enhanced 
(approximately 45%) by comparison with warm acclimated muscles. Shiota & 
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Masumi (274) also examine the effect of cold exposure on perfused rat hindlimb 
metabolism. Cold exposure (4°C for up to 20 days) did not significantly affect basal 
metabolic rate. However, responsiveness to NE was markedly enhanced by cold (> 
50% increase in V0 2). The stimulatory effects of NE were diminished by prior 
addition of ouabain, propranolol, or phentolamine to the perfusate. These data were 
interpreted as evidence of increased muscle NST during cold exposure, via increased 
sodium pump activity (274). 
Age, physical activity, and hormonal status are significant factors in the 
regulation of sodium pump number and activity (66; 67). Excitation is the primary 
stimulus for Na +/K+-ATPase activation (68; 76), though pump activity is also 
modulated by a variety of humoral factors including epinephrine, norepinephrine, 
insulin, insulin-like growth factor, calcitonin gene related peptide, calcitonin, amylin, 
glucocorticoids, cytokines, and neurotransmitters (67; 74; 288). The stimulatory 
effects of catecholamines on muscle Na+/K+-ATPase are evident in a variety of 
species and preparations (65; 69; 233). Direct effect of catecholamines on the 
Na+/K+-ATPase activity have been demonstrated in isolated incubated muscle 
preparations, with norepinephrine and epinephrine causing hyperpolarization of rat 
soleus fibers, along with increased rates of Na+ extraction (83%) and K+ accumulation 
(34%) (69). This catecholamine effect was shown to be mediated via f3-adrenergic 
mechanisms, since it was blocked by low dose propranolol, and mimicked by cAMP 
and theophylline (69). 
Despite these observations, catecholamines do not directly stimulate oxygen 
consumption in isolated incubated muscle preparations (85; 97). The failure of NE to 
elicit an increase in isolated muscle metabolism, contrasts with the marked 
stimulatory effects of NE in the perfused rat hindlimb (97; 231). It has been 
suggested that the indirect vascular effects of NE and other type A vasoconstrictors 
may be more important in the activation of the sodium pump than direct effects. 
Observations that type A vasoconstrictor-mediated metabolism is reduced by low 
sodium perfusion media (291), and propranolol (292) tend to support this theory. The 
involvement of the Na+/K+-ATPase during type A vasoconstrictor-mediated 
metabolism is therefore a subject of great interest. 
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1.5 Aims 
The regulation of perfused resting skeletal muscle metabolic rate by 
vasoconstrictors is now examined in more detail. Redistribution of flow is an 
important aspect of vasoconstrictor-mediated thermogenesis, and it is now proposed 
that vasoconstrictor-mediated changes in skeletal muscle metabolic rate are the direct 
result of changes in oxygen delivery at the microvascular level. The potential 
activation of cellular thermogenic mechanisms in addition to redistribution of flow is 




METHODS AND MATERIALS 
2.1 Introduction 
The following sections outline the methods and materials utilized for the 
experimental procedures, while experimental protocols are outlined in the individual 
chapters. Contained are details of the perfused rat hindlimb preparation, isolated rat heart 
preparation, and assay techniques. The perfused rat hindlimb has previously been validated 
as a viable in vitro system for the study of skeletal muscle metabolism, with muscle being 
responsible for over 95% of the resting respiration rate (258). Previous work from this 
laboratory has shown that the levels of high energy metabolites (including ATP, creatine 
phosphate, ADP, AMP, glucose-6-phosphate, glycogen and lactate ratios), do not differ 
significantly from in vivo muscle values after 3 hours of perfusion, at 25°C, with a flow 
rate of 4 ml/min (78). Under these conditions, lactate-to-pyruvate ratios were normal, 
ruling out the possibility of tissue hypoxic degeneration (310). 
2.2 Perfused rat hindquarter preparation 
2.2.1 Animals 
Male Hooded Wistar rats of a local strain were housed in a 12hr light/ 12hr dark 
cycle, at a constant temperature of 22°C. Animals had free access to water and 
commercial rat chow (Gibson's, Hobart) containing 20.4% protein, 4.6% lipid, 69% 
carbohydrate and 6% crude fiber with added vitamins and minerals. 
Some experiments required the use of 3-4 week old (70-80g) rats. This was 
necessary for consistency with previous studies by Tong et al. (291; 292), where the 
reported levels of Na+/K+-ATPase were shown to be maximal (72; 177). Owing to the 
small muscle mass, both hindlimbs were perfused at a total flow rate of 4 ml/min in a non-
recirculating fashion (0.47m1/g muscle/min). All other perfusions were conducted as non-
recirculating single hindlimb experiments, with large rats weighing 180-200g, in 
accordance with previous studies from this laboratory (63; 79; 242; 310). Flow was 
maintained at 4 ml/min per single hindlimb (0.26 mug muscle/min). 
35 
Animal care and handling was in accordance with recommendations of the Animal 
Welfare Committee of the National Health and Medical Research Council (in the 
Australian Code of practice for the care and use of animals for scientific purposes, 6 th 
Edition, 1997). All anaesthetic, surgical and experimental procedures were approved by 
the committee for Ethical Aspects of Research Involving Animals of the University of 
Tasmania. 
2.2.2 Surgery 
The surgical procedure has been described elsewhere (79), essentially a modified 
version of the technique used by Ruderman et al. (258). Animals were anaesthetized with 
pentobarbital sodium (Nembutal, Rhone Merieux Australia Pty. Ltd) 60 mg/ml. The 
amount of anaesthetic required per animal was calculated based upon the recommended 
dose of 5-6mg/ 100g body weight. Anaesthetic was diluted with isotonic (0.9%) saline 
and injected i.p. Surgery commenced once animals were completely anaesthetized. 
Figure 2.1 illustrates ligation and cannulation positions. Strong cord was used to 
tie firm ligatures around the base of the tail, and the tarsus of the perfused foot/feet. The 
abdominal cavity was exposed by a midline incision through the skin and the abdominal 
wall, extending from the pubic to hepatic regions. Major vessels including the inferior-, 
and superior-epigastrics, skin vessels, as well as iliolumbars, internal spermatics and 
ureters were ligated to reduce bleeding during surgery. For single hindlimb perfusions, the 
right common iliac artery was also ligated, restricting flow to the left limb (this step was 
omitted for dual hindlimb perfusions). Firm ligatures were placed around the testes, the 
bladder and the seminal vesicles (in mature rats only), followed by the excision of these 
organs. Ligation of the descending colon and the duodenum allowed the removal of the 
viscera. 
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Figure 2.1 Illustration of the ligation and cannulation positions for the surgical preparation of " 
the isolated rat hindlimb. 
The perfusion method was modified from Ruderman et al. (1971). 
Surgery is the same for single and dual hindlimb perfusions, with the exception of an additional 
ligature placed around the right common iliac for the single hindlimb perfusion, and the removal of 
the seminal vesicles in mature rats. 
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The vena cava and the aorta were delicately separated with a fine pair of forceps, 
and silk ligatures placed loosely around the vessels. The preparation was heparinized 
(500p.1, 500 IU/m1- David Bull Laboratories Australia), one minute prior to tightening the 
upper ligature on the vena cava. A Terumo 16G catheter was inserted into the vena cava 
and secured in position with silk ligatures. Cannulation of the descending aorta was 
carried out with an 18G Terumo catheter filled with isotonic (0.9%) saline. The saline 
inside the syringe was slowly expelled to prevent the entry of air bubbles into the 
preparation, and to aid the washout of red blood cells. The aortic catheter was secured in 
position with silk ligatures, level with the venous catheter. The tips of the catheters were 
positions approximately 3mm above the aortic bifurcation. 
The entire preparation was then transferred to the perfusion cabinet where the 
arterial cannula was connected to the inflow line containing oxygenated medium. Care was 
taken to avoid the entry of air bubbles into the preparation. Approximately 2 minutes 
elapsed between the time the vena cava was ligated and the flow was re-established. 
Venous effluent was collected in a waste reservoir. The animal was then killed with a 
lethal dose of Nembutal administered via an intra-cardiac injection, and a whole body 
ligature was placed around the level of the L3 and L4 vertebrae to prevent the flow of 
perfusate to the upper portions of the body. After a few minutes, most of the red blood 
cells were washed out, and the venous line was connected to the oxygen electrode. 
2.2.3 Perfusion apparatus 
Figure 2.2 illustrates the hindlimb perfusion apparatus. Perfusions were conducted 
at 25°C using 2% BSA with 1.27 MIA calcium (unless otherwise stated). The buffer 
reservoir was continuously stirred and gassed with carbogen (95% 02, 5% CO 2 — BOC 
Gasses). Buffer was pumped via a peristaltic pump (Masterflex, Cole-Panner) at a 
constant flow rate 4 ml/min (for two hindlimb perfusions in small 70-80g. rats, and for 
single hindlimbs in 180-200g rats). From the reservoir, the buffer was pumped through a 
heat exchanger coil maintained at 25 + 1°C by a thermostatically controlled water heater 














Figure 2.2 Perfusion Apparatus 
Following surgical preparation of the isolated hindlimb, the preparation was 
transferred to the perfusion cabinet and connected to the apparatus. Perfusion media 
was pumped at constant-flow from a reservoir through a heat exchanger and artificial 
lung. Warmed, oxygenated media passed through bubble traps before entering the 
hindlimb. After passing through the hindlimb, perfusion media passed through a Clark 
type oxygen electrode. Perfusate samples were collected after the electrode. 
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Perfusate was oxygenated by passage through a sealed silastic artificial lung, 
continuously gassed with carbogen. Bubbles were prevented from entering the 
hindlimb by inline bubble traps located proximally to the rat. The entire apparatus was 
maintained at either 25°C or 37°C. 
Arterial pressure development was recorded by means of a pressure transducer 
(Sphygmomanometer, Malyoung) located proximally to the aorta. Flow was 
maintained at a constant rate, therefore changes in pressure reflect changes in vascular 
resistance. This may be seen by applying Poiseuille's Law, for the steady laminar flow 
of a fluid through a cylindrical tube, where Q = it(P1-P 0)r4/8iL 
where: = flow rate; 
P1-P0 =pressure difference; 
= radius of vascular wall; 
ii 	= viscosity of the perfusate; 
= length of the tubing 
Assuming that Q, TC, n, and L are all constant, then it may be seen that pressure 
is proportional to r I/4 . Therefore, a small decrease in the average radius is reflected by 
a large increase in pressure. Continuous measurement of oxygen content of venous 
effluent occurred via a flow-through a water-jacketed Clark-type oxygen electrode (0.5 
ml capacity), maintained at 25 + 1°C. Calibrations of the oxygen electrode were made 
before and after each perfusion with 100% 02 gas (BOC- Gasses), and air. The oxygen 
content of gassed arterial perfusate was also determined at the end of each experiment, 
allowing the extent of electrode drift to be taken into account for calculation of oxygen 
consumption. 
Both P0 2 , and perfusion pressure (PP) were recorded continuously on WinDaq Serial 
Acquisition Version 2.08 (DATAQ Instruments Inc., Microsoft Corp.). 
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2.2.4 Perfusion media 
2.2.4.1 Modified Krebs-Ringer bicarbonate buffer 
Perfusion medium consisted of a cell free modified Krebs-Ringer bicarbonate 
buffer. The constituents of the buffer (mM) were 118 NaC1, 4.7 KC1, 1.19 KH2PO4, 
1.18 MgSO4, 25 NaCO3, 8.3 D-glucose (monohydrate), with 2% w/v Bovine Serum 
Albumin (BSA - Fraction V, from CSL Ltd.). Medium was filtered (0.451.tm filter 
paper) before use, and maintained at 4°C, while being gassed with 95%02 and 5% CO2, 
(carbogen, BOC-Gasses). CaC12 was added to the perfusion medium to give a final 
concentration of 1.27 mM, after the perfusate had been gassed. 
2.2.4.2 Red blood cell containing medium 
For some perfusions, cell free medium was found to be oxygen limiting, 
therefore a medium containing washed bovine red blood cells was substituted. Fresh 
bovine erythrocytes were filtered through cheesecloth, and washed three times in 
filtered saline (0.9% NaC1). Erythrocytes were then washed twice more in Krebs, and 
stored in gassed (95% oxygen- 5% CO 2) Krebs-Ringer solution at 4°C (317). On the 
day of use, erythrocytes were washed a further 2 times, until all lysed cells were 
removed, and filtered once again through 6 layers of pre-washed cheesecloth. 
Erythrocytes were never more 4 days old when used. The red blood cell containing 
medium was composed of a modified Krebs-Ringer bicarbonate buffer (the same as 
described earlier, 2.2.4.1), 4% BSA, 2.54mM CaCl2, 22801 heparin, and 1.2mM 
pyruvate, combined with washed bovine erythrocytes to give a final haematocrit of 33- 
35%. This perfusion medium resulted in minimal oedema (237). Both the arterial and 
venous perfusate passed through a continuous Arterio-venous Oxygen Difference 
Analyser (A-VOX Systems Inc., Texas USA) which measures the spectral difference of 
arterial versus venous blood at 660nm. 
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2.2.5 Infusion agents 
Agents that were not water-soluble were dissolved first in 100% ethanol, then 
added to the perfusion medium (final ethanol volume never exceeded 1% final 
volume). Water-soluble agents were dissolved directly into the perfusion medium. All 
other agents were prepared freshly on the day of use. NE was prepared in ascorbic acid 
saline; All, 5-HT and propranolol in saline; veratridine (free base) was dissolved in 
dH20, and neutralized with concentrated HC1; tetrodotoxin was readily soluble in 
dH20. 
2.2.6 Calculation of oxygen consumption (V 02) 
2.2.6.1 V02 in cell free BSA medium 
The rate of the volume of oxygen consumed (V02) by the perfused hindlimb 
was calculated from the arteriovenous (A-V) difference in oxygen content of the 
perfusate, with the following formula. 
02 uptake = ap 25 x (Pa02  -Pv02) x flow rate x 60 
muscle mass 
where ap 25 
	
=Bunsen solubility coefficient for 02 in human plasma, at 25°C. 
= 1.509 mmo1/1 per mmHg 
Pa02 	= arterial partial pressure of 02 (mmHg) 
Pv02 	= venous partial pressure of 02 (mmHg) 
flow rate 	= pi /min 
muscle mass = mass of skeletal muscle perfused in grams, 
small rats (2-HL) = body weight (g) x 0.141-2.534 (236) 
large rats (1-HL) = body weight /12 (258) 
2.2.6.2 Measurement of V0 2 in red blood cell containing medium 
The AVOX analyser gave an estimate of the arterio-venous oxygen difference 
based upon the spectral differences of arterial and venous blood at 660nm. Dissolved 
oxygen content was not measured by the AVOX. The protocol in Chapter 3 requires the 
arterial oxygen content to be varied, ie. blood was gassed with lessening amounts of 
42 
oxygen, hence the arterial blood changed colour as the experiments progressed. The 
linearity of the AVOX was questionable at these low oxygen tensions, therefore an 
alternative method for measuring total oxygen content (dissolved and carried) of the 
blood was sought. 
The total oxygen content of perfusate samples was determined using a galvanic 
cell oxygen analyser (TasCon oxygen content analyser manufactured by the Physiology 
Department, University of Tasmania). Small blood samples were collected from the 
arterial line (immediately before the rat), and from the venous line in air tight insulin 
syringes (1m1 B-D Ultra-Fine Insulin Syringe). The rates of oxygen uptake were 
calculated from arterio-venous oxygen differences, flow rate, expressed per gram of 
perfused muscle, as previously described (96). 
2.3 Perfused rat heart preparation 
2.3.1 Animals 
Male rats of the local Hooded Wistar strain (180-230g body weight) were used 
for heart perfusions. Housing conditions, and anesthesia were the same as described in 
Section 2.2.1. 
2.3.2 Isolation and cannulation of the rat heart 
Hearts were perfused in a Langendorff manner using a system based on that of 
Williamson (306). During anesthesia, a cut was made across the upper abdomen; the 
incision continued laterally through all the layers of the thorax including the ribs, 
collapsing the lungs, and exposing the beating heart. The aorta was cut at a length 4- 
5mm from the ventricle, adequate for cannulation. Following removal from the 
thoracic cavity, the heart with the attached length of aorta was placed into ice cold 
Krebs. The metal cannula on which the heart was to be mounted in the cabinet, was 
freely dripping warm oxygenated medium, awaiting carmulation. The aorta was 
grasped from opposite sides with two pairs of fine curved forceps, gently lifted over the 
straight metal cannula, and held in position with a metal clip. A ligature was then tied 
around the aorta, securing the heart on the cannula. 
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2.3.3 Pe?fused heart apparatus 
The apparatus for heart perfusions was essentially the same setup described in 
Section 2.2.3. Briefly, perfusion medium (modified Krebs-Henseleit bicarbonate 
buffer, Section 2.2.4) was pumped at a constant flow through a series of heat exchange 
coils, and a silastic lung gassed to equilibration with carbogen (95% 02: 5% CO2). The 
perfusion cabinet, and heat exchange system was maintained at 37°C. Hearts were 
perfused at a constant flow (6.79 ± 0.12 ml.min -1 ), equivalent to 8.94 ± 0.25 ml.min -l .g 
wet wt heart -I . Oxygen content of the venous perfusate was constantly monitored at 
37°C with an in-line Clark-type oxygen electrode, calibrated with 02 gas and air (as 
described in Section 2.2.3). Oxygen uptake was calculated according to the method 
outlined in Section 2.2.6). The cannulated heart was contained within a sealed chamber 
(volume 10 ml) to prevent exchange of 02-0O2 between effluent perfusate and the 
atmosphere. In this system, drift in measurement was less than 2% hr -I (243). Aortic 
pressure was continually recorded with a CFP blood pressure monitor (Model 8138). 
2.3.4 Heart perfusion medium 
Hearts were perfiised with a modified Krebs-Henseleit bicarbonate buffer 
(described in Section 2.2.4.1) containing 0.05mM EDTA, 5mM pyruvate, and 5mM 
glucose. 
2.4 Measurement of membrane potential (Em) in the perfused rat hindquarter 
Measurement of skeletal muscle membrane potential was conducted at Flinders 
Medical Centre between November 1998, and April 1999. Work was carried out in the 
Smooth Muscle laboratory under the supervision of Dr. Tim Neild. All experiments 
were conducted at 25°C, at 4 ml/min flow rate with juvenile (70-100g) rats, with 
approval of Flinders Medical Centre Animals Ethics Committee. The hindlimb was 
prepared for a dual hindlimb non-recirculating perfusion (Sections 2.2.1 —2.2.3). 
Perfusion pressure and oxygen consumption were recorded continuously on a laptop 
computer with the WinDaq Data Acquisition software installed. 
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2.4.1 Preparation of the muscle 
During the period of equilibration, the hindlimb was prepared for the 
measurement of membrane potential. A small section of skin covering the tibialis 
muscle of the animal's left hindlimb was exposed with sharp scissors, taking care not to 
damage the underlying fascia. The exposed surface was kept moist with perfusion 
medium, and covered with a piece of laboratory parafilm to prevent drying. Using a 
felt tip marker, a mark was made on the parafilm, and a small hole pierced through the 
parafilm with fine scissors. This served as the target area for insertion of the glass 
electrode. 
2.4.2 Apparatus and equipment. 
Glass electrodes were made on the day of each experiment, with the use of an 
electrode pulling machine. Electrodes were filled with 2M KC1 solution, and attached 
to the micromanipulator, with a silver wire electrode in contact with the KC1 inside the 
electrode. This arrangement allowed changes in electrical potential to be detected and 
quantified. Signals from the electrode were amplified and fed into an oscilloscope. 
The membrane potential (E N') data was recorded continuously with MacLab data 
acquisition software. Figure 2.3 shows the apparatus. 
Every effort was made to ensure minimal electrical interference. A thin layer of 
aluminium foil shielding was used to minimize interference from surrounding light, and 
electromagnetic equipment. The rat, surrounding equipment, stage and aluminium foil 
shielding were grounded. The micromanipulator was used to slowly wind the glass 
electrode downwards, until contact was made with the tissue, and the muscle fascia 
pierced. At this time, the potential was adjusted to a "zero" reference. Resistance of 
around 50-200MQ was optimal, and those electrodes with resistances outside of this 











Figure 2.3 Schematic Representation of the equipment setup for the 
measurement of membrane potential in the perfused rat hindlimb. 
The perfused muscle preparation was allowed 50 mins equilibration before 
commencement of membrane potential measurement. Glass electrodes were used to 
pierce the muscle in the exposed tibialis region. 
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With a suitable electrode resistance, and a stable zero position, the 
micromanipulator was used to wind the electrode down further into the tissue. A 
successful clean cell entry was indicated by a sudden jump from 0 to —70mV, as 
visualized by the oscilloscope. When the change to —70mV was slow, this typically 
indicated a poor entry, and was not pursued. Following each impalement, the electrode 
was wound back upwards to the exterior of the cell to check that there zero reference 
was still stable, and had not drifted. 
2.4.3 Measurement of Em during agonist infusion 
Measurements of membrane potential were made before and during infusion of 
drugs of interest. During the initial moments of vasoconstrictor infusion, the electrode 
was withdrawn from the tissue, since vasomotion might damage the fine glass 
electrode. To ensure that the electrode was not impaling the same damaged fibers 
repeatedly, the positioning of the electrode was moved slightly with each impalement 
(in a lateral direction). In each rat, the change in oxygen consumption was allowed to 
completely recover, before another infusion commenced. The order of experiments was 
randomized. The glass electrodes used during this study were too large to measure 
membrane potential in vascular smooth muscle cells, or endothelium, therefore the 
study was restricted to measurement in skeletal muscle fibers only. 
2.4.4 Experimental protocol 
Once a stable basal measurement of resting Em was obtained, the glass electrode 
was withdrawn from the tissue, and infusion commenced. This was especially 
important for the infusion of vasoconstrictors, where considerable movement of the 
tissue was noted. After the change in vascular resistance had plateaued (this often 
preceded the plateau in V02), the electrode was re-inserted into the tissue for a 
measurement of Em during stimulated V02. 
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2.4.5 Calculation for the estimation of membrane potential in skeletal muscle fibers 
The Nernst equation allows calculation of plasma membrane potential based 
upon intra- and extracellular concentrations, and membrane permeability to individual 
ions. The Goldman-Hodgman-Katz equation is a modified version of the Nernst 
equation, given by 
EN' = RT log(1o)BOAC + E_NarNa]l 
EK[K] o  ENa[Na]o 
Where R 	= the thermodynamic gas constant 
= the absolute temperature 
= the Faraday constant (96485.309 C/mol) 
EK 	-= potassium permeability constant (1.0 mammalian skeletal muscle) 
[K] ; 	= intracellular potassium concentration (mM) 
[K]a = extracellular potassium concentration (mM), 4.74mM 
ENa 	= sodium permeability constant (0.03 mammalian skeletal muscle) 
[Na] 1 = intracellular sodium concentration (mM) 
[Na] 0 = extracellular sodium concentration (mM), 145mM in perfusion 
medium 
NB. At room temperature, the RTiF component of this calculation is approximated at 
58mV. Values for intracellular potassium and sodium are estimated at 140, and 10 mM 
respectively. 
2.5 Methods for assessing nutritive and non-nutritive flow in the perfused rat hindlimb 
2.5.1 Conversion of 1-MX 
Xanthine oxidase, an enzyme located on the capillary endothelium (175), 
catalyzes the conversion of the exogenous substrate 1-methylxanthine (1-MX) to 1- 
methylurate (1-MU). Changes in the conversion rate of 1-MX to 1-MU potentially 
indicate changes in the ratio of nutritive to non-nutritive flow. The conversion rate of 
1-MX was shown to increase during exercise in the blood perfused rat hindlimb (317) 
while the type B vasoconstrictor serotonin decreased 1-MX conversion (234). An 
increase in the ratio of 1-MU concentration (11M): 1-MX concentration (.M) is 
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indicative of enhanced nutritive perfusion, while •a decrease in 1-MIJ/1-MX ratio 
indicates decreased nutritive flow. 
20 11M 1-MX was included in perfusion medium. 1-MX (Sigma) was first 
dissolved in dH20, with 1M NaOH (1001.1.1) at a final concentration of 20 mM, and 1 ml 
of this solution was added for every litre of perfusion medium. Arterial + venous 
samples were collected for later analysis with HPLC (outlined in Section 2.6.2). 
Samples were centrifuged briefly to remove red blood cells (4°C), and 0.5 ml of the 
supernatant was added to 0.1 ml of 2M HC104 and left to precipitate at 0°C. Samples 
were again centrifuged (8000g for 5 min) to remove precipitate, awaiting HPLC 
analysis. 
• 2.5.2 Microdialysis sampling of interstitial milieu during perfusion 
2.5.2.1 Microdialysis probes 
Microdialysis was carried out according to the methods described in Newman et 
al. (221). Probes were linear in construction, with short length (25mm) of 
microdialysis tubing (Bioanalytical Systems Inc, Indiana USA, molecular weight cutoff 
30 kDa) glued into the blunted end of a snapped off 23G Terumo needle, leaving 20mm 
tubing free of the needle. The amount of glue was kept to a minimum so that the 
overall diameter was less than the internal diameter of an 18G syringe needle. 
2.5.2.2 Implantation of the microdialysis probe 
During surgery (just before heparin injection), a small amount of skin covering 
the gastrocnemius and tibialis muscles groups was removed. The microdialysis probe 
was inserted into the muscle via an 18G steel needle, with at least 10mm of dialysis 
tubing positioned within the muscle bed. During equilibration (shortly after connection 
of the preparation to the apparatus), the needle end of the microdialysis probe was 
attached to a syringe pump (WPI, sp101I syringe pump) and flushed with 200111 saline 
(0.9% NaC1) containing 10mM 14C-ethanol (100nCi/m1) and 3H20 (500nCi/m1) (inflow 
solution). 
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2.5.2.3 Microdialysis sampling 
For the remainder of the experiment the syringe pump was set at 2111/min. The 
hindlimb preparation was allowed to equilibrate for 20 minutes at 4 ml/min of hindlimb 
perfusate flow before sampling from the probe commenced. During the last 10 minutes 
of each treatment, 2 microdialysis samples (5 minutes each) were collected into pre-
weighed micro-centrifuge tubes (outflow solution). The volume of sample collected 
was then determined by re-weighing the tubes. The tube along with the sample was 
then placed into 5 ml counting vials containing 3 ml of scintillant. A known volume of 
the inflow solution was sampled in the same manner. Vials were then counted for 14C 
and 3 H in a Beckman counter (LS 6500) and the out/in (0/I) ratio for both 14C-ethanol 
and 3H20 determined. 
2.5.3 Laser Doppler Flowmetry 
2.5.3.1 Implantation of laser Doppler probes 
Impaled laser Doppler flowmetry (LDF) probes were used to measure changes 
in microvascular perfusion. LDF measurement of nutritive flow is based primarily 
upon the measurement of non-vectorial cell speed (56). Fiber optic Moor Instruments 
Lab Server and Lab Satellite fitted with two P 1 OM master probes were used, with two 
•P 1 Os-TCG . 260 pm slave probes, each fitted with TCG-fixed fiber. The operational 
wavelength of the laser light source was 780nm (55). Shortly after connection of the 
rat to the apparatus, skin covering the calf muscle group was removed, and probes were 
positioned randomly. The site of implantation was varied, but always within the 
tibialis, gastrocnemius, or vastus lateralis muscle group. Probes were undisturbed for 
the remainder of the experiment, while data was recorded continuously using Windaq 
software. 
2.5.3.2 Diagnosis of LDF signal 
After implantation, a short (10 min) period was allowed for settling of the 
probes. Previous studies with LDF probes in perfused muscle show that three different 
LDF responses are found [nutritive, non-nutritive or mixed, (55)]. To assess the nature 
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of the site monitored by each probe, a bolus injection of 5-HT (100 at 0.51.1M) was 
used. 5-HT is known to cause shunting of blood flow through the non-nutritive region. 
In response to the 5-HT bolus, a nutritive site responded with a downward trend in laser 
output (signifying decreased flow through the region), while a non-nutritive site was 
identified by an upward shift in the laser output (increased flow through non-nutritive 
regions). A site that did not respond satisfactorily as either nutritive or non-nutritive 
was diagnosed as a mixed site. Data was collected continuously using Windaq 
software. The approximate proportion of nutritive to non-nutritive sites was 60:40. 
Data obtained from the laser is expressed as a change from the first measured point in 
each experiment. That is, the first point is always 1.0. Therefore an increase from 1.0 
indicates increased flow through that region. 
2.6 Assay of perfusate samples 
2.6.1 Lactate assays 
Venous samples collected from perfusions were assayed for their lactate 
content. Samples were centrifuged to remove red blood cells and either assayed 
immediately or stored at -20°C. Lactate assays were carried out on the YSI Model 
2300 STAT Plus Glucose and L-Lactate Analyzer (Yellow Springs Instruments Co. 
Inc, Yellow Springs, Ohio USA). Values for lactate concentrations were given as mM, 
which was later converted to urno1.g -l .hr-1 production or uptake based on flow rate, 
arterio-venous differences and perfused muscle mass. All samples for one perfusion 
were assayed in duplicate on the same day. 
Lactate efflux (urnol.e.hf l ) was calculated with the use of the following formula. 
Lactate Efflux = (arterial-venous) x flow x 60  
perfused muscle mass(g) 
where 	(arterial-venous) 	= A-V lactate difference in mM 
flow rate 	= ml/min 
muscle mass 	= see oxygen calculation (Section 2.2.6.1) 
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2.6.2 Determination of 1-MX and 1-MU, uracil and uric acid content of petfusate 
samples. 
On the day of analysis, precipitated protein was centrifuged out of the sample 
(3000xg 5 min). Uracil, uric acid, 1-methylurate, and 1-methylxanthine content of the 
perfusate samples was determined using reverse phase HPLC, essentially as described 
by Wynants et al. (307), with modifications described by Clark et al. (63), and Rattigan 
et al. (234). Briefly, these compounds were separated on a LichroCART C8 RP 18e 
5p.m particle column (Purospher, Merck, Darmstadt Germany), under isocratic 
conditions at flow rate 1.2 ml/min, with run buffer consisting of 50mM NaH4PO4/ 0.3% 
methanol/ 0.3% acetonitrile/ 0.1% tetrahydrofuran, pH 4.0 with phosphoric acid. 50p1 
samples were injected, with detection between the wavelengths 259nm to 287nm. 
Analysis of HPLC profiles was carried out with Star Toolbar Chromatography 
Workstation v. 5.5.1 (1982-2000) Varian, Inc. 
2.7. Determination of high-energy phosphate content offreeze clamped muscle samples 
For experiments where determination of intracellular metabolites was required, 
muscle samples (gastrocnemius, plantaris, soleus group) were collected at the end of 
the perfusion. The hindlimb was skinned while still perfusing, and then freeze clamped 
in situ with tongs dipped into liquid nitrogen. The freeze clamped muscle was then cut 
out, and placed into liquid nitrogen, and stored at -80°C. Muscle samples were ground 
to a fine powder under liquid nitrogen. 100mg samples of powdered muscle were added 
to 2 ml of ice cold 0.42M HC104, vortexed 3 times for 10 sec each (resting on ice in 
between), and centrifuged at 3000 rpm for 5 mins (IEC centrifuge). 1.0 ml of the 
supernatant was transferred to a fresh eppendorf tube, and neutralized with 2300 of 
1M K2CO3, and left for 10 mins on ice. The sample was centrifuged for a further 5 
mins at 3000rpm (eppendorf bench-top centrifuge). The supernatant was kept on ice 
until the time of injection on the HPLC. 
Analysis of freeze clamped muscle extracts was essentially the technique of Ye, 
Clark, et al. (308), with modifications to the solvent system. The HPLC was primed 
with a run buffer consisting of 20g11 NH4H2PO4, 0.5g TBAHS (ion pairing agent), pH 
to 6.0 with ammonium hydroxide. Samples were separated on a Luna 5p. C8, 250 x 6 
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mm column (Phenomenex, Australia), under reverse phase ion paired conditions 
(described elsewhere (272)). A 20p.1 aliquot of the muscle supernatant was injected, and 
detection of ATP, ADP, AMP, adenosine, inosine, IMP, NAD, creatine, and creatine 
phosphate was between the wavelengths 215-254 nm. 
2.8 Chemicals 
2.8.1 Perfusion medium 
NaC1, KC1, CaC12 were obtained from Ajax Chemicals Australia. KH2PO4, 
NaHCO3, and D-Glucose mono-hydrate were obtained from BDH Chemicals. MgSO4 
was from M&B Chemicals -England. Bovine serum albumin was purchased from 
CSL-Ltd. 1-MX was obtained from CSL, University of Tasmania.. 
2.8.2 Infusion Agents 
NE, All, 5-HT, veratridine, ryanodine, dantrolene, propranolol, ouabain, 
digitoxin and digoxin were all obtained from Sigma Chemical Company (St Louis, 
Mo.), and sodium nitroprusside from Merck (Darmstadt, Germany). Tetrodotoxin was 
obtained from Alamone Labs (Israel). 
2.8.3 HPLC Solvents 
All solvents used in HPLC buffers were of analytical grade. Methanol, 
acetonitrile and tetrahyrafuran were purchased from BDH Chemicals. Phosphoric acid, 
and NaH4PO4 used in the preparation of HPLC buffers were obtained from M&B 
(Victoria, Australia). Ion pairing agent tertbutyl ammonium hydrogen sulphate 
(TBAHS) was purchased from Sigma Chemical Company. 
53 
CHAPTER 3 
EFFECTS OF VARIED OXYGEN DELIVERY ON OXYGEN CONSUMPTION AND 
FLOW REDISTRIBUTION OF THE PERFUSED RAT HINDLIMB 
3.1 Introduction 
Oxygen is an essential requirement for energy production and mammalian cell 
survival. Intricate vascular networks ensure adequate oxygen delivery, and the extent 
of microvascular perfusion may be varied in accordance with metabolic demand. 
Hypoxia results in the release of metabolites that regulate local blood flow (202), while 
muscle contraction is thought to recruit capillaries via cell to cell signalling up the 
vascular tree (269), facilitating blood flow access and oxygen delivery to the actively 
respiring tissue. In this scenario, it is the metabolic rate that regulates blood flow and 
oxygen delivery. However, evidence has also been obtained that blood flow and 
oxygen delivery may regulate muscle metabolic rate (180; 181; 305; 310). 
Type A and B vasoconstrictors are known increase and decrease respectively 
oxygen consumption of the perfused rat hindlimb (59). Though vasoconstrictors do not 
alter total flow, the fractional distribution of flow between the nutritive and non-
nutritive pathways is altered (220). The possibility is now considered that 
vasoconstrictor-mediated changes in muscle metabolism are a reflection of varied 
oxygen delivery. The following experiments attempt to define the effects of altered 
oxygen delivery on perfused skeletal muscle resting metabolic rate. 
3.2 Methods 
3.2.1 Animals and perfusion medium 
The oxygen carrying capacity of BSA is relatively low, therefore an erythrocyte 
containing medium was used for the following experiments. All perfusions were 
conducted in 180-200g animals, as single hindlimb perfusions (Section 2.2.1), at 37°C, 
with bovine red blood cell containing medium (Hct 33-35%), at 4 mUmin, in a Krebs 
Henseleit buffer, with 4% BSA, 2.54mM CaC12, 1.2 mM pyruvate, and 228 IU/1 
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heparin (Section 2.2.4.2). Flow rate and haematocrit was held constant throughout all 
experiments. 
3.2.2 Varied arterial oxygen mix 
The perfusion apparatus was consistent with previous studies (317) with the 
following modifications. Erythrocyte media was split into two separate flasks, and 
gassed to equilibration with either Air:CO2 (95% Air: 5% CO2) or N2 :CO2 (95% N2: 
5% CO2). The following pump configuration was based on a model designed by Peter 
Arthur (personal communication). Total flow was kept constant at 4 ml/min, as 
determined by the first pump (Figure 3.1). Pump 1 drew medium from the air-gassed 
reservoir (henceforth referred to as air). A second pump drew medium from the 
nitrogen (N2) gassed reservoir. When only pump 1 was on, the entire 4 ml volume was 
drawn from the air reservoir. By varying the speed of pump 2, different arterial mixes 
of air and N2 blood were achieved, to give varied mixtures of air and N2 gassed blood. 
Pump 1 
Constant 4 mUmin Pump 2 
Speed varied 
(0-4m1/min) 
Figure 3.1 Pump configuration 
The dual pump configuration allowed control over the mixture of air and N2 
equilibrated blood. Pump 1 was a constant 4m1/min, while the speed of pump 2 was 
varied (0-4m1/min) to obtain differing mixes. 
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The following arterial mixes were obtained in.this manner (Table 3.1), with 30 mins of 
perfusion allowed at each mixture. The resulting oxygen concentration of each mixture 
is shown in Figure 3.2. 
Table 3.1 Arterial mixture of Air and N2 equilibrated blood 
Gas Mixture 
(% air) Pump 1 setting (ml/min) Pump 2 setting (ml/min) 
100% 4 0 
75% 4 1 
50% 4 2 
25% 4 3 
0% 4 4 
3.2.3 Determination of arterial and venous oxygen concentrations 
The arterial and venous perfusate passed through an arterio-venous oxygen 
difference analyser (AVOX) (2.2.6.2), comparing the spectral differences in the A-V 
blood at 660nm. However, these particular experiments presented two problems for the 
AVOXimeter. Firstly, small leaks in the apparatus were unavoidable (allowing 
exchange with atmospheric air through tubing and joints etc.). In order to minimize 
this risk, apparatus tubing was replaced with impermeable polyethylene HPLC grade 
tubing (1.57mm internal diameter with 0.8mm wall thickness), and tubing lengths 
between the rat and the AVOX were kept to an absolute minimum. Secondly, the 
linearity of AVOX measurements at low oxygen tensions was questionable (since the 
machine is usually calibrated with constant arterial oxygen, and in these experiments 
arterial oxygen was variable). Therefore an alternative method was sought for the 
definitive measurement of oxygen content. Samples were drawn in airtight syringes 
from a port immediately before the rat, and from the venous line, and analysed using a 
galvanic cell oxygen analyser [TasCon oxygen content analyser manufactured by the 
Physiology Department, University of Tasmania) (2.2.6.2)]. Total oxygen extraction 
by the hindlimb was calculated based upon arterio-venous oxygen differences (from 
both the AVOX and the oximeter), flow rate, and the mass of tissue perfused (2.2.6.2). 
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3.2.4 Lactate efflux 
Small blood samples were collected from the arterial and venous lines, and 
assayed immediately for their lactate content with a YSI glucose/lactate analyser 
(Section 2.6.1). Lactate efflux was calculated from A-V differences. 
3.2.5 Nutritive and non-nutritive bloodflow during varied oxygen delivery 
In the current series, flow rate was maintained while oxygen content was varied. 
Varied oxygen delivery is not expected to alter the distribution of blood flow under 
resting conditions, however care was taken to rigorously monitor the ratio of nutritive 
to non-nutritive blood flow. This ensured that oxygen concentration was the only 
varied parameter, without the added complication of recruitment. Three independent 
•methods were employed to monitor potential changes, these being 1-MX metabolism, 
microdialysis, and laser doppler flowmetry. 
3.2.5.1 1-MX metabolism 
201.4.M 1-MX was added to the total blood volume, and allowed sufficient 
mixing time before splitting into two flasks (air and N2). Arterial samples were drawn 
from the infusion port immediately before the rat, while venous samples were taken 
from the venous line. Red blood cells were removed from the samples by 
centrifugation, and 0.5 ml of supernatant was added to 0.1 ml 2M HC104 (Section 
2.5.1) for later analysis with HPLC (2.6.2). Samples collected were also analysed for 
uracil and uric acid contents at the same time as 1-MX. 
3.2.5.2 Microdialysis 
Microdialysis probe construction, and positioning are outlined in Section 2.5.2. 
Microdialysate samples (2x5-min) were collected in the last 10-min of each 30-min 
period of each gas mixture, according to the method of Newman, Di Maria, et al. (221). 
3.2.5.3 Laser Doppler Flowmetry 
Implantable LDF micro-probes were positioned randomly within the tibialis, 
gastrocnemius, or vastus lateralis muscle groups (Section 2.5.3). Laser sites were 
identified as either nutritive, non-nutritive, or mixed at the start of each experiment 
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with a bolus of 5-HT (101.1.1 at 0.51.iM) according to the method of Clark, Youd, et al. 
(55). Once the laser site was identified, probes were undisturbed for the remainder of 
the experiment, while data recorded continuously with Windaq software. The first 
recorded data point was normalized to 1.0. Data from the mixed sites was not retained. 
3.2.6 Determination of muscle high energy phosphates and creatine content 
The effect of lowered oxygen tension on cellular energy status was assessed. 
Muscle samples (gastrocnemius, plantaris and soleus) were collected at each steady 
state oxygen level, by freeze clamping the muscle in situ. Muscles were ground to a 
fine powder under liquid nitrogen, and analyzed with HPLC for creatine, 
phosphocreatine, inosine, IMP, AMP, adenosine, ADP, and ATP levels under reverse 
phase, ion paired conditions (Section 2.7). Cellular Energy charge was calculated by 
[ATP]/ [ATP] + [ADP] + [AMP], while cellular energy potential was calculated from 
the formula [PCr] + 2[ATP] + [ADP] (9). 
3.2.7 Statistics 
All data are presented as means ± SE. Differences were assessed by one-way 
repeated measures analysis of variance (ANOVA), with pair-wise comparisons by the 
Student-Newman-Kuels test. All values were compared to control (100% air). 
Repeated measures ANOVA was not appropriate for the metabolite profiles, since the 
"end-point" muscle sampling technique only allowed one sample per experiment. 
Statistical significance was recognized at P<0.05. All statistics were carried out using 
Jandel Scientific SigmaStat software. 
3.3 Results 
3.3.1 Effects of varied arterial oxygen on hindlimb oxygen extraction 
Figure 3.2 illustrates the effects of varied oxygen delivery on arterial (n=7) and 
venous (n=7) oxygen content as detected by the oximeter (Panel A). Each consequent 
change in the gas mixture led to a significant decline in arterial and venous oxygen 
contents. Mean arterial oxygen content was 7.7 ± 0.4 ilmol.m1 -1 at 100% air mixture, 
declining to 7.2 ± 0.3 (75%), 6.0 ± 0.3 (50%), 4.7 ± 0.5 (25%), and finally 3.5 ± 0.7 at 
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0% (P<0.001, n=5). Though given sufficient time to equilibrate with nitrogen gas prior 
to the experiment, the 0% gas mixture still contained detectable amounts of oxygen 
owing to small unavoidable air leaks in the apparatus. Similarly, venous oxygen 
content also declined with each gas mixture (open symbols, Panel A). The A-V 
difference in oxygen content was significant at every gas mixture tested (statistics not 
shown), indicating significant oxygen extraction even at the lowest oxygen delivery. 
Oxygen consumption calculated from these A-V differences (Panel B) was significantly 
different from 100% air at 50% and below (P<0.05). Panel C shows a positive 
correlation between arterial oxygen concentration and arterio-venous oxygen delivery. 
Figure 3.3 shows the changes in oxygen extraction based upon the spectral 
differences in arterial and venous blood measured by the AVOXimeter, along with the 
changes in perfusion pressure, and lactate efflux at each gas mixture. At 100%, air, 
VO2 was 32.19 ± 2.55 jimol.e.hr" I (n=32), with perfusion pressure 35.7 ± 1.1 mmHg 
(n=32), and lactate efflux of 10.9 ± 1.4 gmol.g -l .hr-1 (n=9). As arterial oxygen 
concentrations declined, V02 also decreased. At 50% gas mixture and below, the rate 
of oxygen consumption was significantly lower than the 100% air value, (P<0.001, at 
50%, 25%, and 0%). Return to 100% air at the end of the experiment allowed a 
complete recovery of V02 to near control levels, 31.5 ± 2.4 innol.g -l .hr-1 (P= 0.193). 
The calculated rates of oxygen consumption from the oximeter and the AVOX 
compared well, and were not significantly different from each other. The decline in 
arterial oxygen also caused a gradual increase in perfusion pressure. However, this 
difference was not significant until 25% air, where pressure was 16.5 mmHg greater 
than 100% air, (P<0.001, n=9). Pressure remained elevated (P<0.001), even after 
100% air was restored. Lactate efflux climbed steadily with each successive change in 
oxygen delivery, failing to reverse when 100% air was restored at the end of the 
experiment (Figure 3.3, Panel C). 
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Figure 3.2 Direct Measurement of Arterio-Venous Oxygen Content 
Blood samples were drawn in airtight syringes before and immediately after the perfusing limb, and 
assayed for their oxygen content with an oximeter. Data shown are means ± SE. Panel A shows changes 
in arterial (•), and venous (0) oxygen content as gas mixture was varied. * and # denote significant 
changes from arterial and venous 100% values respectively. Panel B shown oxygen uptake (V02) 
calculated from arterio-venous oximeter values. * P<0.05, significantly different from 100% air. 



















100 75 50 	25 	0 	100 
Gas Mixture (% air) 
Figure 3.3 Effects of varied arterial oxygen on V02, PP and LE. 
Oxygen consumption (panel A), Perfusion Pressure (panel B), and Lactate efflux (panel 
C). Values are means i-  SE. Statistical differences were assessed by one-way repeated 
measures ANOVA with pairwise-comparisons by the Student-Newman-Kuels test. 
* P<0.05. significantly different from 100% air value. 
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3.3.2. Monitoring Redistribution of Flow 
3.3.2.1 1-MX metabolism, and purine/pyrimidine efflux during varied oxygen delivery 
The conversion rate of the exogenously applied substrate 1-MX to 1-MU by the 
capillary endothelial enzyme xanthine oxidase is regarded as a useful tool in gauging 
changes in proportion of nutritive flow in the hindlimb. Increased rates of 1-MU 
production, and 1-MX disappearance are thought to indicate increased capillary blood 
flow. In the current experiments, no changes in the rate of 1-MU production or 1-MX 
disappearance were detected at any of the gas mixtures (Figure 3.4, Panels A & B). 
Similarly, when expressed as a ratio (1-MU production: 1-MX disappearance), no 
changes were apparent, indicating that no changes occurred the ratio of nutritive to non-
nutritive flow during varied oxygen delivery (Panel E). The efflux rates of both uracil 
and uric acid increased significantly with declining arterial oxygen (Panels C & D) 
3.3.2.2 Microdialysis 
The out/in ratios for 3 H20 (Panel A) and 14C-ethanol (Panel B) are shown in 
Figure 3.5. Data are means ± SE from 18 separate experiments. A downward shift in 
the 0/I ratio is thought to represent increased clearance from the probe, reflecting 
enhanced nutritive flow (221). However, in this set of experiments no significant 
changes were detected in the 0/I ratios for either 3H20 or 14C-ethanol. These results 
demonstrate no changes occurred in the exchange rate of diffusible radioactive 
substances between the microdialysis probe and the perfused tissue, thus the ratio of 
nutritive to non-nutritive did not change during varied oxygen delivery. 
3.3.2.3 Laser Doppler Flowmetry 
The response of laser sites diagnosed as nutritive, and non-nutritive to varied 
oxygen delivery is shown in Figure 3.6 (nutritive Panel A, non-nutritive Panel B). The 
first recorded signal was converted to 1.0. Varied arterial oxygen caused small 
fluctuations in LDF signal at both sites, however these changes were not significantly 
different from the first recorded data point. 
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Figure 3.4 1-MU, 1-MX, uracil and uric acid content of perfusate samples 
Venous samples were collected and analyzed by HPLC. The effects of varied oxygen delivery on 
1-MU (Panel A), 1-MX (Panel B), uracil (Panel C), and uric acid (Panel D) are shown. The ratio 
of I-MU/1-MX is also shown in Panel E. Statistical testing Was repeated measures one way 
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Figure 3.5 Effects of varied arterial oxygen on Microdialysis 01I ratios. 
Out/ In ratios for 3112 0 (Panel A), and ' 4C-Ethanol (Panel B). Known concentrations of 3H20 and 
R IC-Ethanol were pumped at 2,u1/min through microdialysis tubing embedded in the perfused 
muscle. Outflow samples of dialysate were collected and compared with the inflow solution. No 
changes were detected in the out/in ratios for either 3 112 0 or ' 4C-Ethanol. Statistical tests using 
one-way repeated measures ANOVA with pairwise comparisons using the Student-Newman-Kuels 
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Figure 3.6 Laser Doppler Response during varied Arterial Oxygen 
Laser sites were diagnosed as either nutritive or non-nutritive at the beginning of each 
experiment, as judged by the response to 5-HT bolus (Clark et al. 2001). Data are expressed in 
relation to the first recorded data point (100% 02 is always 1.0). Panel A shows laser 
response embedded in nutritive sites, while Panel B illustrates the laser response at non- 
nutritive sites. Data are means ± SE (n=6 for nutritive and non-nutritive), analysed by one-way 
repeated measures ANOVA with pairwise comparisons by the Student-Newman-Kuels test. 
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3.3.3 High energy phosphates content of muscle samples 
Shown in Table 3.2 are the results from HPLC analysis of freeze-clamped 
muscle samples (n=5 for each gas -mixture, total of n=30 muscles). As the arterial 
oxygen content declined, phosphocreatine (PCr) levels declined, with a corresponding 
increase in creatine (Cr). - These differences were significant at 25% gas mixture 
(P<0.05) and below. The return to 100% air at the end of the experiment did not allow 
for full recovery of PCr levels in the 30-min time period. No significant changes were 
detected in the levels of ATP, ADP or AMP at any gas mixture. 
Inosine levels remained fairly constant throughout the oxygen curve, until the 
lowest oxygen delivery (0% air) was reached, at which time inosine levels showed a 
large increase from 33.4 ± 9.9 at the start of the experiment, to 170.4 ± 39.2 at 0% 
(P<0.001). Reversal of the gas mixture to normoxia allowed recovery of inosine to pre-
hypoxia levels. Adenosine was not detected (detection level 0.01 nmol/g wet wt) in 
any of the samples. 
Data from various metabolite profiles was used to calculate rates of cellular 
ATP utilization. Based upon [ATP], [ADP] and [AMP] levels, the energy charge (EC) 
of the muscle remains relatively stable despite the large change in oxygen delivery. 
There does not appear to be any loss, or degradation of adenine nucleotides from the 
tissue during the period of hypoxia or recovery. The ratio of PCr/ATP demonstrates a 
different pattern. While the ATP levels remain relatively constant (Table 3.2), PCr 
levels are gradually declining. It therefore appears that ATP levels are maintained at 
the expense of PCr stores. This is also reflected in the calculation for cellular energy 
potential. The cellular energy potential calculation takes into account both [ATP] and 
the falling [PCr] when examining cellular energy status. Based upon this calculation, it 
becomes clear that the total cellular energy potential is under threat by low arterial 
oxygen tension. Reversal to normoxia at the end of the experiment shows some signs 
of recovery, though far from complete in the 30-minute recovery period. 
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Table 3.2. Effects of gas mixture on freeze-clamped Muscle Energy Metabolites. 
Freeze-clamped muscles were ground under liquid nitrogen and extracted with HC104 , then neutralized (Section 2.7) for HPLC analysis under 
reverse phase-ion paired conditions. Data are means 21- SE for n= 5 at each gas mixture (total of n = 30 freeze clamped muscles), and the return 
to 100% air at the end of the experiments (100#) expressed as units per gram wet weight). Data were analysed statistically with one-way ANOVA 
with pairwise comparisons by the Student-Newman-Kuels test, * P<0.05. ND = not detectable. 
100 75 
Gas Mixture (% air) 
50 	 25 0 100# 
Phosphocreatine (umol/gww) 20.2 ± 1.8 17.1 ± 2.0 14.1 ± 0.9 10.5 ± 2.2 * 6.0 ± 1.8 * 8.25 ± 2.1 * 
Creatine (gmol/gww) 17.4 ± 0.9 19.5± 1.5 19.4± 1.9 23.6 ± 1.6 * 23.1 ±0.9 24.6 ± 0.8 * 
ATP (umol/gww) 6.3 ± 0.2 6.8 ± 0.2 5.9 ± 0.4 5.9 ± 0.6 4.8 ± 0.9 5.8 ± 0.5 
ADP (pmol/gww) 0.93 ± 0.11 1.04 ± 0.1 0.85 ± 0.06 0.78 ± 0.2 1.11 ± 0.13 1.15 ± 0.14 
AMP (nmol/gww) 92.6 ± 22.2 56.0 ± 6.6 67.3 ± 13.1 91.4 ± 26.9 85.1 ± 13.5 109.4 ± 13.5 
Inosine (nmol/gww) 33.4 ± 9.9 30.7 ± 3.7 36.8 ± 7.8 19.7 ± 8.1 170.4 ± 39.2 * 61.4 ± 25.8 
Adenosine (nmol/gww) ND ND ND ND ND ND 
Phosphocreatine / ATP 3.23 ± 0.25 2.53 ± 0.3 2.42 ± 0.19 1.71 ± 0.24 * 1.17 ± 0.24 * 1.53 ± 0.48 * 
Energy Charge 0.85 ± 0.02 0.86 ± 0.01 0.87 ± 0.01 0.86 ± 0.04 0.80 ± 0.04 0.82 ± 0.02 
Cell Energy potential 33.7 ± 2.2 31.7 ± 2.0 26.8 ± 1.4 23.0 ± 3.2 * 13.4 ± 4.4 * 20.9 ± 1.4 * 
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3.4 Discussion 
The current findings demonstrate a positive relationship between oxygen 
delivery and resting muscle oxygen consumption (Figure 3.2, Panel C). Failure to 
detect significant changes in 1-MX metabolism, microdialysis out/in ratios and laser 
doppler signal during varied oxygen delivery (Figs. 3.4, 3.5 & 3.6) indicates that the 
decline in V0 2 occurred independently of redistribution of flow. Thus, varied oxygen 
delivery did not cause capillary recruitment, de-recruitment or variations in the mass of 
perfused tissue. With assurance that oxygen concentration was the only variable 
parameter in these experiments, it is concluded that oxygen delivery has a significant 
role in the regulation of resting skeletal muscle V02. Limitation of muscle V02 by 
oxygen delivery has been reported by many other groups in both resting (161; 180; 
181), and contracting skeletal muscle preparations (14; 156; 165; 247). 
The gradual progression from normal to low oxygen delivery (100-0% air) was 
accompanied by a noticeable increase in perfusion pressure. The reason for this 
pressure change is not clear. Pressure development was not causal for redistribution, 
since no changes were detected in the metabolism of 1-MX, microdialysis exchange or 
laser doppler signal. Endothelial cells are a likely source of vasoactive substances, and 
short-term exposure to low oxygen environments is known to induce release of 
vasoactive substances [reviewed in (114)]. The partial reversibility noted upon return 
to 100% air (Figure 3.3, Panel B) implies that the constriction was due to the release of 
local vasoactive substances, production of which ceased once 100% air was restored. 
The decline in arterial oxygen concentration was accompanied by a significant 
increase in lactate efflux (Figure 3.3, Panel C). Lactate efflux increased from 10.9 ± 
1.4 (at 100% air) to 31.9 ± 6.1 umol.e.hf l (at 0% air) (P<0.001). The 30-minute 
period of normoxia at the end of the experiment did not allow for reversal of LE, 
instead efflux rates continued to climb, reaching a maximum of 51.7 ± 12.1 umol.e.hr " 
I . Similar patterns were also noted for the efflux rates of uracil, and uric acid (Figure 
3.4, Panels A & B). The close association between lactate, uracil and uric acid efflux 
has been noted previously with the infusion of the type A vasoconstrictor angiotensin II 
(242). 
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Traditionally lactate release is regarded as a sign of inadequate oxygen supply. 
When aerobic ATP production falls, anaerobic metabolism is activated in order to 
compensate. Assuming a P:0 ratio of 2.5 (254), and that 1 mol of ATP is produced for 
every mol of lactate, the relative contributions of aerobic and anaerobic metabolism to 
total ATP production may be calculated by simple conversion of VO2 and LE values. 
During normoxia (100% air), total ATP production was calculated at 171 umol ATP.g" 
'.hr-1 . Between 100 and 0% air, ATP derived from aerobic sources decreased from 160 
to 63 umol ATP.e.hr-1 (60% decrease). In order to fully compensate for this loss, total 
LE would need to be in the vicinity of 108 mol.g-l .hr-1 . This is 3 times higher than the 
actual value (31.9 umol.e.hr" 1 ) observed at 0% air. 
Total ATP production calculated from V02 and LE actually decreased from 171 
to 95.2 mai ATP.g -1 .hr-1 (representing a decrease of 44%) as the arterial gas mixture 
was changed from 100 to 0% air, indicating that ATP production is also a function of 
oxygen delivery. However, the proportional contributions of aerobic and anaerobic 
metabolism were also varied. At 100% air, the percent contributions to ATP 
production from aerobic and anaerobic metabolism were 93 and 7% respectively. This 
proportion changed to 66 and 33% at 0% air. Though the proportion of ATP derived 
from anaerobic sources is elevated, this is still not the dominant source of energy 
production. 
Alternatively, one must consider the possibility that the P/0 ratio is 
substantially less than 2.5, perhaps closer to 1.5 owing to decreased coupling efficiency 
in the event of basal proton leak (251; 253). Under these conditions, it is estimated that 
the ATP production changes from 103.9 (100% air) to 68.7 umol ATP.e.hr -1 (0% air). 
Of the initial 100% air value, aerobic respiration is estimated to contribute 89.5% of 
total ATP production, while LE accounts for the remaining 10%. Under more limited 
conditions (0% air), it is estimated that LE now contributes a considerably larger 
proportion of total ATP production (47%). Even under this hypothetical situation, LE 
is still not the major source of energy production. While LE was significantly elevated 
in the current data series, this increase is not considered great enough to compensate 
fully for the loss of ATP production from aerobic sources, confirming that total ATP 
production declines as a function at oxygen delivery. - 
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If not sufficient to compensate for lost ATP production, why then is lactate 
-release increased during low oxygen delivery? The view that LE is the result of 
inadequate oxygen delivery has recently been challenged. In a study of human skeletal 
muscle during graded exercise, lactate release was shown to increase even though 
intracellular Po2 remained constant (244). While examining canine gracilis muscle 
Connett and colleagues (80; 81) noted that intracellular P02 levels were unrelated to 
muscle lactate release, and that lactate release also occurred under fully aerobic 
conditions. Furthermore, Jobsis & Stainsby (176) demonstrate no difference in the 
oxidation-state NADH/NAD± between muscles at rest and while producing lactate. 
The view now presented, is that muscle LE is attributable to factors other than 0 2- 
limitation of mitochondrial ATP synthesis. Thus, the elevated lactate efflux observed 
during the course of these experiments is not necessarily the result of inadequate 
oxygen delivery. 
Lactate efflux has also been shown to increase during type A vasoconstrictor 
mediated metabolism in the perfused rat hindlimb (144; 242). While it is no longer 
accepted that vasoconstrictor-mediated oxygen V02 is due to work performed by 
vascular smooth muscle, it is still possible the lactate may originate from vascular 
tissue as it maintains tone (145). This is in agreement with the current findings, since 
both perfusion pressure and lactate efflux remain elevated upon return to 100% air 
(Figure 3.3). Muscle V02 recovered completely upon return to 100% air, despite 
elevated pressure and lactate, reinforcing our conviction that elevated V02 is not the 
direct result of vasoconstriction. 
An alternative explanation for the appearance of lactate during low oxygen is 
presented in a paper by Gutierrez and colleagues (136). Comparison of the effects of 
ischemia and hypoxia in perfused rabbit skeletal muscle led to the following findings. 
Ischemia caused depletion of muscle PCr levels, but no change in the rate of lactate 
efflux was noted during or following ischemia. Restoration of normal flow allowed 
complete recovery of PCr levels. Conversely, hypoxia caused a decrease in PCr that 
did not recover with re-oxygenation. Lactate efflux began to rise, and continued to 
climb despite re-oxygenation, consistent with observations in the perfused rat hindlimb. 
Gutierrez et al: (136) propose that during total ischemia the rate of glycolytic flux is 
totally dependent on cellular glycogen stores, and this may limit the amount of lactate 
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produced. However, partially ischemic or hypoxic tissue may suffer damage as a result 
of unlimited glucose supply, where lactate production continues unchecked, and lactic 
acidosis may result. No evidence of tissue damage was apparent in these experiments, 
since V02 recovered completely, and cellular ATP levels were maintained (Fig. 3.3 & 
Table 3.2). However, a constant glucose supply was maintained, and may have 
allowed glycolytic pathways to continue unhindered, resulting in a situation where 
glycolytic intermediates are available in abundance, but oxidative phosphorylation is 
limited. Thus, elevated lactate efflux observed may be the result of constant glucose 
supply during low oxygen delivery rather than activation of anaerobic glycolysis. 
Examination of muscle high-energy phosphates showed no significant changes in 
the intracellular concentrations of [ATP], [ADP], [AMP] or [IMP]. However, PCr 
stores began to decline as soon as arterial oxygen levels were decreased, with a 
corresponding increase in Cr (Table 3.2), though these changes were not significant 
until 25% air. Since ATP levels remain constant, it would appear that ATP levels were 
buffered at the expense of PCr via the creatine kinase reaction. The return to normoxia 
showed beginnings of very slow PCr recovery, though far from complete in the 30-min 
recovery period. A very large peak of inosine was detected in samples collected at 0% 
air. Inosine levels increased over 4 times between 25 and 0% air, however this peak 
subsided with return to 100% air. Adenosine was not detected in any of the samples. 
This is not surprising, since adenosine is rapidly broken down in the venous perfiisate. 
However, the sudden appearance of inosine at 0% air, may be a lasting shadow of 
adenosine release. Similarly, the gradual increase in uric acid (Figure 3.4, Panel D) 
may also be a breakdown product of adenosine. Though total adenine nucleotide 
content was not significantly reduced, even a small (nM) loss of adenine from the large 
(1.1M) skeletal muscle pool might account for the appearance of nM quantities of 
inosine and uric acid in the venous samples, perhaps reflecting local adenosine 
production in response to low oxygen delivery. 
Various estimates of cellular energy status are also shown in Table 3.2. No 
changes were detected in the cellular 'energy charge. Based on this calculation alone, 
one might assume no threat upon cellular energy turnover with low oxygen delivery. If 
no attempt is made to recover loss ATP (via anaerobic sources), and total cellular ATP 
levels are not declining, then total ATP utilization must be decreasing with oxygen 
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delivery, and one may speculate on the possibility of oxygen conformance in perfused 
muscle. However, examination of PCr/ATP ratio reveals that low oxygen delivery does 
in fact have detrimental effects of on cellular energy turnover. Similar findings were 
reported by Idstrom and colleagues (165) in the perfused contracting rat hindlimb with 
31 P- NMR spectroscopy, where muscle PCr levels were reduced with low oxygen 
delivery. Calculation of cellular energy potential from the equation ([PCr] + 2[ATP] + 
[ADP]) also exposes the threat posed to the cell by low oxygen delivery. Thirty 
minutes after return to 100% air, signs of improvement in cellular energy status are 
evident, though far from complete. Maintenance of ATP levels is probably not a 
reflection of decreased ATP utilization, but the result of PCr sacrifice. Presumably 
prolonged perfusion at the lowest oxygen delivery would exhaust PCr supplies, and 
ATP levels would also eventually decline. 
In order to address the question "is the perfused hindlimb an oxygen 
conforming tissue?" one must consider a number of issues. In response to 
progressively decreased arterial oxygen levels, Gutierrez et al. (137) found evidence for 
both oxygen conformance and oxygen regulation in the blood perfused rabbit hindlimb. 
The decrease in V02 was always accompanied by increased levels of lactate and Pi, and 
decreased PCr, consistent with the current data series. Taken together, these findings 
suggest 02 supply limitation of metabolism, and activation of anaerobic ATP 
production. The classical definition of oxygen conformance is a proportional variation 
in cellular energy requirement in response to changes in oxygen supply (153), without 
compensatory activation of anaerobic mechanisms. In this regard, the perfused rat 
hindlimb may not be regarded as a strict oxygen conformer. 
On the other hand, skeletal muscle oxygen conformance may only be evident 
above critical values. The cultured mouse skeletal muscle cell line C2C12 shows 
evidence of oxygen conformance in the range of 100-10pM (8). V0 2 was decreased 
between 25-40%, while cellular ATP and PCr were maintained. Lactate efflux did not 
increase significantly until oxygen levels fell below 4p.M. In the perfused hindlimb, 
ATP levels were maintained at all oxygen deliveries, and PCr levels did not decline 
significantly until 25% air (4.7 umol/m1). At this stage, total oxygen delivery had 
declined by 38%, and oxygen consumption had been suppressed by more than 45%. 
Though lactate began to increase at around 50% air (6.0 p.mol/m1), this is not 
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necessarily due to activation of anaerobic ATP production (as discussed earlier). Thus, 
above 4.7 innol/ml, oxygen consumption is significantly suppressed without depletion 
of ATP or PCr stores. It is therefore concluded that the perfused rat hindlimb is 
capable to a certain extent of oxygen conformance, though this may only be evident 
above critical values. 
Though arterial oxygen concentrations reported here are considerably higher 
than those for isolated cells (mM versus iM), it must be remembered that tissue mass 
of the perfused hindlimb is considerably larger (around 15g). The flow rate of 4 
ml/min results in tissue perfusion rates of 0.3 mug muscle/min, combined with 
diffusion gradients and heterogeneous perfusion, oxygen delivery at the microvascular 
level is likely to be in the tM range. This has been demonstrated with the use of 
oxygen microelectrodes impaled into autoperfused feline muscles, where 
intramyocellular PO2 was in the vicinity of 8mmHg (305). Thus comparisons of 
isolated and perfused muscle preparations are valid. 
The strong relationship between 0 2 delivery and VO2 may be fundamental to 
the mechanism by which type A vasoconstrictors stimulate resting metabolism in the 
perfused rat hindlimb. Type A vasoconstrictors do not increase the oxygen content of 
the blood, nor the total blood flow, but may be effective in increasing the oxygen 
delivery by enhancing the extent of capillary perfusion. Ergo, the underlying 
implication of this finding is that even under standard conditions (suitable flow rate and 
oxygen saturation), muscle metabolic rate is oxygen limited. Previous data obtained in 
aerobically contracting perfused rat skeletal muscle supports this notion, since the 
addition of the type A vasoconstrictor angiotensin II was noted to improve tension 
development by 80%, and contraction-induced oxygen uptake (237). Richardson and 
colleagues present data along the same lines (244-246), where increased oxygen 
delivery [through increased oxygen content of inspired air] considerably enhanced 
VO2MAX in contracting human muscle. It is thus concluded, that type-A mediated 
redistribution of flow and capillary recruitment is likely to reduce heterogeneity of 
perfusion, and increase oxygen delivery at the microvascular level, thereby removing 
physiological restraint on muscle oxygen uptake. 
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The blood perfused rat hindlimb shows a strong correlation between oxygen 
delivery and V02 (Figure 3.2). Reduced oxygen delivery did not affect the proportion 
of nutritive flow, since no significant changes were detected in the rates of 1-MX 
metabolism, microdialysis 0/I ratios for 3H20 and I t-Ethanol, or laser Doppler 
flowmetry. The elevated rates of lactate efflux, and decreased muscle PCr content 
suggest secondary activation of anaerobic energy producing pathways during low 
oxygen delivery. However V02 was significantly depressed before these effects (LE 
and PCr) were significant. The perfused rat hindlimb may not be a strict oxygen 
conformer according to the definition of Hochachka & Guppy (153), however, the 
relationship between oxygen delivery and muscle V0 2 opens new corridors for the 
investigation of type-A vasoconstrictor mediated metabolism. 
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CHAPTER 4 
IN 	OF Na+/K+-ATPase AND SODIUM CHANNELS DURING TYPE A- AND 
VERATRIDINE-STIMULATED METABOLISM. 
4.1 Introduction 
Stimulation of metabolism by type A vasoconstrictors is known to be sensitive to a 
variety of treatments, including vasodilators acting via nitric oxide (NO), cAMP, or 
calcium channel blockade (58), compounds affecting the respiratory chain, and low oxygen 
tensions (96). The inhibitory effect of propranolol (13-antagonist) on norepinephrine-
mediated metabolism in the hindlimb was not entirely unexpected, and has been reported 
previously by other groups (69; 132; 274). However, the chance finding that high dose ± 
propranolol (±100uM) blocked the effects of another non-adrenergic type A 
vasoconstrictor angiotensin II (All), offered new insight into the potential mechanism of 
vasoconstrictor-mediated thermogenesis (292). 
High dose propranolol selectively blocked the vasoconstrictor-mediated increase in 
V02, and LE, but did not interfere with the development of pressure, or the redistribution 
of blood flow (as judged by red cell washout). Inhibition was not attributable to 13 -
antagonism, since other 13-antagonists (nadolol and atenolol) were without effect on 
angiotensin-mediated thermogenesis (292). Comparison with another membrane stabilizer, 
quinidine (291) led to the conclusion that the inhibitory effects of high dose propranolol 
and quinidine on angiotensin-mediated metabolism were due to the membrane-stabilizing 
properties of these agents. 
In perfusion, the alkaloid veratridine (sodium channel opener) has also been shown 
to stimulate V02 and LE, independently of vasoconstriction (292). Veratridine causes 
persistent activation of sodium channels at resting membrane potentials (45) thus allowing 
Na+ influx. Like type A vasoconstrictors, veratridine-mediated metabolism was also 
blocked by high dose propranolol, and the stimulatory effects of both agents were 
abolished by low sodium media (291). Combined, these results led to the hypothesis that 
destabilization of the muscle plasma membrane, and increased rates of ion cycling possibly 
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involving the Na+/K+-ATFase pump were shared events in the mechanism of stimulated 
metabolism by both type A vasoconstrictors and the membrane labilizer veratridine (291). 
The aim of the current chapter is to assess the involvement of Na+/K+-ATPase pump and 




For the purpose of this study, experiments were conducted on rats sized between 
70-80g. (3-4 weeks old). Ouabain binding studies suggest maximal Na +/K+-ATPase 
concentrations in this age group (71; 177). Further, it has previously been noted that the 
maximal NE effect is of a greater magnitude (60% higher) in small rats (70-80g) when 
compared with larger rats (180-200g) (291). 
4.2.2 Dual hindlimb perfusion 
The nature of the present study depends upon the integrity of the skeletal muscle 
plasma membrane being maintained. Many systems employed for the study of muscle 
metabolism involve the use of cut, isolated, or non-intact muscle preparations. Removal of 
the muscles, or cutting, will disrupt ion concentration gradients across plasma membranes 
(51; 76) leading to artificial states of ion distribution. One advantage of the perfused 
hindlimb model is the intact nature of the preparation, thus maintaining integrity of the 
skeletal fiber plasma membranes. Owing to the limited muscle mass in small rats, animals 
were prepared surgically for dual hindlimb non-recirculating perfusion, at a flow of 4 
ml/min per 2 hindlimbs (approximately 0.40 - 0.45 ml/min/g muscle), with medium 
containing 2% BSA, at 25°C. Details of the surgical technique, and perfusion 
medium/apparatus are outlined in Sections 2.2.2 & 2.2.3. 
4.2.3 Perfusion medium and infusion agents 
Perfusion media details are given in Section 2.2.4.1. Ouabain and digoxin were 
dissolved directly into the perfusion medium to give final concentrations of 1mM (dose 
shown to produce maximal inhibition of active Na +a+-ATPase transport in rat soleus 
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muscle (73)), and 30p.M respectively. Digitoxin (301.IM final) was dissolved in a small 
quantity of 50% ethanol before being added to the perfusion medium. The final 
concentration of ethanol in the entire volume never exceeded 0.6%. 
Following the 50-min equilibration period with normal medium, the reservoir was 
changed to one of the designated media (1mM ouabain, 3011M digoxin or 301.tM digitoxin). 
A further 30-mins equilibration was allowed with each new media before vasoconstrictor 
or veratridine dose curves commenced. Sodium nitroprusside (SNP, 0.5mM) was included 
in the media for all veratridine experiments to ensure no development of pressure (291), or 
possible redistribution effects. 
4.2.4 NE- and veratridine- dose response curves 
Dose response curves were constructed by infusing a concentrated solution of NE to 
achieve final concentrations of 3, 10, 30, 100 and 300nM, allowing 20-mins at each. Dose 
response curves were repeated in the presence of 1mM ouabain medium, or 301.IM 
digitoxin. Similarly, veratridine dose response curves were constructed to achieve 3, 10, 
30, 100 and 300gM final concentrations, allowing 20 mins at each dose. Veratridine dose 
response curves were repeated in the presence of 1mM Ouabain, 301.1M Digoxin or 301AM 
Digitoxin (0.5mM SNP included in all veratridine experiments). Venous effluent samples 
were collected and assayed for their lactate content with a YSI glucose/lactate analyzer 
(Section 2.6.1). 
4.2.5 Effects of tetrodotoxin on NE- and veratridine-mediated changes in metabolism 
The involvement of voltage-gated sodium channels was assessed with the use of the 
sodium channel inhibitor tetrodotoxin (TTX). Following 50-mins equilibration, a constant 
infusion of either 100nM NE, or 301AM veratridine commenced. Once steady state V02 




4.3.1 Basal metabolism 
Equilibration of the hindquarter for 50-min in normal 2% BSA led to steady-state 
values for .702 (11.35 ± 0.33 ilmol.g -l .hr-1 ) and PP (16.7±1.27 mmHg) before the addition 
of any agents (n=30), data shown in Table 4.1. Lactate efflux was also steady in this time, 
and remained so for up to 180-min of perfusion (data not shown). 
Table 4.1 Effects of sodium nitroprusside, ouabain, digoxin and digoxin on basal metabolism. 
Pre-equilibration of the constant flow perfused hindlimb with normal perfusion media allowed 
measurement of basal metabolism. Following the 50-min pre-equilibration period, perfusion media 
was changed to either 1 mM ouabain (i- 0.5 mM SNP), 30 ,uM digoxin + SNP, or 30 ,uM digitoxin + 
SNP. New steady state values for V0 2, PP and LE were obtained within 30-40 min. Values are 






12.8 ± 0.4 
12.6± 0.4 
21.5 ± 1.3 
19.5 ± 0.9 
10.4 ± 1.1 
11.3 ± 1.1 
Basal 11.5 ± 0.3 21.5± 1.2 7.5 ± 0.2 
1mM Ouabain 10.7 ± 0.6 27.5 ± 1.9* 6.8 ± 0.2* 
Basal 11.6 ± 0.4 23.5 ± 0.5 9.2 ± 0.1 
1mM Ouabain + 0.5mM SNP 11.3 ± 0.2 22.5 ± 0.3 11.2 ± 0.9 
Basal 11.3 ±0.5 22.5 ± 1.2 6.1 ±0.2 
3011M Digoxin + 0.5mM SNP 10.3 ± 0.3 25.5 ± 1.7 6.2 ± 0.3 
Basal 9.2 ± 1.5 24.4 ± 2.7 5.0 ± 0.9 
301.tM Digitoxin + 0.5mM SNP 9.2 ± 1.5 26.6 ± 2.8 4.5 ± 0.2 
78 
Substitution of the equilibration medium for one containing linM ouabain caused a 
slight (though insignificant) depression of basal V02. Ouabain also caused small pressure 
effects (6 mmHg above basal, P<0.05, Table 4.1), and a minor suppression of basal lactate 
efflux (9.3%, P<0.05). The inclusion of 0.5mM SNP with ouabain ameliorated these minor 
effects. Neither 30pM digoxin, nor 30pM digitoxin in the presence of 0.5mM SNP had 
any significant effects on basal V02, PP or LE within the 30-40 min equilibration period 
(Table 4.1). 
4.3.2 Effects of ouabain on NE dose curve 
Figure 4.1 compares the effects of a NE dose response curve ± 1mM ouabain on 
hindlimb oxygen uptake (V02), perfusion pressure (PP), and lactate efflux (LE). The dose-
dependent increase in V02 mediated by NE was almost completely abolished by 1mM 
ouabain at all doses of NE (3-300nM). The greatest inhibition of V02 by ouabain occurred 
at the three highest doses of NE (30, 100 and 300nM, where P<0.01 for each). Lactate 
efflux was similarly affected, though significance was found only at 100nM NE. There 
was some inhibition of PP development by ouabain, however this difference was 
significant only at the two highest doses of NE (100 and 300 nM, P<0.05). 
Digitoxin did not significantly affect the NE dose curve, although an inhibitory 
trend was noted on V02 towards the upper end of the NE curve (data not shown). 
Unexpectedly, digoxin displayed a slow onset intrinsic pressor effect. Separate control 
experiments illustrate a time dependent increase in perfusion pressure with 30p.M digoxin, 
commencing after the 50-min equilibration period even in the presence of SNP (data not 
shown). Thus, it was not possible to test digoxin against NE, since the pressor effect of 
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Figure 4.1. Effects of norepinephrine (NE) dose response curve ± 1mM ouabain on 
oxygen uptake (V02), perfusion pressure (PP), and lactate efflux (LE). 
Both hindlimbs were perfused at a constant flow. Perfusions were either control (0), which 
has been reported previously (Tong et al. 1998), or in the presence of] mM ouabain media 
(•). Basal and steady-state values are given in Table 4.1. Mean values for changes (from 
basal or steady state) ± SE are shown (n=5). Significant differences from steady-state 
stimulation: * P<0.05; ***P<0.001. 
4.3.3 Effects of ouabain, digoxin, and digitoxin on veratridine dose curve. 
All three media (ouabain, digoxin and digitoxin) in the presence of 0.5mM SNP 
significantly inhibited veratridine-mediated stimulation of V02 and LE (Figure 4.2). At 
doses of veratridine greater than, and equal to lOpM, inhibition of V02 by all agents tested 
was highly significant (P<0.001). The relative percent inhibition of VO2 stimulated by 
301.IM veratridine was 69, 89, and 61% by ouabain, aigoxin, and digitoxin respectively. 
The inclusion of 0.5mM SNP in control, ouabain and digitoxin media abolished the 
minor pressure effects due to veratridine. However, the intrinsic pressor effect of digoxin 
was not attenuated by inclusion of SNP. Since veratridine is not dependent on 
vasoconstriction to mediate changes in metabolism (as shown by the control veratridine 
curves in Figure 4.2), the pressor effect of digoxin was not considered problematic. Time 
control experiments with 30pM digoxin showed the pressure effects to be time dependent. 
Hence veratridine-mediated changes in metabolism in the presence of digoxin were 
calculated against a constant moving baseline (data not shown). 
Ouabain and its analogues had significant inhibitory effects on veratridine-mediated 
changes in LE. Maximum inhibition of LE occurred at the maximal stimulatory dose of 
veratridine (30p.M) where all three agents inhibited LE by more than 80% when compared 
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Figure 4.2. Effects of cardiac glycosides against veratridine-mediated changes in oxygen 
uptake (V02), perfusion pressure (PP, and lactate efflux (LE). 
Both hindlimbs were perfused at constant flow. Perfusions were either control + 0.5mM SNP (6), 
reported previously in Tong et al. (1998), or with media containing 1mM ouabain + 0.5mM SNP 
(A), 30,uM digoxin + 0.5mM SNP (•), or 30,uM digitoxin + 0.5mM SNP (t. Mean values for . 
changes (ft-Om basal or steady state) _± SE are shown (n=5). Basal and steady-state values for V0 2, 
PP and LE are shown in Table 4.1. Significant differences from control + SNP are indicated by the 
following: * P<0.05; ** P<0.01; P<0.001. 
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4.3.4 Effects of TTX on NE- and veratridine-mediated increases in V02 
Figure 4.3 shows the effects of increasing doses of tetrodotoxin against a constant 
infusion of either 100nM NE, or 30;_iM veratridine. Control TTX curves (no other agent 
present) revealed no effect of TTX on basal oxygen consumption (P>0.05, data not shown). 
A pre-infusion of either 100nM NE, or 30tiM veratridine was allowed to plateau before 
TTX infusion commenced. 100nM NE increased V02 7.21 ± 1.2 lArnol.e.hr-1 above basal 
(P<0.05, n= 6), while 30p.M veratridine increased 'O2 by 5.64 ± (P<0.05, 
n=5). NE-mediated changes in V02 were unaffected by doses of TTX in the range 0.1 to 
501.1M. The veratridine-mediated increase in V0 2 was highly sensitive to TTX infusion. 
Above 0.1p.M, TTX had almost completely reversed the veratridine effect (P<0.01), Figure 
4.3). 
-8 	-7 	-6 	-5 	-4 
log FIX] (M) 
Figure 4.3 Effects of tetrodotoxin (TTX) dose-response curve against steady-state stimulation 
of oxygen consumption by NE, or veratridine. 
Both hindlimbs were perfused at a constant flow rate. Perfusions were either constant infusion of 
100nM NE It- TTX dose-response curve (•), or constant infusion of 30itM veratridine ± TTX dose- 
response curve (IC. Values are mean changes from basal ± SE, (n= 3 for 501.4M TTX, and n =5 




The aim of this study was to examine the effects of cardiac glycosides and 
tetrodotoxin on NE- and veratridine-mediated metabolism, with a view to further explore 
the mechanism by which type A vasoconstrictors stimulate resting muscle metabolism in 
the perfused rat hindlimb. Ouabain caused a significant inhibition of both NE- and 
veratridine-mediated V02, and LE without interfering with the vasoconstrictor properties of 
NE. While all three cardiac glycosides were effective against veratridine (Figure 4.2), only 
ouabain was fully effective in antagonizing the effects of NE (Figure 4.1). In addition, the 
sodium channel blocker tetrodotoxin blocked the effects of veratridine on V0 2 at relatively 
low dose (0.0111M), while doses of tetrodotoxin up to 50p,M had no effect on 
norepinephrine-mediated V02. The current data confirm the involvement of the Na+/K+- 
ATPase, but not voltage-gated sodium channels during vasoconstrictor-mediated skeletal 
muscle metabolism. 
In a recent report from this laboratory (291), it was proposed that a common 
thermogenic mechanism underpinned the stimulatory effects of veratridine and type A-
vasoconstrictors in the perfused rat hindlimb. It was proposed that destabilization of the 
plasma membrane allowed sodium influx, and the observed increase in V02 was most 
likely a reflection of increased ATP utilization by the Na ÷/1(±-ATPase pump (291). The 
possibility that type A vasoconstrictors act directly upon the Na ±/K+-ATPase pump is 
unlikely, given that isolated incubated muscle preparations are not stimulated by 
vasoconstrictors (50; 69; 85; 97). Activity of the sodium pump does however vary in 
proportion to intracellular Na+ (70; 109; 271), as demonstrated in rat and turtle brain 
synaptosomes with the use of veratridine and tetrodotoxin (105). Thus manipulation of 
intracellular sodium concentrations has the potential to influence cellular metabolic rate. It 
is now considered that type A vasoconstrictors may stimulate muscle V0 2 by increasing 
myocyte intracellular Na+ levels, thereby causing a secondary activation of the Na +/K+- 
ATPase. 
At rest, basal VO2 was not significantly affected by 1mM ouabain (Table 4.1). This 
denotes minimal contribution of the Na +/K+-ATPase during basal metabolism, which is in 
general agreement with previous reports from this lab (291) and others (76). Neither 
ouabain nor tetrodotoxin (0.01 to 5011M) significantly affected basal oxygen consumption, 
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thus sodium pumps and sodium channels do not appear to make a significant contribution 
to resting muscle oxygen consumption. Microcalorimetric determination in isolated intact 
resting mammalian skeletal muscle estimates the contribution of the sodium pump to be 
somewhere between 5-7% of the basal metabolic rate (26; 51; 113). In the rat diaphragm 
muscle, sodium pump activity may account for as little as 2% of the total energy 
consumption (86). Higher values have been reported [in mouse soleus and diaphragm, 
(128)], but these values should be regarded with caution, as discussed by Clausen (76), and 
others (26). The ouabain-suppressible fraction of muscle heat production is to a large 
extent-determined by the rate of Na+ influx (76), therefore the greater efficacy of ouabain 
during agonist-infusion is assumed to be related to increased intracellular sodium levels. 
Using literature values, it was interesting to attempt to calculate the potential 
contribution of active sodium pumping to cellular oxygen consumption. Binding studies 
with 3 H-ouabain estimate the concentration of Na +/K+-ATPase pumps in mammalian 
skeletal muscle to be somewhere between 300- 800 pmol/g wet weight (141). At 37°C, 
active sodium pumping has been estimated at 16900 nmol Na±/g/min (75). Using the ratio 
of 1 ATP for every 3 Na+ pumped, this corresponds with a maximal rate of ATP turnover 
of 5600 nmol ATP/g/min (equivalent to 336p.mol ATP/g/hr). Assuming 1 mol 0 2 is 
consumed for every 6 mol ATP utilized, this corresponds with a maximal oxygen 
consumption of 561.1mo1 02/g/hr. Therefore, maximal activation of the sodium pump could 
easily account for the increase in V02 seen with veratridine, and norepinephrine at 25°C. 
The observation that tetrodotoxin blocked veratridine mediated increases in V02 
confirms the previous findings of others that veratridine binds to, and acts directly upon 
voltage-gated sodium channels (198). Only a very small dose (0.01 pM) of TTX was 
required to almost completely block the veratridine effect (Figure 4.3). However, NE-
mediated V02 was not sensitive to tetrodotoxin, even at doses of up to 50 p.M (Figure 4.3). 
It is not clear how NE may activate the sodium pump, if voltage-gated sodium channels are 
not directly involved. Other potential sodium entry pathways include sodium/calcium 
exchangers, sodium/hydrogen exchangers, and sodium symports, though it is unlikely that 
sodium influx via these alternate pathways would be fast enough to account for the rapid 
onset of type A metabolic effects. There is a slim possibility that NE may be acting upon 
TTX-resistant (TTX-R) sodium channels. However, this also seems unlikely given that 
TTX-R sodium channels are usually only found in cardiac muscle (238), immature 
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myotubes, and denervated skeletal muscle fibers from the adult (45; 120; 250). There are 
no reports to date of TTX-R sodium channels in normal adult innervated skeletal muscle, 
but their presence has not been totally discounted. Primary cultures of fetal rat skeletal 
muscle cells show populations of both TTX-sensitive (high affinity) and TTX-resistant 
(low affinity) sodium channels co-existing, the two subtypes having different 
developmental regulation (273). As the myotubes mature, the TTX-R population is 
gradually replaced with a TTX-S population (120; 138). It is worth considering the age of 
the rats in this study, at 4-weeks some TTX-R channels may still exist. However, this 
explanation is also flawed, since type A vasoconstrictors are still effective in mature rats 
where only TTX-S sodium channels are expected. It is therefore unlikely that type A 
vasoconstrictors increase intracellular sodium via activation of voltage-gated sodium 
channels (TTX-R or otherwise). 
Skeletal muscle Na+/K+-ATPase concentrations also change during the early stages 
of post natal development. Starting with low Na +/K+-ATPase levels at birth, the activity 
reaches optimal levels at 4 weeks of age (an increase of 5-fold), then declines to a lower 
plateau in the adult rat (177). It was therefore interesting to note the different effects of NE 
in 4-week old rats (70-80g), and larger 7-week old rats (180-200g). The same dose of NE 
(100nM, at 25°C with 2% BSA medium) produced a much larger stimulation of V02 in the 
smaller rats when compared with larger rats (5.9 ± 0.6 compared with 4.4 ± 0.291.imol.g -
I .hr-1 ), with less pressure development (44.4 ± 3.8 versus 76.4 ± 3.7mnifig) (291). It was 
speculated at the time that muscle from the smaller rats had a greater concentration of 
sodium pumps, and therefore a greater capacity for ATP turnover when stimulated by 
agonists. 
Skeletal muscle oxygen metabolic rate is influenced by a variety of ionic 
interventions, not all of which are dependent on sodium cycling. Metabolic rate is known 
to be stimulated by high K+ (20mM) medium in isolated-incubated frog muscle (226), and 
in perfiised rat skeletal muscle (294). Isolated incubated muscle oxygen consumption is 
also stimulated by ryanodine (24), hyper-osmolar media (49; 85), and caffeine (23). These 
treatments are all thought to stimulate cellular oxygen consumption by triggering 
intracellular calcium cycling. Slow intracellular calcium leaks (caused by depolarization in 
response to elevated extracellular K+ etc.) trigger the Ca2+-ATPase of the sarcoplasmic 
reticulum. The demand for ATP stimulates oxidative phosphorylation and thus increases 
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oxygen consumption. No contraction of the muscle is observed during caffeine exposure, 
or KC1 depolarization, because intracellular calcium levels are sub-threshold for 
contracture. Calcium cycling as a thermogenic mechanism in skeletal muscle has been 
proposed previously (28; 89; 201). The potential involvement of skeletal fiber calcium 
cycling during type A mediated metabolism will be considered further in the next chapter. 
The relationship between ion flux, and cellular respiration is well established (38; 
105; 152; 164). The energetic cost of ion pumping during normoxia is considerable, but 
the phenomena of "channel arrest" offers a survival advantage to species regularly exposed 
to low oxygen environments. During normoxia, the energetic cost of ion pumping in 
hepatocytes of the western painted turtle was estimated to be in the vicinity of 28% (38). 
However, conditions of anoxia suppress pump activity by approximately 75%. No changes 
in plasma membrane potential were detected, and since the activity of the sodium pump 
was known to be depressed, it was concluded that ion flux was also depressed (38). Thus 
anoxia has the potential to reduce ion cycling, and the energetic cost of maintaining ionic 
homeostasis. If the same phenomena of "channel arrest" occurs in mammalian skeletal 
muscle, it is conceivable that redistribution of flow with type A vasoconstriction might 
participate in the removal of regional hypoxia imposed by heterogeneous flow during basal 
conditions. Concomitant with redistribution is enhanced perfusate and oxygen delivery, 
which may increase membrane permeability and the demand for ATP by the sodium pump 
as it acts to counter the ionic imbalance. The sensitivity of type A vasoconstrictors to 
membrane-stabilizers may be a reflection of this phenomena. 
In summary, veratridine and type A doses of norepinephrine share ouabain 
sensitivity. This finding supports the notion of a shared mechanism of action involving 
activation of Na+/K+-ATPase. However, the second major finding, that NE was not 
blocked by tetrodotoxin is apparently in conflict with this theory. Further studies are 
required to investigate the role of sodium and calcium cycling during vasoconstrictor-
stimulated metabolism in perfused skeletal muscle, and other mechanisms that may 
potentially activate the Na +/K+-ATPase pump. 
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CHAPTER 5 
MEASUREMENT OF MEMBRANE POTENTIAL (E N!) IN SKELETAL MUSCLE FIBERS DURING 
AGONIST-STIMULATED METABOLISM 
5.1 Introduction 
In terms of their effects upon perfused skeletal muscle, NE and veratridine share several 
- --features in common. The stimulatory effects of both agents on perfused hindlimb oxygen 
consumption and lactate efflux are abolished by low sodium media (292), membrane stabilizers 
quinidine and propranolol (291), and the cardiac glycoside ouabain (Chapter 4). Based on these 
similarities it was proposed destabilization of the plasma membrane, and increased rates of ion 
cycling might be common events in the stimulation of metabolism by both agents: Type A 
vasoconstrictors are not blocked by the sodium channel.blocker tetrodotoxin (Chapter 4), though this 
does not exclude the possibility that intracellular sodium levels are elevated via other routes (e.g. 
tetrodotoxin resistant sodium channels, or sodium exchangers). In order to further investigate this 
possibility, a study was undertaken to evaluate the effects of type A vasoconstrictors and veratridine 
on skeletal fiber membrane potential (EM) during agonist-stimulated metabolism. 
Membrane potential (E m) is the result of the weighted average of the equilibrium potentials 
for all permeant ions. The weighting factor for each ion is the fraction of the total membrane 
conductance caused by that ion. That is, the higher the permeability of the membrane to one 
particular ion, the closer EN! will be to the equilibrium constant for that ion. If stimulated 
metabolism is dependent upon destabilization of the plasma membrane (e.g. via sodium entry), then 
depolarization would be expected as E N' moves from resting values (near —70mV) closer to the 
equilibrium of Na+ (close to + 60mV). 
5.2 Methods 
The methods used for this study are described in detail in Section 2.4. The controls and 
experimental protocols are briefly outlined here. All perfusions were dual hindlimb perfusions 
conducted in 70-100g animals, at 25°C, 4 mllmin with 2% BSA, and 1.27mM CaC1 2 . The order of 
the experiments was randomized. Measurement of EN! during perfusion has not been attempted 
previously by this group, therefore several controls were required. Time control studies were 
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conducted to show that there was no deterioration of membrane potential with time, and a positive 
internal control to check that changes in membrane potential were detectable in the perfused 
hindlimb preparation 
5.2.1 Time controls 
Membrane potential (EN), V02, and PP were monitored continuously over a three-hour period 
of perfusion, with no other intervention. Collection of data commenced after a 50-min equilibration 
period. Data collected in the 10-min immediately after equilibration were regarded as part of the 1' 
hour. The average Em, V02, and PP between hours 1,2 and 3 of perfusion were compared, and 
analyzed for statistical differences. 
5.2.2 Positive internal control —potassium depolarization 
A modified version of the Nernst equation (the Goldman-Hodgkin-Katz equation, shown in 
Section 2.4.5) allows estimation of plasma membrane potential based upon the relative ionic 
permeability of each species. By substituting known literature values into the Goldman-Hodgkin-
Katz equation, it was calculated that an extracellular concentration of 9.4mM potassium chloride 
(KC1) was required to achieve a 10mV depolarization. Resting E N' was measured in normal 
(4.74mM KC1 buffer), after which the buffer reservoir was changed to one containing 9.4mM KC1. 
Time was allowed for equilibration with the new medium (20-min), and another measurement of E N' 
was made. Potassium depolarization of skeletal muscle fibers was fully reversible, therefore two 
potassium depolarizations were carried out in each preparation, with a recovery period of 40-mins in 
between. 
5.2.3 Agonist-stimulated metabolism 
Veratridine was infused at a final concentration of 30 iAM, NE at 100 nM, and All at 5nM. 
Two different types of vasoconstrictor were used to ensure that any effects observed were a general 
property of type A vasoconstrictors, and not a particular feature of the adrenergic vasoconstrictor NE 
alone. Measurements of V02, PP and Em were made just after equilibration, and compared with 
measurements obtained once a plateau state of pressure was attained during agonist infusion. 
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5.2.4 Intracellular metabolites 
At the end of each experiment, perfused muscles were skinned and freeze clamped in situ for 
later analysis of intracellular metabolites (Section 2.7). Muscle samples were collected after 40- 
mins of basal or 9.4mM KC1 perfusion. For experiments where the agonist was infused (veratridine 
and NE), a 30-min equilibration period was first allowed, followed by 20-mins of agonist infusion. 
5.2.5 Statistical analysis 
One way analysis of variance (ANOVA) was used to determine any statistically significant 
differences in V02, PP and Em between hours 1, 2 and 3 of perfusion for the time control 
experiments, with pairwise comparisons by the Student-Newman-Kuels method. For KC1, 
veratridine, NE and All experiments, data were compared before and after treatment with a students 
paired t-test. Statistical significance was recognized at P<0.05. 
5.3 Results 
5.3.1 Time controls 
Over three hours of time control perfusion, V02 and PP remained stable (Figure 5.1) 
averaging 13.5 ± 1.0 p.mol.g-l .min-1 , and 19.9 ± 0.34 mmHg respectively (n=5). The resting 
membrane potential (EN') was also stable over this period, averaging —58.6 ± 1.78 mV (n:=5). There 
were no statistically significant changes in V02, PP or resting membrane potential between the first, 
second or third hour of perfusion. V02, PP and EN! are therefore quite stable in time frame utilized 
for the remaining experiments. 
5.3.2 Positive internal control -potassium depolarization 
A total of 3 depolarization experiments were completed, with two trials in each animal (3 
animals, n=6 trials). Average V02, PP and E N( measured during basal perfusion (normal medium) 
were 11.4 ± 0.01 19.4 ± 0.03 mmHg, and —63.3 ± 0.3 mV respectively (Figure 5.2). 
The change from normal (4.7mM) KC1 buffer to high (9.4mM) KC1 buffer did not cause any 
significant change in V02 or PP, however a depolarization of —10mV to —54.0 ± 0.4 was observed (P 
<0.003). 
1 2 	3 
1 	2 	3 
Hour of Perfusion 




• Figure 5.1 Comparison of V02, PP and E m  between first, second and third hour of perfusion 
Data were recorded continuously over the three-hour period, then averaged for each hour. No 
statistically differences were detected in basal v02, PP or &If  over the three hour period. 
normal media 
9.4mM KCI media 
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Figure 5.2 Positive Internal Control - Potassium Depolarization 
It was calculated that a change in buffer KC1 concentration from 4.7mM to 9.4mM should 
cause a 10mV depolarization. Shown is the effect of normal (4.7mM) and high (9.4mM) 
KC1 media on V02, PP and Em, for a total of n=6 experiments.  
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5.3.3 Agonist-stimulated metabolism 
All three agents 30p.M Veratridine, 100nM NE and 5nM All caused significant stimulation 
of V02 above basal (P<0.001, n=6, Figure 5.3). Veratridine caused a small, but significant increase 
in perfusion pressure (about 4mmHg above basal, P=0.003). Both NE and All caused a substantial 
increase in perfusion pressure above basal, 31.2 mmHg (P<0.001), and 39.4 mmHg (P<0.001) 
respectively. Veratridine was the only agent to affect membrane potential, causing depolarization 
from -62.0 to -41.6 mV, (P<0.001). NE and All infusion did not affect membrane potential. 
5.3.5 Intracellular metabolites 
The effects of each treatment on muscle metabolites are shown in Table 5.1. Intracellular 
metabolites did not vary significantly between basal, 9.4mM KC1 and NE samples (P>0.05). When 
compared with basal, samples collected during veratridine infusion showed significantly elevated 
creatine levels (10.8 ± 0.4 to 18.1 ± 1.8 prriol/g wet wt, P<0.001), and a depletion of creatine 
phosphate content (20.3 ± 0.4 to 11.9 ± 2.0 pmol/g wet wt, P<0.01). Cellular energy status 
(calculated from CrP/ATP) was also decreased by veratridine from 3.2 ± 0.1 to 1.9 ± 0.3 (P<0.01). 
ATP levels were not compromised by veratridine infusion (P>0.05). 
Table 5.1 Muscle Energy Metabolites 
Muscle samples were collected after 40-mins of basal perfusion, 40-mins of 9.4mM KC1 medium 
perfusion, or after 20-mins of 100nM NE or 30,uM veratridine infusion, n=5 for all values. 
**P<0.01, ***P<0.001, assessed by one way ANO VA, with pairwise comparisons to the 
corresponding basal values by the Student-Newman-Kuels method. 
Treatment 
Basal 9.4mM KC1 100nM NE 301.IM Vera 
Creatine (.anol/g wet wt) 10.8 ± 0.4 12.7 ± 0.9 10.5 ± 0.6 18.1 ± 1.8*** 
Phosphocreatine (pmol/g wet vv. 20.3 ± 0.4 17.8 ± 1.5 19.4 ± 0.7 11.9 ± 2.0 ** 
AMP (nmol/g wet wt) 57.2 ± 7.1 56.9 ± 9.0 62.8 ± 7.5 76.3 ± 12.4 
ADP (gmol/g wet wt) 0.9 ± 0.02 0.9 ± 0.04 0.8 ± 0.03 0.9 ± 0.06 
ATP (pmol/g wet wt) 6.5 ± 0.1 6.3 ± 0.2 6.3 ± 0.2 6.4 ± 0.1 
Phosphocreatine/ATP 3.2 ±0.1 2.8 ± 0.2 3.1 ± 0.1 1.9 ± 0.3** 





vera NE All 
Figure 5.3 Agonist stimulated metabolism 
Effects of 30pM veratridine, 100nM NE, and 5nM All on V02, PP, and resting membrane potential. 
Basal values (solid bars) compared with agonist stimulated values (hatched bars). *, #, § = P<0.05, 




The perfused rat hindlimb preparation remained stable over the 3-hour time control period, 
without deterioration of basal oxygen consumption, perfusion pressure or membrane potential. 
Raising the extracellular [1(C1] of the perfusion medium initiated a small depolarization of the 
skeletal fibers that was readily detectable. Thus, the current setup provides a viable preparation for 
monitoring discrete changes in skeletal muscle membrane potential during agonist-stimulated 
metabolism. All three agents trialled (veratridine, NE and All) stimulated resting V02. Perfusion 
pressure was significantly elevated by NE and All. We have previously demonstrated that 
veratridine-mediated metabolism is not dependent on vasoconstriction, since the inclusion of 
nitroprusside abolished the pressure without interfering with the stimulatory oxygen effect (Chapter 
4), thus the minor pressure development noted here (-4mmHg) is not considered further. 
Veratridine was the only agent to cause a measurable change in plasma membrane potential (E N ), 
consistent with activation of voltage-gated sodium channels. Type A vasoconstrictors NE and All 
did not change skeletal muscle E N', despite significant stimulation of V0 2 . Muscle phosphocreatine 
stores were depleted by veratridine, but not by NE, further distinguishing these two agents. It 
therefore seems unlikely, that type A vasoconstrictors stimulate muscle V02 via the same 
mechanism as veratridine. 
Failure to detect depolarization by NE or All is not entirely unexpected. Only one paper 
reporting a depolarizing effect of NE on skeletal muscle fibers was found in the literature (289), 
however no other reports have been made. The possibility that type A-mediated metabolism is due 
to direct activation of the Na +/K+-ATPase pump itself is unlikely, given that type A vasoconstrictors 
have no effect on VO2 in isolated incubated muscle preparations (50; 69; 97; 145), and direct 
activation of the pump would have been expected to cause hyperpolarization (67). It is possible that 
type A vasoconstrictors caused a transient depolarization that was not detected by the glass 
electrode, or missed in the interim of sampling. The sampling technique required that the electrode 
be lifted clear of the tissue at the onset of vasoconstriction, in order to avoid damage the electrode 
tip. Again, this seems unlikely given that elevated V0 2 was sustained for the duration of agonist 
infusion. If stimulation of V02 was dependent on sodium influx, then depolarization should have 
been sustained for the same duration as agonist infusion, as noted during veratridine-mediated 
metabolism. Coupled with finding that type A metabolism is not sensitive to sodium channel 
blockade, it is concluded that the mechanism of type A-mediated skeletal muscle oxygen uptake is 
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not dependent on voltage-gated sodium channels or elevated intracellular sodium concentrations, and 
is thus distinct from veratridine-mediated metabolism. 
The question remains, why should type A mediated metabolism be sensitive to low-sodium 
media, membrane stabilizers and cardiac glycosides? Attention is now drawn to the possibility that 
vasoconstriction in the vascular smooth muscle participates in the generation of an electrical or 
diffusible (paracrine) "signal", which has the potential to regulate skeletal muscle metabolism. If 
generation or transduction of the signal is dependent on changes in smooth muscle membrane 
potential, the presence of treatments affecting ion permeability would be expected to interfere. The 
intact nature of the vascular connections may be critical for generation or conduction of the signal, 
possibly explaining the failure of type A vasoconstrictors to elicit an effect in isolated incubated 
muscle preparations (97). Unfortunately this hypothesis is difficult to test in the perfused hindlimb, 
since the glass electrodes used were far too big to successfully penetrate vascular smooth muscle, 
and it would be virtually impossible to repeatedly locate and successfully penetrate vascular smooth 
muscle cells in the intact perfused hindlimb without dissection or disruption of flow delivery. 
Experiments on vascular smooth muscle in arterioles of the hamster cheek pouch confirm 
depolarization in association with vasoconstriction when norepinephrine and phenylephrine were 
applied (303). Depolarization and vasoconstriction were recorded at the site of release and along the 
length of the arteriole, indicating that both the electrical and vasomotor responses were conducted, 
most likely via gap junctions. It has been suggested by Segal & Neild (270), that conduction of 
membrane potential changes between arteriolar smooth muscle and endothelial cells participates in 
the regulation of blood flow, by coordinating activity of the many branches of the arteriolar network. 
Conduction of signals via the vascular tree may have a profound effect on skeletal muscle blood 
flow, and a potentially greater effect on skeletal muscle metabolism. The phenomena of 
redistribution observed with type A vasoconstrictors may in fact be a concerted conduction of 
electrical signals along the arterioles, enabling enhanced perfusate access and oxygen delivery. 
Anatomically, feed arterioles are positioned to control blood flow into skeletal muscle, thus 
integration of dilator and constrictor stimuli in these vessels may be a key determinant of muscle 
blood flow during exercise (266), and in our opinion also during type A mediated vasoconstriction. 
This argument is strengthened by the observation that vascular smooth muscle cells possess 
tetrodotoxin-resistant sodium channels (296; 314). In addition, experiments in rat mesenteric veins 
and arterioles of the hamster cheek pouch demonstrate that TTX does not directly affect resting tone, 
or norepinephrine-induced constriction of vascular smooth muscle (197). Thus transduction of 
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electrical (sodium dependent) signals along the vascular smooth muscle will be not be blocked by 
TTX. 
Even if the effects of type A vasoconstrictors were due to a paracrine signal of vascular 
origin, the biochemical mechanism responsible for skeletal muscle thermogenesis is still unknown. 
Whatever the mechanism, it appears to occur without any detectable change in skeletal fiber plasma 
membrane potential. The alkaloid ryanodine is known to stimulate skeletal muscle V02 without 
depolarization (24), therefore intracellular calcium cycling is an attractive explanation, albeit one 
that is difficult to address experimentally. Exclusion of extracellular calcium from the medium 
would prevent vasoconstriction (96), thereby wiping out the potential type A effect. Skeletal muscle 
contains a large pool of intracellular calcium in the sarcoplasmic reticulum, hence skeletal muscle 
calcium cycling may proceed even in the absence of extracellular calcium. Studies with the Ca2+- 
ATPase blocker dantrolene may be able to address this issue in perfusion, providing dantrolene 
achieves suitable access to Ca 2+-ATPase sites (located intracellularly). Despite this, stimulation of 
perfused muscle metabolism by increased intracellular calcium is a slow onset effect (taking up to 10 
minutes to substantially increase V02, unpublished observations from this laboratory). Type A 
vasoconstrictors stimulate V02 rapidly, a response that more closely resembles changes in 
microvascular oxygen delivery that activation of intracellular ion cycling. 
Analysis of muscle high-energy phosphates further distinguishes between NE and 
veratridine. Veratridine samples showed a marked depletion of phosphocreatine (Table 5.1), but no 
changes in [ATP]. It seems that the short-term demand for ATP by sodium pump is catered for, at 
the expense of phosphocreatine. More extreme sodium loads (induced by the sodium ionophore 
monensin in the isolated guinea pig aorta) have been shown to deplete cellular ATP levels, but only 
in the absence of glucose (227). Thus raised intracellular sodium places a strain on the cell that 
ultimately overcomes the metabolic capacity, and compromises cellular energy status. Elevated 
metabolism with veratridine is probably not a "stimulation" as such, but more of a "resale attempt". 
This view is supported by the observation that in isolated incubated contracting rat soleus muscles, 
veratridine markedly decreased the force of contraction (Tong et al. unpublished observations). In 
the presence of veratridine, the combined metabolic demand of contraction and increased sodium 
load was simply too much, and contraction was unsustainable. In contrast, type A vasoconstrictors 
are not deleterious to the energy status of the cell, since muscle samples collected after 20-mins of 
NE infusion did not differ from basal in terms of high energy-phosphate content (Table 5.1). 
Similarly, after three hours of perfusion in the presence of a type A vasoconstrictor (vasopressin), 
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Colquhoun, Hettiarachchi, et al. (78) found no differences in the high energy-phosphate content of 
perfilsed and in vivo muscle samples. There is also some evidence that type A vasoconstrictors may 
actually enhance cellular energy status [Appendix Figure 1, from (300)]. Herein lies a fundamental 
difference between veratridine and type A vasoconstrictors. 
Despite the apparent similarities, it is now clear that type A vasoconstrictors and veratridine 
do not stimulate perfused hindlimb metabolism by the same mechanism. Veratridine-mediated 
metabolism is accompanied by plasma membrane depolarization, and depletion of cellular energy 
reserves. In conjunction with susceptibility to tetrodotoxin (291), these data are consistent with 
direct activation of voltage-gated ion channels on the skeletal fibers. In contrast, type A mediated 
metabolism does not affect plasma membrane potential, or cellular energy status of skeletal fibers. 




COMPARISON OF VASOCONSTRICTOR-MEDIATED THERMOGENESIS IN 
PERFUSED SKELETAL AND CARDIAC MUSCLE 
6.1 Introduction 
It is not known if the phenomena of vasoconstrictor-mediated thermogenesis 
occurs in cardiac muscle as it does in skeletal muscle. The current chapter aims to 
ascertain if the same tetrodotoxin-resistant vasoconstrictor-mediated thermogenic 
mechanism demonstrated in the perfused rat hindlimb (Chapter 4), also occurs in 
perfused arrested rat heart. Evidence from this (59) and other laboratories (17; 127; 
229) favour the existence of dual vascular pathways in skeletal muscle. However the 
existence of dual vascular pathways or significant heterogeneity of blood flow is less 
likely in heart, due to the comparatively smaller mass and consistently higher rate of 
contraction. 
The main aim of this study was to make a direct comparison between perfused 
heart and skeletal muscle, and the response to type A vasoconstrictors. If type A 
vasoconstrictors fail to stimulate arrested heart thermogenesis, this would indicate a 
heavy reliance on redistribution for the thermogenic effects. However, if type A 
vasoconstrictors successfully stimulate thermogenesis in the arrested heart, then the 
thermogenic effects would be attributable to direct activation of a cellular mechanism, 
since there is less capacity for capillary recruitment in heart than in skeletal muscle. 
6.2 Methods 
6.2.1 Animals 
All experiments were conducted with male Hooded-Wistar rats between the 
weights of 180-230g. 
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6.2.2 Perfusions 
6.2.2.1 Hindlimb perfusions 
The surgical method and apparatus were previously outlined (Section 2.2.2; 
2.2.3). Single hindlimb perfusions were conducted at 37°C, with cell free medium, 4% 
BSA, and 2.54mM CaCl2 . Flow rate was maintained at a constant rate of 14 ml/min 
(0.87 ml/minig), along with a higher BSA concentration to compensate for the higher 
rate of oxygen extraction at this temperature. 
6.2.2.2 Heart perfusions 
Heart perfusions were carried out in accordance with the method outlined in 
Richards et al. (243). Detailed descriptions of surgery, and apparatus are found in 
Section 2.3. Perfusion medium was a Krebs-Henseleit bicarbonate buffer, containing 
0.05mM EDTA, 5mM pyruvate, and 5mM glucose, equilibrated with carbogen (95% 
02: 5% CO2). Following removal and carmulation, hearts were perfused at a constant 
flow rate (6.79 ± 0.12 ml/min), equivalent to 8.94 ± 0.25 mllmin/g wet wt heart (mean 
± SE, n = 18), at 37°C. 
After cannulation a 20-30 min equilibration period was allowed, until oxygen 
uptake and perfusion pressure reached steady states. Preliminary experiments were 
conducted to determine an adequate dose of the a-adrenergic combination of 
phenylephrine plus 0.3mM atenolol that would reproducibly increase both oxygen 
uptake and perfusion pressure at constant flow. The preliminary results showed that the 
heart was considerably less sensitive to phenylephrine that the perfused hindlimb, and 
thus a higher dose of phenylephrine (5011M) was considered optimal. 
6.2.3 Experimental protocols 
6.2.3.1 Perfused hindlimb preparation 
For the hindlimb perfusions where phenylephrine was used, 0.3mM atenolol 
was also included in the perfusion medium, in order to prevent activation of p-
adrenoreceptors (ensuring an a-adrenergic effect only). At this dose, atenolol has no 
effects on basal or agonist stimulated oxygen uptake (292). Phenylephrine was infused 
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at a final concentration of 1 !AM. Putative sodium channel involvement during 
phenylephrine-stimulated metabolism was tested with the sodium channel inhibitor 
tetrodotoxin (TTX, 10iiM). For the veratridine perfusions (14M), sodium 
nitroprusside (SNP 0.5mM) was included in the perfusion medium to prevent any 
possible vasoconstrictor effects on smooth muscle. 
6.2.3.2 Perfused heart preparation 
The a-adrenergic combination of 0.3mM atenolol and 5011M phenylephrine was 
tested in the heart during conditions of normal contraction, and in hearts arrested by 
infusion of TTX (10)AM). For the veratridine experiments, KC1 was used in place of 
TTX to arrest the heart, since TTX is a known inhibitor of veratridine mediated oxygen 
uptake in perfused hindlimb (Chapter 4), and is likely to be so in heart. When present, 
veratridine was infused at a final concentration of 10[1M. 
6.2.4 Statistical analysis 
Statistics were carried out using SigmaStat statistical program (Jandel Software 
Corp.). Each data set was analysed for significant differences by one-way repeated 
measures analysis of variance, with pair-wise comparisons by the Student-Newman-
Kuels test. Statistical significance was recognized at P<0.05 level. 
6.3 Results 
6.3.1 Effects of phenylephrine in perfused hindlimb 
Figure 6.1 shows a typical trace of the oxygen uptake and perfusion pressure 
obtained during 11.1M phenylephrine infusion ± 1011M tetrodotoxin (TTX) (0.3mM 
atenolol included in all phenylephrine experiments). Figure 6.2 illustrates mean values 
± SE (n=5). Mean basal values in the perfused hindlimb (before phenylephrine) were 
31.5 ± 1.01..tmo1.e.hf l and 40 ± 5mmHg for oxygen consumption and perfusion 
pressure respectively (n=5). One-way repeated measures analysis of variance with 
pair-wise comparisons using the Student-Newman-Kuels test demonstrates that 
phenylephrine caused a significant increases (P<0.05) in oxygen uptake, under basal 
conditions (24.1%) and during infusion of TTX (28%). Perfusion pressure was 
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significantly (P<0.05) elevated by phenylephrine during basal (32.2%) and TTX 
infusion (30.6%). Thus 101.tM TTX did not interfere with phenylephrine stimulated 
oxygen uptake or pressure development in the perfused rat hindlimb. 
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Figure 6.1. Time course for the effects of PHE ± TTX on perfused hindlimb V02 and PP 
Hindlimbs were perfused at a constant flow of 14m1/min. Infusion of 1,uM phenylephrine (PHE) 
commenced after 30-mins equilibration. V02 and PP recovered after PHE infusion to near basal 
values, and tetrodotoxin (TTX, 10,uM) infusion commenced thereafter. The effects of 101 PHE in the 
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PHE 
Figure 6.2 Effects of phenylephrine ± tetrodotoxin on perfused hindlimb\702 and PP 
Phenylephrine (PHE) was infused at a final concentration of 1 pM, while tetrodotoxin (TTX 
was infused at 1 OpM. Values are means ± SE for n=5; *P<0.05, significantly different from 
basal; # P<0.05, significantly different from TTX treatment tested by repeated measures one-
way analysis of variance and pair-wise comparisons using the Student-Newman-Kuels test. 
*P<
0.05, signific antly different from
 basal. 
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6.3.3 Effects of phenylephrine in the perfused arrested heart 
Shown in Figure 6.4 is a typical trace of the effects of a 7-10-min infusion of 
50).tM phenylephrine (with 0.3mM atenolol in buffer) while the heart was contracting. 
15-20 mins after cessation of phenylephrine infusion, when oxygen and pressure had 
returned to pre-infusion levels, infusion of 10p.M TTX commenced. Contraction 
rapidly declined within 2-mins of TTX infusion, and no further contraction was 
observed for the remainder of the experiment (data not shown). When oxygen uptake 
and pressure had again stabilized, infusion of phenylephrine re-commenced at the same 
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Figure 6.4 Time course for the effects of phenylephrine ± TTX on V02 and PP of the 
perfused rat heart. 
The perfusion buffer contained 0.3mM atenolol, and perfusions were conducted at constant 
flow. Phenylephrine (PHE) was infused at a final concentration of 50,uM, while tetrodotoxin 
(TTX) was infused at 10,uM. A representative trace for one experiment is shown. 
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For some hearts, there was a transient stimulation of oxygen uptake coinciding 
with the commencement of phenylephrine infusion, however, this effect was short lived 
and soon subsided (Figure 6.4), despite a marked increase in perfusion pressure (Figure 
6.5). Figure 6.5 illustrates mean values ± SE (n=10) for the effects of 5011M 
phenylephrine on cardiac V02 and PP, before and after cardiac arrest with 1011M TTX. 
Phenylephrine caused a significant (P<0.05) increase in oxygen uptake (70.4%) when 
infused into contracting heart, but not in TTX arrested hearts. Perfusion pressure was 
significantly (P<0.05) increased by phenylephrine in both contracting (32.7%) and 
TTX-arrested (51.4%) hearts. TTX-arrest of contracting hearts caused a significant 
(P<0.05) decrease in basal V0 2 (52.5%) but no significant change in perfusion 
pressure. 0.3mM Atenolol did not affect basal oxygen uptake or perfusion pressure 
















Figure 6.5. Effects of phenylephrine ± TTX on perfused heart V0 2 and PP. 
Phenylephrine (PHE) was infused at a final concentration of 50,uM, while tetrodotoxin (TTX) 
was infused at 10,uM. Values are means i- SE, for n=8 experiments; *P<0.05, significantly 
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6.3.4 Effects of veratridine in perfused arrested heart 
Shown in Figure 6.6 is a typical trace of oxygen uptake and perfusion pressure 
obtained during veratridine infusion. Infusion of 40mM KC1 caused cardiac-arrest. 
Contraction ceased within 2-mins of KC1 infusion, and no contractions were observed 
for the remainder of the experiment (data not shown). After 15-mins of KC1 infusion, 
oxygen uptake and perfusion pressure had stabilized, at this time veratridine infusion 
(101.1M) commenced. Oxygen uptake was stimulated by veratridine after a short 
(approximately 3 min) delay, similar to the delay observed in perfused hindlimb (Tong 
et al. 1998). 
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Figure 6.6 Time course for the effect of veratridine on V02 and PP in the KC1-arrested 
perfused rat heart. 
Beating hearts were arrested by infusion of 40mM KC1. Once steady state 902 and PP were 
attained, 10,uM veratridine (Vera) infusion commenced. A representative trace for one 







Beating hearts were arrested with high KC1 infusion (40mM). Following arrest, the effects of 
*P< 0.05, significantly different from KC1 treatment. 
1 0,uM veratridine (Vera) were examined. Values are means ± SE for n=8 experiments. 









































and a further small rise (12 .8%) in perfusion pressure . 










































The current experiments were designed to compare the effects of type A 
vasoconstrictors in perfused heart and skeletal muscle at rest, in order to determine if 
type A effects were dependent primarily on redistribution of flow, or direct activation 
of a cellular mechanism. Heart is the ideal candidate tissue in which to examine this 
issue, since there is less potential for capillary recruitment, and in the non-contractile 
state cardiac muscle is a comparable resting model. Skeletal muscle V02 was enhanced 
by the a-adrenergic combination of phenylephrine and atenolol, even in the presence o'f 
the sodium channel inhibitor tetrodotoxin (Figs. 6.1 & 6.2), consistent with the findings 
in Chapter 4. During contraction, the a-adrenergic combination of phenylephrine and 
atenolol also stimulated cardiac oxygen uptake and perfusion pressure (Fig. 6.5). This 
was attributed to the well-established a-adrenergic inotropic effect of phenylephrine 
and other catecholamines (1). However, in the TTX-arrested heart, phenylephrine 
failed to stimulate oxygen uptake despite development of similar perfusion pressures 
(Figs. 6.4 & 6.5). Thus, tetrodotoxin-insensitive type A vasoconstrictor-mediated 
thermogenesis found in perfused skeletal muscle at rest is absent from the perfused 
arrested rat heart. 
The difference between perfused heart and skeletal muscle in terms of 
vasoconstrictor mediated thermogenesis may be due differences in vascular anatomy. 
By comparison capillary perfusion is more homogenous in heart, therefore the capacity 
for capillary recruitment is less than in skeletal muscle. Evidence in favour of this 
theory comes from microdialysis experiments. In the perfused rat hindlimb at rest, 
increased flow rate causes a monotonous decrease in out/in ratios of 14C-ethanol and 
3H20 (Appendix, Figure 2), however the inclusion of type A and B vasoconstrictors 
cause a significant change in these ratios. The type A vasoconstrictor norepinephrine 
(70nM), accelerates the decline in radioactive out/in ratios with increasing flow rate, 
while type B (300nM serotonin) impedes the decline in flow induced out/in ratios 
(221). These effects are attributed to recruitment and de-recruitment respectively, 
either enhancing or impeding the removal radioactive tracer from the microdialysis 
tubing by affecting local distribution of flow (221). In contrast, similar experiments in 
the anesthetized autoperfused contracting sheep heart, do not support the existence of 
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significant heterogeneity of blood flow, or redistribution of flow in cardiac tissue. 
Microdialysis out/in ratios for 3H20 also decreased with increasing flow rate 
(Appendix, Figure 3), however, the addition of the vasoconstrictor norepinephrine, or 
vasodilators adenosine or sodium nitroprusside did not influence the flow induced 
microdialysis out/in ratios (Richard Hodgson honours thesis 2001). Thus, other than 
changes in total flow, redistribution of flow is not a significant occurrence in the 
contracting heart. Without the potential for redistribution of blood flow, type A 
vasoconstrictors may simply be ineffectual in stimulating metabolism. Alternatively it 
must be considered that the tetrodotoxin-insensitive mechanism triggered by 
vasoconstrictors in skeletal muscle simply does not exist in perfused arrested heart. It 
has been suggested that vasoconstrictor-mediated redistribution of blood flow causes 
production of a paracrine signal of vascular origin, which then triggers thermogenesis 
in the skeletal fibers (59). Heart may lack this signalling system, therefore even if some 
redistribution of flow did occur no change in oxygen consumption would be observed. 
Cessation of cardiac contraction (by TTX or KC1) significantly decreased 
cardiac oxygen consumption (Figs. 6.5 and 6.7), indicating that most of oxygen 
consumed by the beating heart is dedicated to supporting cardiac contractility. 
Interestingly, cessation of cardiac contractility was also associated with an increase in 
perfusion pressure when compared with basal (Fig. 6.7). Cardiac contractility may 
enable production of vasodilatory substances, or prevent the production of 
vasoconstrictors. 
In skeletal muscle (Fig. 6.3) the combination of veratridine and sodium 
nitroprusside caused a significant increase in V0 2 that was not dependent on pressure 
development or redistribution. Resting cardiac oxygen consumption was also enhanced 
by the addition of veratridine (Fig. 6.7). Increased ionic permeability is thus capable of 
directly stimulating a thermogenic mechanism in both skeletal and cardiac muscle at 
rest. The absence of a type A effect in perfused arrested heart, leads us to the 
conclusion that type A vasoconstrictor-mediated metabolism does not directly activate 
a cellular thermogenic mechanism. It follows, that the stimulatory effects of type A 
vasoconstrictors in the perfused hindlimb are likely to be more dependent on 
redistribution than activation of a cellular mechanism. Thus, increased rates of oxygen 
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consumption with type A vasoconstriction may be related to changes in perfusate 
delivery, rather than activation of cellular mechanisms. 
In summary, type A vasoconstrictors do not have the same effects in perfused 
skeletal and cardiac muscle. The TTX-insensitive type A thermogenic effect observed 
in perfused skeletal muscle is absent from perfiised arrested heart. This confirms that 
the stimulatory effects of type A vasoconstrictors are not due to activation of a cellular 
mechanism directly. In contrast, the stimulatory effects of veratridine were apparent in 
both skeletal and cardiac muscle at rest. Thus, direct sodium channel activation can 
evoke thermogenesis in both tissues, but this is an apparently separate phenomenon 
from type A mediated thermogenesis. It is therefore concluded that type A mediated 
thermogenesis in the perfused hindlimb is dependent (at least in the first instance) on 
redistribution, and enhanced oxygen delivery. 
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CHAPTER 7 
DISCUSSION AND CONCLUSIONS 
7.1 Supply and Demand 
One of the main findings to emerge from this study is that skeletal muscle 
metabolic rate may be manipulated by changing substrate supply or by changing the 
metabolic demand [in agreement with the findings of other groups (48; 254)]. In 
attempting to define the mechanism of vasoconstrictor-mediated metabolism in the 
perfused rat hindlimb both substrate supply and metabolic demand were considered. 
Evidence in favour of either mechanism has been presented in the past [(59; 97) & 
(292)](291) and this issue is now re-evaluated in light of the current findings. 
7.2 Muscle metabolism and supply 
7.2.1 Oxygen conformance in perfused skeletal muscle 
In order to assess the potential regulation of hindlimb metabolism by 
vasoconstrictor-mediated changes in oxygen delivery, it was first necessary to 
establish if the perfused hindlimb preparation was responsive to changes in oxygen 
delivery alone. Results in Chapter 3 demonstrate clearly that perfused skeletal muscle 
is indeed responsive to changes in 02 delivery, without the complication of 
redistribution or changes in cellular energy status. Lactate levels were elevated, 
however these changes were not sufficient to compensate fully for the loss of aerobic 
energy production. After careful consideration of this data, it is concluded that the 
perfused rat hindlimb preparation is capable of oxygen conformance, at least to a 
limited extent. Oxygen conformance in perfused muscle may not be strict as in 
isolated muscle preparations (8; 38; 44; 152), owing to heterogeneous perfusion, 
however a general relationship between V02 and oxygen delivery was apparent. 
7.2.2 Vasoconstrictors affect V0 2 by changing oxygen delivery 
Following the demonstration of oxygen conformance in perfused muscle, the 
role of vasoconstrictors on oxygen delivery may now be examined in more detail. It 
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has been suggested that micro-scale heterogeneity in blood flow and oxygen delivery 
may take part in normal control of muscle respiration (48). The following 
calculations demonstrate an enormous range over which oxygen consumption is 
regulated simply by changing total flow or the redistribution of flow. In the blood 
perfused rat hindlimb, changing the total flow from 1.0 to 9.0 ml/min increases resting 
oxygen consumption by a factor of almost 3 fold [from 15.7 to 46.9 umol.e.hr -
1 (221)]. The addition of NE or 5-HT to the constant-flow blood perfused hindlimb 
(70 or 300nM respectively at 4 ml/min), results in development of similar perfusion 
_pressures, though NE enhanced basal V02 by 63%, while 5-HT depressed basal 
oxygen consumption by 10.5%. The mere redistribution of blood flow at constant 
flow rate therefore has the capacity to influence the resting rate of skeletal muscle 
oxygen consumption by a factor of almost 2 fold. The combination of varied flow 
rate and redistribution further augments these effects. At 1.0 ml/min in the presence 
of 300nM 5-HT, basal V02 was 15.0 1.tmol.g -1 .hr-1 , while 70nM NE at 9 ml/min 
increased resting V02 to 72.6 p.mol.e.hr -1 . Therefore, the combination of varied 
flow rate and vasoconstrictor-mediated redistribution of flow has an enormous 
capacity (almost 5 fold) to regulate resting skeletal muscle V02. 
While muscle V02 is enhanced by increased flow rate (53; 103; 209; 285), 
muscle V02 is also responsive to increased oxygen carrying capacity of the perfusate 
(181). Furthermore, muscle perfused with high 02 affinity blood had a low V02, 
despite increased flow rates (182). Thus, muscle oxygen uptake is determined to a 
greater extent by oxygen delivery than by flow rate. The net effect of increased flow 
is enhanced microvascular perfusion and improvements in oxygen delivery. Though 
total flow remains constant during type A vasoconstriction, changes in blood flow 
distribution may have the same net effect as increased flow, namely improvements in 
microvascular perfusion. Since, the perfused rat hindlimb is now known to respond to 
changes in oxygen delivery, it is likely that regulatory influence of vasoconstrictors 
on perfused rat hindlimb metabolism is the result of variations in oxygen delivery at 
the microvascular level, via redistribution of blood flow. 
If muscle V02 is increased by improvements in oxygen delivery, then it must 
also be assumed that prior to this, oxygen delivery was limiting on muscle metabolic 
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rate. Muscle oxygen consumption has been shown to be delivery dependent below 
critical values of oxygen delivery [estimated at 16111 02/min/g in perfused rat gracilis 
muscle (183)]. Since perfused hindlimb V02 was delivery dependent at all gas 
mixtures trialled, it follows that oxygen delivery was below these critical values. This 
is intriguing, since flow rate and oxygen content of the perfusion media should have 
been more than sufficient to adequately supply the entire mass of perfused muscle. 
Gassing the blood with an air:CO2 mixture, gives a final blood content of 7.9 gmol 
021m1. Combined with a flow rate 4.0 mUmin per 15g perfused muscle mass, this 
should deliver 2.1grnol 0 2/min/g perfused muscle [equivalent to 53.4 gl/min/g, a 
value far in excess of the 16gUmin/g reported by Jansk et al. in perfused rat gracilis 
(183)]. Why then should muscle \:/02 be oxygen limited? This discrepancy is most 
likely due to heterogeneous perfusion under basal conditions, where only a small 
portion of the total blood flow reaches the nutritive capillary beds. Type B 
vasoconstrictors apparently exacerbate this situation by restricting nutritive access, 
further limiting oxygen delivery. However, type A vasoconstrictors are likely to 
relieve the restriction on perfusate access, restoring a non-restricted state of 
respiration. The observations that type A vasoconstrictors (300), high flow rates 
(209), and hyperoxic medium (308) all improve resting muscle ATP and PCr levels, 
appear to support this view. 
Some important questions raised in the introduction are now addressed. Time 
course graphs show that following the removal of a type B vasoconstrictor, 
metabolism returns from a depressed level back towards pre-infusion values (94). 
The questions were posed, can this increase be considered as a stimulation of 
metabolism, and if so, is this due to the same mechanism as type A vasoconstriction? 
Assuming oxygen delivery and heterogeneity of flow are the key determinants of 
hindlimb metabolism, then yes, type B removal is a stimulation of metabolism, and 
the mechanism is akin to application of a type A vasoconstrictor. Type B 
vasoconstrictors (serotonin) increase perfusion pressure and cause shunting of blood 
flow through non-nutritive vessels (219), thereby restricting oxygen delivery and 
basal metabolic rate. The removal of a type B vasoconstrictor alleviates the situation, 
allowing pressure to return to pre-infusion levels and restoring flow to a greater 
number of nutritive vessels. This is essentially the same sequence of events leading to 
stimulation of metabolism during type A vasoconstriction. 
114 
7.2.4 Heterogeneous perfusion leads to metabolic suppression 
An interesting sideline also emerges from these results. If perfused hindlimb 
metabolism is oxygen limited under basal conditions, one might expect to see 
metabolic indications of hypoxia. When aerobic ATP production fails, anaerobic 
mechanisms are turned on resulting in lactate efflux. If anaerobic metabolism is 
insufficient to meet energetic requirements, then PCr levels begin to decline, and 
eventually ATP levels will also fall (258; 308). However, muscle samples collected 
in vivo, and after 50 and 180 mins of basal perfusion show no changes in cellular 
ATP, PCr content or lactate efflux (78). Thus, the usual indices of hypoxia do not 
indicate under-perfusion during basal conditions. 
A more extreme example of oxygen limiting conditions might be expected 
during type B vasoconstriction, where regional hypoxia may result from perfusate 
shunting (220). Curiously, type B vasoconstriction (serotonin) was shown to inhibit 
lactate efflux below the basal level in the perfused Bettong hindlimb (311). Freeze 
clamped muscle samples collected during serotonin infusion into the perfused rat 
hindlimb show some evidence of PCr decline (300), though it is acknowledged that 
PCr is a more sensitive indicator of early ischemia (308). Despite this, muscle energy 
charge and ATP levels were not depleted by serotonin [Appendix Figure 1]. Thus 
regions of hypo-perfused skeletal muscle appear to be able to tolerate hypoxic 
conditions without suffering significant damage. In order to maintain cellular 
• viability during hypoxia, one of two responses must occur, either anaerobic ATP 
producing pathways are activated, or ATP utilization is decreased to match decreased 
rates of production. Since lactate is not elevated and cellular ATP is not decreased by 
type B vasoconstrictors, it follows that skeletal muscle viability is maintained during 
regional hypoxia by decreasing ATP utilization. It is now proposed that the regions of 
the hindlimb that are less than maximally perfused assume a state of depressed 
metabolism or hibernation. 
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7.2.5 Mechanisms of metabolic suppression 
The phenomenon of metabolic hibernation has been noted in isolated non-
contracting neonatal rat cardiomyocytes (44). When exposed to oxygen 
concentrations of 5-6 umoUl, isolated cardiomyocytes decreased their basal rates of 
oxygen uptake by 36%, though intracellular ATP and PCr concentrations were 
maintained, with no evidence of anaerobic ATP production. It was concluded that 
non-contracting isolated cardiomyocytes were able to down-regulate energy utilizing 
processes during oxygen limiting conditions. However, under more severe conditions 
(2-3 limoUl oxygen), isolated cardiomyocytes decreased basal oxygen uptake by 91%, 
while intracellular ATP was maintained but PCr was decreased by 40%, with a 
significant switch to anaerobic metabolism (44). Thus, cellular ATP utilization is 
decreased during both moderate and severe hypoxia, but under more severe conditions 
cells show signs of energetic stress. These findings are consistent with the present 
observations in the perfused rat hindlimb. 
Metabolic suppression appears to be a widespread protective mechanism 
employed during hypoxia in ectotherm (91; 93; 135; 152; 283) and endotherm species 
(44). By decreasing ATP utilization during oxygen limited conditions, substrate 
reserves are spared and there is no accumulation of toxic end products (283), though 
exactly which ATP consuming reactions are down-regulated remains unresolved. The 
major contributors to standard metabolic rate are ion pumping, synthetic pathways, 
pump/leak cycles and substrate cycling (254). In hypoxia tolerant species (frogs & 
turtles) evidence has been presented that energy conservation is achieved through a 
combination of down-regulation of synthetic pathways (38), and reduced membrane 
permeability through channel arrest (92; 93; 151; 152). It must be noted that these 
cells are specifically adapted to cope with low oxygen environments, with specific 
modifications geared towards lowering ATP turnover. By comparison, decreased 
ATP turnover in mammalian cells is expected to be more modest, occurring over a 
narrower range of oxygen concentrations than in hypoxia tolerant species. It is not 
clear if the phenomenon of channel arrest occurs in mammalian tissue as it does in 
reptilian tissue, though some data has been presented to suggest that membrane-
permeability may have a role in regulating metabolic rate in mammalian tissues (164). 
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Other ATP consuming reactions in mammalian skeletal muscle that may be 
considered include protein synthesis, urea synthesis, RNA/DNA turnover and 
substrate cycling (254). Examination of oxygen conformance in the murine skeletal 
C2C12 cell line shows no decline in the rate of protein synthesis between the oxygen 
concentrations of 100 and 10p.M, despite a significant reduction in basal oxygen 
consumption (30-40%) (8). However, under more severe conditions (<0.511m 
oxygen), cells displayed signs of energetic stress (36% decrease in PCr), and protein 
synthesis was. reduced by 43% (8). Thus, in mammalian tissue, ATP consuming 
reactions may only be down-regulated during energetic stress. Based on these 
observations, one may speculate on the order of down-regulation of oxygen 
consuming reactions during oxygen conformance. While muscle V02 is decreased 
during moderate hypoxia, protein synthesis was not changed and muscle intracellular 
ATP levels were maintained (8). This suggests that whichever oxygen consuming 
mechanism is down-regulated in order to accommodate the decrease in muscle V02, 
is not linked to ATP production. In skeletal muscle, V0 2 not linked to ATP 
production is likely to be the result of mitochondrial proton leak (252). Declining 
arterial oxygen may first limit the rate of uncoupled respiration (mitochondrial proton 
leak), while ATP utilization continues normally, until oxygen supply also becomes 
limiting on ATP production, at which time ATP utilization will also be down-
regulated. 
7.2.6 Oxygen delivery and mitochondrial proton leak 
While the phenomenon of channel arrest has been demonstrated in hypoxia 
tolerant species (38; 152), the possibility of "proton conductance arrest" has also been 
suggested as a mechanism enabling energy conservation during hypoxic conditions 
(282). The high rates mitochondrial proton leak occurring during normoxia 
[estimated to account for up to 50% of standard metabolic rate in perfused skeletal 
muscle (251)] may be reduced to barely detectable levels during oxygen limitation. It 
has been demonstrated in isolated mitochondria from rat liver by Gnaiger et al. (122) 
that under hypoxic conditions, proton leak and uncoupled respiration are depressed, 
while the coupling efficiency of oxidative phosphorylation and ATP production is 
improved. It was speculated that this may have been the result of decreased 
permeability of the mitochondrial inner membrane during hypoxia (122). A study by 
117 
Andersson et al (3) appears to support this, since proton conductance of the 
mitochondrial membrane was shown to be reduced during 30 mins of hypoxia in rat 
hepatocytes. This may be also be the case in perfused skeletal muscle [Chapter 3]. At 
higher rates of oxygen delivery [100% air] coupling efficiency may have been low, 
leading to P/0 ratios close to 1.5, though under more limiting conditions [0% air] 
coupling efficiency may have been improved, allowing P/0 ratios closer to the 
predicted value of 2.5. However, studies in mitochondria from cold 
submerged/anoxic frog skeletal muscle suggest that the kinetics of proton 
conductance are not different between anoxia and normoxia, but proton leak may be 
reduced as a secondary consequence of reduced electron transport activity (284). The 
so called "proton conductance arrest" may be more the result of decreased electron 
transport flux (due to oxygen limitation) than decreased mitochondrial membrane 
permeability. Nonetheless, proton leak does appear to be reduced during hypoxia. 
Taking into account previous estimates [50% skeletal muscle oxygen consumption is 
due to proton leak (251)], decreased proton leak in perfused skeletal muscle 
mitochondria may offer a significant energy saving during hypoxia. 
With this in mind, one questions the mechanism by which vasoconstrictors 
may affect the rate of mitochondrial proton leak in perfused skeletal muscle. While 
increased oxygen delivery with type A vasoconstrictors is likely to increase the rate of 
coupled and uncoupled respiration, it is not immediately clear how type B 
vasoconstriction, and low oxygen delivery may decrease proton leak. It has been 
suggested that mitochondrial proton leak may be reduced in four different ways (284). 
First is to alter the kinetics of proton leak, though this does not appear to occur even 
after several months of hypoxic submersion in frog skeletal muscle (284). The second 
is to alter mitochondrial membrane potential by changing electron transport efficiency 
or cellular ATP turnover. In perfused skeletal muscle, this is probably the most likely 
explanation, since alterations in oxygen delivery at the microvascular level will affect 
flux through the electron transport chain, and may also affect cellular ATP turnaround 
at more severe hypoxia. Finally, proton leak may be influenced by changing the 
volume density of mitochondria in relation to the cell, or the mitochondrial cristae 
surface area. During long term metabolic depression, such as that seen in estivating 
snails (135), remodelling of the phospholipid and protein content of the mitochondrial 
inner membrane of snail hepatopancreas appears to suppress membrane associated 
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processes, possibly including proton leak (287). However, type A and B 
vasoconstrictors affect oxygen delivery in the short term, and are not expected to 
affect mitochondrial inner membrane structure or composition. 
It is therefore concluded that vasoconstrictor mediated metabolism is likely to 
be the result of varied oxygen delivery, and the subsequent regulation of flux through 
the electron transport chain. Improved oxygen delivery with type A vasoconstriction, 
will increase electron transport, and rates of coupled and uncoupled respiration 
proceed unhindered. One may speculate that the higher the rate of oxygen delivery, 
the greater the rate of mitochondrial proton leak. Once the immediate cellular 
requirements for ATP are met, oxygen consumption in excess of this requirement will 
drive proton motive force and the rate of proton leak. Alternatively, during low 
oxygen delivery (regional ischemia/hypoxia with type B vasoconstriction) uncoupled 
respiration will be the first component of oxygen consumption to be down-regulated, 
until oxygen delivery becomes so low that ATP production is also compromised. At 
this time, skeletal muscle fibers may assume a state of metabolic hibernation, 
preventing hypoxic damage. 
7.3 Metabolic demand 
7.3.1 Muscle V02 stimulated by metabolic demand 
Metabolic demand is usually the result of metabolic "stress". Stress may take 
the form of ionic or osmotic disequilibrium, or increased energy demand induced by 
cold exposure or muscular contraction. Homeostatic mechanisms are activated in 
response to these stresses, most of which require ATP. In order to match the 
increased demand, glycolytic and aerobic ATP production rates are elevated above 
basal. In the case of the sodium channel opener veratridine, muscle resting VO2 is 
elevated (291), while the sodium ionophore monensin increases basal glucose uptake 
(25), both in response to the increased demand for ATP-dependent sodium pumping. 
Similarly, raised intracellular calcium (resulting from KC1 depolarization, caffeine, 
ryanodine, thapsigargin etc.) increases V02 through increased ATP-dependent 
calcium pumping (52). Elevated rates of oxygen uptake observed during perfusion 
•with hyper-tonic media- (mannitol, glucose, or NaCl) (64; 179) may be the result of a 
similar phenomenon. Stimulation of cellular oxygen uptake in response to stress, is 
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the direct result of increased ATP demand. Observations in the perfused rat hindlimb, 
that the effects of type A vasoconstrictors were blocked by agents interfering with 
sodium permeability (291; 292), led the development of the hypothesis that type A 
vasoconstrictors may increase skeletal muscle V0 2 by increasing the rate of ATP-
dependent sodium pumping. Comparisons were made between type A 
vasoconstrictors, and veratridine. 
Veratridine-stimulated metabolism displayed all of the characteristic changes 
in skeletal muscle metabolism one would predict when sodium cycling is directly 
involved. There were significant increases in resting oxygen uptake, and lactate 
efflux. These effects were abolished by low sodium medium, and by membrane 
stabilizers (291; 292). Veratridine-mediated metabolism was also abolished by 
addition of sodium channel inhibitors, and inhibitors of the Na +/K÷-ATPase pump 
(Chapter 4), reflecting a direct relationship between ion cycling and cellular energy 
turnover. Furthermore, veratridine-stimulated metabolism resulted in a detectable 
plasma membrane depolarization of perfused skeletal fibers, which was accompanied 
by a significant decrease in freeze-clamped muscle PCr content (Chapter 5), 
consistent with increased ATP utilization. The stimulatory effects of increased 
sodium load on cellular metabolic rate were apparent in both perfused resting skeletal 
and cardiac muscle (Chapter 6). These findings support the idea that stimulated 
metabolism during veratridine infusion is the direct result of increased ATP demand 
by the Na+/K+-ATPase pump. 
7.3.2 Vasoconstrictors do not increase metabolic demand 
In contrast, the results obtained during type A vasoconstrictor-mediated 
metabolism are not entirely consistent with increased rates of ATP-dependent ion 
pumping. While low sodium medium, propranolol (291; 292) and ouabain (Chapter 
4) were effective inhibitors of the type A vasoconstrictors in perfusion, this was not 
conclusive evidence that increased V02 was the result of ATP-dependent sodium 
pumping. Data presented in Chapters 4, 5 & 6 offers firm evidence against this idea. 
First, failure of tetrodotoxin to block the type A effect in perfusion rules out the 
involvement of voltage gated sodium channels (Chapter 4). Second, no changes in 
skeletal muscle plasma membrane potential were detected during type A infusion 
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(Chapter 5). Third, type A vasoconstrictors do not deplete cellular energy stores 
(Chapter 5), in fact there is some evidence that cellular energy status may be 
enhanced in the presence of type A vasoconstrictors (300). Clearly, sodium cycling is 
not stimulated in skeletal muscle fibers under the impetus of type A vasoconstrictors. 
Finally, the type A vasoconstrictor effect was absent from perfused arrested heart. If 
the mechanism of type A vasoconstrictor-mediated thermogenesis was directly 
dependent on increased intracellular sodium, then an effect should have been apparent 
in perfused arrested heart. This was not the case. In summary, the evidence presented 
does not support a role for sodium cycling in skeletal muscle fibers during type A 
vasoconstrictor-mediated metabolism. 
7.3.3 Unresolved issues 
The inhibitory effects of low sodium medium, propranolol and ouabain on 
vasoconstrictor-metabolism remains a perplexing issue. Sodium cycling may still be 
an important aspect of type A mediated metabolism, though clearly not in the skeletal 
muscle fibers themselves. Conducted depolarization has been proposed by Segal et 
al. as a mechanism for transmission of vascular signals along the vascular tree during 
exercise and application of vasoactive substances (265; 267; 268; 270). Similarly, it 
is possible that redistribution of flow may be facilitated by a sodium dependent 
transduction mechanism in vascular smooth muscle during vasoconstrictor-mediated 
capillary recruitment. Agents that interfere with transduction of electrical signals in 
the vascular smooth muscle will not only stop the spread of the signal, but will also 
prevent sustained capillary recruitment. 
Previously presented data (292) is now reconsidered in light of this revised 
opinion. In the original publication, the stimulatory effects of norepinephrine on 
hindlimb V02 were significantly inhibited by both (+) and (—) enantiomers of 
propranolol. The combination of 100gM (±) propranolol inhibited angiotensin II 
mediated V02 by 64%, though perfusion pressure was also inhibited around 30%. 
Though stated in the paper that propranolol had only "marginal" effects on 
angiotensin mediated vasoconstriction, these small changes in perfusion pressure may 
have been enough to impair vasoconstrictor-mediated capillary recruitment, and thus 
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redistribution of flow. Similarly, low sodium medium and ouabain may also have 
interfered with vascular cell signalling, thereby preventing transduction of electrical 
signals and redistribution of flow. However, tetrodotoxin would not be expected to 
interfere with this vascular transduction/ capillary recruitment process, since smooth 
muscle cells have been shown to carry tetrodotoxin-resistant sodium channels (296; 
314). 
A surrogate indicator of vasoconstrictor-mediated capillary recruitment, is the 
post equilibration red cell washout, where red cells trapped in the nutritive capillary 
network are swept out of the preparation during type A vasoconstrictor infusion (219). 
The apparent observation that propranolol did not interfere with angiotensin II 
mediated post-equilibration red cell washout (292) implies that vasoconstrictor-
mediated redistribution occurs normally, even in the presence of a membrane 
stabilizer. However, closer inspection of this data reveals that angiotensin II mediated 
red cell washout is incomplete in the presence of propranolol, since a second smaller 
red cell washout was detected when propranolol infusion ceased. This suggests that 
propranolol had prevented complete access to the nutritive region, leaving some red 
cells•trapped in the tissue. This region was only fully accessible by angiotensin II 
when the membrane-stabilizing agent had been removed, and conduction of the 
vascular signal was uninterrupted. It is concluded that the inhibitory effects of 
propranolol, ouabain and low sodium medium on vasoconstrictor-mediated 
metabolism result from impaired vascular recruitment and limitation of perfusate 
access, and not as previously suggested from inhibition of a cellular thermogenic 
mechanism. 
One final issue that remains to be addressed is the possibility that muscle 
metabolism is enhanced by changes in local perfusate ion concentration during type A 
mediated recruitment of flow. That is, regions of the hindlimb that are less than 
optimally perfused during basal conditions may have reached a stage where ionic 
exchange rates have reached a relative state of equilibrium. The sudden opening of 
these capillaries will change not only flow rate and oxygen delivery, but also ionic 
and osmolar gradients between the vessel lumen and muscle fibers. It has been 
suggested that increased flow rate may increase the rate of K + exchange by perfused 
muscle (194), while hyperosmolar buffer has been shown to induce changes in vessel 
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diameter (204). Unpublished observations from this lab have noted the stimulatory 
effects of hypertonic or hyperosmolar perfusion media on muscle V02, however these 
effects are generally slow in onset, and are quite small by comparison with type A 
vasoconstriction. The results from Chapter 3 demonstrate quite clearly that perfused 
muscle is highly responsive to changes in Oxygen delivery under normo-osmotic 
conditions, since total flow and the ratio of nutritive to non-nutritive flow remained 
constant. Thus, the stimulatory type A vasoconstrictor effect is more likely to be 
related to changes in oxygen delivery, than ionic perturbance during capillary 
recruitment. 
7.5 Summary 
In summary, the regulatory influence of vasoconstrictors on perfused skeletal 
muscle metabolism is attributed to changes in microvascular oxygen delivery, and not 
activation of ATP consuming reactions. Oxygen delivery appears to be a major 
regulatory factor in the control of perfused rat hindlimb metabolic rate, and the 
heterogeneity of blood flow and oxygen delivery imposed by dual vascular pathways 
has profound effects on skeletal muscle metabolic rate. Utilization of this flow 
heterogeneity enables regulation of skeletal muscle metabolic rate. Setting a 
conservative ratio of nutritive blood flow in skeletal muscle, may contribute 
considerably to whole body energy conservation. However, the full thermogenic 
capacity of skeletal muscle is readily recruitable simply by enhancing the extent of 
nutritive perfusion. The increase in metabolism observed with type A 
vasoconstrictor-mediated redistribution of flow is therefore likely, to be the result of 
enhanced perfusate access ameliorating oxygen limitation. Alternatively, the decrease 
in perfused muscle metabolism with type B vasoconstriction is likely to be the result 
of decreased oxygen delivery and metabolic hibernation in the hypo-perfused regions 
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Effect of vasoconstrictors and microspheres on intra-muscular PCr/Cr, PCr/ATP 
and Energy Charge (EC) ratios as a function of V02 of the constant-flow perfused rat hindlimb. 
1.5x106 microsphere injection have been used. Treatments were Vehicle ( 0), Vehicle + MS ( • ), 
I jiM 5-HT ( d ), 1 ,uM 5-HT + MS ( • ), 5 nM All ( ) and 5 nM All + MS ( N ). 
Reproduced with permission from Michelle Vincent, 
[original figure appears in the paper Vincent, Rattigan et al. 1998 (300)] 
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Effects of vehicle (0), NE (II) or 5-HT (A ) on the outflow-to-inflow (0/I) ratio of 31120 in the 
perfused rat hindlimb at varyingflow rates, n=8 for all conditions at all flow rates. Microdialysis 
flow rate was 21.11/min. Data were compared to 1.0 ml/min within each condition (#P<0.05), or to 
vehicle (*P<0.05). OH ratio decreased as a function of increasingflow rate, NE potentiates the 
decrease, while 5-HT impedes the decrease. Figure reproduced with permission of John Newman, 
[original findings reported inNewman, Di Maria et al. 2001 (221)] 
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Microdialysis out/in ratios for H2O3 	in the autoperfused anesthetized sheep heart 
The same microdialysis technique used in the perfused rat hindlimb was applied to 
the beating heart of the anesthetized sheep. Microdialysis probe was 20mm long, and 
a flow through rate of 10 ,u1/min was used. Placement offlow probes around the left 
coronary circumflex artery and pulmonary artery enabled flow rate to be carefully 
monitored. Additions were either noradrenaline (n=6), sodium nitroprusside (n=3) 
or adenosine (n=5). The average regression lines for norepinephrine, nitroprusside 
and adenosine were not significantly different from each other. Graph reproduced 
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Na+ channel and Na+-K+ ATPase involvement in 
norepinephrine- and veratridine-stimulated 
metabolism in perfused rat hind limb 
Alex C.Y. Tong, Carla A. Di Maria, Stephen Rattigan, and Michael G. Clark 
Abstract: In the constant flow perfused rat hind limb, norepinephrine (NE) evoked increases in oxygen uptake (1 ./o2) 
and lactate efflux (LE) were inhibited by the cardiac glycoside ouabain (I mM), without interrupting the NE-mediated 
vasoconstriction. The membrane labilizer veratridine, previously shown to increase Vo 2 and LE, without increasing 
perfusion pressure, was also shown to be inhibited by the cardiac glycoside . ouabain, as well as by the ouabain 
analogues digitoxin and digoxin. The stimulatory actions of veratridine on Vo 2 were inhibitable by low doses of the 
specific sodium channel blocker tetrodotoxin (TTX), while NE effects were unaffected, suggesting that NE may be 
acting via a 'ITX-insensitive sodium channel. It is concluded that agents such as NE (a vasoconstrictor) or veratridine 
(a membrane labilizer), which stimulate V0 2 in the perfused rat hind limb, do so by increasing Na+ influx. The 
observed increases in oxygen consumption and LE are due to Nat-K* ATPase activity to pump Nal - out of the cell at 
the expense of ATP turnover. Energy dissipation due to Na+ cycling may be a form of facultative thermogenesis 
attributable to NE that can be stimulated by membrane labilizers such as veratridine in the constant flow perfused rat 
hind limb. 
Key words: membrane labilizer, digitoxin, digoxin, cardiac glycosides, Nat-K+ ATPase, ouabain. 
Résumé : Dans le membre posterieur perfuse A debit constant du rat, les augmentations induites par la norepinephrine 
(NE) de la capture d'oxygene (Vo 2) et du flux sortant de lactate (FL) ont ete inhibees par le glucoside cardiotonique 
ouabane (1 mM) sans que la vasoconstriction induite par la NE soit interrompue. Le labilisateur membranaire 
veratridine, connu pour augmenter la Vo 2 et le FL sans augmenter la pression de perfusion, a aussi ete inhibe par le 
glucoside cardiotonique ouabaine ainsi que par les analogues de l'ouabane, digitoxine et digoxine. Les actions 
stimulatrices de la veratridine sur la Vo 2 ont pu etre inhibees par de faibles doses du bloqueur specifique des canaux 
sodiques tetrodotoxine (TTX), sans que la NE soit influencee, ce qui pone A penser que la NE peut agir par 
l'intermediaire d'un canal sodique sensible A la TTX. On conclut que des agents comme la NE (un vasoconstricteur) 
ou la veratridine (un labilisateur membranaire) stimulent la Vo 2 dans le membre posterieur perfuse du rat en 
augmentant le flux entrant de Na' Les augmentations observees de la consommation d'oxygene et du FL resultent de 
l'activite de la 	ATPase pour extraire le Na* des cellules aux &pens du renouvellement de l'ATP. La 
dissipation d'energie induite par le cycle du Na+ pourrait etre une forme de thermogenese facultative attribuable A la 
NE, qui pourrait etre stimulee par des labilisateurs membranaires tels que la veratridine dans le membre posterieur 
perfuse A debit constant du rat. 
Mots des : labilisateur membranaire, digoxine, Nat-K+ ATPase, digitoxine, glucosides cardiotoniques, ouabaine. 
[Traduit par la Redaction] 
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Introduction 
Skeletal muscle at rest contributes to whole-body thermo-
genesis in response to both cold and overeating (Jansky 
1995). However, unlike brown adipose tissue, where the 
mechanism of thermogenesis is defined, the exact mecha-
nism of thermogenesis in resting skeletal muscle remains 
unclear. Candidate mechanisms include mitochondrial pro- 
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ton leak (estimated to be responsible for about one-half of 
the resting muscle thermogenesis (Rolfe and Brand 1996)) 
and regulated uncoupling of mitochondria involving the re-
cently discovered third member of the uncoupling protein 
family (UCP-3). However, the exact function of UCP-3 is 
unknown, even though the involvement of this protein in 
skeletal muscle thermogenesis has been implied (Gong et al. 
1997; Larkin et al. 1997). A third candidate mechanism for 
resting muscle thermogenesis relates to the observed stimu-
latory effects of adrenergic vasoconstrictors, particularly in 
perfused muscle preparations (Jansky and Hart 1963; Grubb 
and Folk 1977; Richter et al. 1982; Cote et al. 1985), where 
apart from an accompanying increase in perfusion pressure, 
little is known about the underlying mechanism. Studies 
from this laboratory have extended those original findings 
by showing, in the perfused rat hind limb preparation, that 
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thermogenesis is stimulated by other vasoconstrictors in-
cluding angiotensin II (All) and vasopressin (Colquhoun et 
al. 1988; Ye et al. 1990). In addition, increased flow rate 
leading to elevated perfusion pressures also stimulated oxy-
gen consumption (Ye et al. 1990). The relationship between 
vasoconstriction and changes in muscle metabolism (Clark 
et al. 1994) appeared to be obligatory since the addition of 
vasodilatory agents decreased vasoconstriction and reversed 
the metabolic effects (Colquhoun et al. 1988, 1990; Ye et al. 
1990). Since the stimulatory effects of these vasoconstrictors 
were demonstrable in perfusion only, and not in isolated in-
cubated muscle preparations (Dubois-Ferriere and Chinet 
1981; Hettiarachchi et al. 1992), it was proposed that the in-
crease in oxygen consumption observed under vasoconstric-
tion was due to work performed by the smooth vascular 
muscle itself as it contracted to hold perfusion pressure 
(Colquhoun et al. 1988, 1990; Ye et al. 1990; Colquhoun 
and Clark 1991; Clark et al. 1994). 
However, more recent studies where membrane-
stabilizing agents were found to inhibit the vasoconstrictor-
mediated increase in oxygen uptake (Vo2) without affecting 
vasoconstriction (Tong et al. 1997) suggested that the in-
crease in Vo2 originates from skeletal muscle and was the re-
sult of an indirect vascular effect. A key element of the 
indirect vascular mechanism appears to be the redistribution 
of flow between two distinct vascular pathways within muscle 
(Clark et al. 1997). Evidence includes the vasoconstrictor-
mediated washout of red blood cells from the perfused tis-
sue, even after a suitable equilibration period (Newman et 
al. 1996). In addition, fluorescent dextran (M,. 150 000) stud-
ies showed that this marker was entrapped in a new vascular 
space accessed by low-dose norepinephrine (LDNE) (New-
man et al. 1996). Furthermore, LDNE vasoconstriction was 
shown to cause an increase in the number of vessels filled 
with vascular casting medium and, in other experiments, to 
decrease the diameter of large tendon vessels in the tibialis 
region of the biceps femoris as shown by surface fluorimetry 
(Newman et al. 1996, 1997). On the basis of this evidence, it 
was proposed that vasoconstrictors cause a redistribution of 
flow from a non-nutritive route to a nutritive route where 
vessels are in close proximity to regions with high metabolic 
activity. 
Conversely, other vasoconstrictors that inhibit metabolism 
are thought to restrict flow to the nutritive pathway and redi-
rect flow through functional vascular shunts or the non-
nutritive pathway. For example, serotonin (5HT), which in-
hibits metabolism including Vo 2, was shown to decrease the 
total number of vessels perfused with casting medium and to 
increase the diameter of the large tendon vessels (Newman 
et al. 1996, 1997). No red blood cell washout was observed, 
regardless of the magnitude of the increase in perfusion 
pressure due to 5HT infusion (Newman et al. 1996). More 
recently, veratridine (a putative Na* channel opener) has 
been found to increase perfused hind limb Vo 2 (Tong et al. 
1998) without significant pressure development. Thus it is 
possible to have a marked stimulation of oxygen consumption 
without vasoconstriction. The increase in oxygen consump-
tion was dose dependent, accompanied by a large increase in 
lactate efflux (LE), and was similar in magnitude to the 
changes caused by norepinephrine (NE) (Tong et al. 1998). 
The increase in Vo2 by resting perfused hind limb due to 
NE, All, or veratridine may each involve the same mecha-
nism of destabilization of skeletal muscle plasma membrane 
Na+ channels. Such a shared mechanism is suggested by the 
observation that NE-, All-, or veratridine-mediated increases 
in metabolism are each inhibited by low Na+ medium, or 
high ("membrane-stabilizing") doses of (±)-propranolol (a 
membrane stabilizer makes voltage-sensitive channels less 
voltage sensitive, and therefore harder to activate) (Tong et 
al. 1997, 1998). Since previous work by others on a non-
muscle tissue indicates that the activation of Na+ influx is 
accompanied by activation of the Na+-1C+ ATPase to main-
tain membrane potential with corresponding changes in me-
tabolism (Edwards et al. 1989), we have investigated the 
involvement of the Na+-1C+ ATPase and Na+ channels by us-
ing cardiac glycosides and tetrodotoxin, respectively, on NE-
and veratridine-mediated increases in metabolism in the con-
stant flow perfused rat hind limb. 
Materials and methods 
Animals 
Animals were cared for in accordance with the recommenda-
tions of the Animal Welfare Committee of the National Health and 
Medical Research Council (in Australian Code of Practice for the 
Care and Use of Animals for Scientific Purposes, 1990). The Com-
mittee on the Ethical Aspects of Research Involving Animals of 
the University of Tasmania approved all subsequent experimental 
procedures used. Male Hooded Wistar rats of a local strain were 
housed in a 12 h light : 12 h dark cycle at 22°C. Water and com-
mercial rat chow (Gibsons, Hobart) were freely available. Pento-
barbital sodium (5-6 mg/100 g body weight intraperitoneally) was 
administered to the animals prior to surgery. 
Hind -limb perfusions 
The surgical procedure for dual hind limb perfusion was the 
same protocol described in previous papers (Tong et al. 1998), an 
adaptation from Colquhoun et al. (1988). 
Young rats (70-80 g, approximately 4 weeks of age) were used 
in this series of experiments. Previous experimentation has demon-
strated the optimal NE response to be approximately 60% higher in 
smaller (70-80 g) rats than larger (180-200 g) animals (Tong et al. 
1997, 1998). 
Both hind limbs of young rats were perfused using a constant 
flow rate of 4.0 ± 0.1 mL.min-I (0.45 mL.min-1 • -1 muscle). The 
perfusion was carried out in a non-recycling mode at 25°C, using 
medium comprising modified Krebs—Henseleit bicarbonate buffer 
with 2% (w/v) bovine serum albumin (BSA, fraction V), 8.3 mM 
glucose, and 1.27 mM CaCl 2, and gassed with 95% 02 — 5% CO2 . 
An equilibration period of 50 min preceded each investigation. 
Perfusion pressure was constantly recorded via a pressure trans-
ducer fitted to a side arm proximal to the arterial catheter. The con-
stant arterial oxygen content (Pao2) was determined at the 
commencement and end of each perfusion. Venous effluent oxygen 
levels (Pvo2) were monitored continuously using a flow-through 
Clark-type oxygen electrode, and samples of the effluent were col-
lected at specified times for lactate analysis. The volume of oxygen 
consumed (Vo2) was calculated from the arteriovenous difference 
as micromoles per gram of hind limb tissue perfused per hour 
(timol.g-1 .0) with the use of the following equation: 
— p- 	a 25 x (Pao2 — Pvo2 ) x flow rate x 60 V02 
muscle mass (g) 
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Table 1. Steady-state values for oxygen uptake (Vo 2), perfusion pressure (PP), and lactate efflux 
(LE) with normal medium in the presence or absence of 0.5 mM nitroprusside (NP); 1 mM 
ouabain medium (with or without 0.5 inM NP); 301.IM digoxin with 0.5 mM NP;. and 30 i.tM 
digitoxin with 0.5 mM NP in the constant flow perfused rat hind limb. 
Vo2 




(limol.11-1 1-1 ) 
Basal 12.8 ± 0.4 21.5 ± 1.3 10.4 ± 1.1 
0.5 mM NP 12.6 ± 0.4 19.5 ± 0.9 11.3 ± 	1.1 
Basal 11.5 ± 0.3 21.5 ± 1.2 7.5 ± 0.2 
1 m/vl ouabain 10.7 ± 0.6 27.5 ± 1.9* 6.8 ± 0.2* 
Basal 11.6 ± 0.4 23.5 ± 0.5 9.2 ± 0.1 
1 mM ouabain + 0.5 mM NP 11.3 ± 0.2 22.5 ± 0.3 11.2 ± 0.9 
Basal 11.3 ± 0.5 22.5 ± 1.2 6.1 ± 0.2 
30 jiM digoxin + 0.5 mM NP 10.3 ± 0.3 25.5 ± 1.7 6.2 ± 0.3 
Basal 9.2 ± 1.5 24.4 ± 2.7 5.0 ± 0.9 
30 j.tM digitoxin + 0.5 mM NP 9.2 ± 1.5 26.6 ± 2.8 4.5 ± 0.2 
Note: Hind limbs were perfused at constant flow and allowed 50 min pre-equilibration with normal 
perfusion medium, at which time the buffer was changed to 1 rnM ouabain or 1 mM ouabain + 0.5 rnM NP, 
30 gM digoxin + 0.5 niM NP, or 30 gM digitoxin + 0.5 mM NP. Companion basal values are shown for each 
change to the perfusion buffer. New steady-state values for Vo 2, LE, and PP were reached within 30-40 min. 
Values are steady-state means ± SE for 5 perfusions. Values for pressure have been corrected for cannula 
resistance. *Significantly different (Student's paired 1-test; p < 0.05) from Basal. 
where ap25 is the bunsen solubility coefficient for 0 2 at 25°C in 
human plasma (1.509 nunoL-L-I -mmHg-1 ), Pao2 and Pvo2 are the 
measured arterial and venous oxygen levels (in mmHg), flow rate 
is in 1.11/min, and for small rats the mass (in g) of the perfused 
muscle is calculated as body weight x 0.141 - 2.534 (Rattigan et 
al. 1995). 
Other media 
Trial perfusions were conducted beforehand to ascertain the op-
timal effects for a given concentration of each agent. Ouabain, 
from Sigma Chemical Company (St. Louis, Mo.), was dissolved in 
the perfusion medium to give a final concentration of 1 inNI (dose 
shown by prior testing to give optimal effects). Digoxin (Sigma) 
and nitroprusside (Merck, Darmstadt, Germany) were dissolved 
into the perfusion medium to give 30 11M and 0.5 mM, respec-
tively. Digitoxin (Sigma; final concentration 30 1.tM, optimal dose 
for ouabain analogues shown by prior testing) was dissolved in a 
small quantity of 50% ethanol before being added to the 2% BSA 
with the 0.5 mM sodium nitroprusside. The final concentration of 
ethanol in the entire buffer volume was less than 0.6%. Each of the 
following reagents (from Sigma Chemical Company) was freshly 
prepared as a stock solution and infused at a rate of less than or 
equal to 1:200 of the flow rate: 10 mM veratridine (free base) dis-
solved in H 20, and neutralized with concentrated HC1; 1 mM NE 
dissolved in 0.1% ascorbic acid - 0.9% NaCl. Tetrodotoxin with 
citrate (Alomone Labs, Israel) was prepared in distilled water. 
Dose curves for NE and veratridine 
After a 50-min equilibration period, stepwise increasing doses 
of the drug were infused, with each dose period lasting 20 min 
(Tong et al. 1998). Doses of NE tested ranged from 0.003 to 
0.3 1.1M. The NE dose-response value for each data point was the 
average of four equally spread 5-min time points during the 20-min 
dose. Doses of veratridine tested ranged from 3 to 300 [tM. For ve-
ratridine, the dose-response value for each data point was the aver-
age of three points taken at 10, 15, and 20 min during the 20-min 
dose period. 
Dose-response curves for NE and veratridine in the 
presence of cardiac glycosides 
For .1 mM ouabain, 301.iM digoxin, and 30 jiM digitoxin perfu-
sions, the hind limb was first pre-equilibrated with normal buffer 
for 50 min, after which time the buffer was changed to the desig-
nated medium (ouabain, digoxin, or digitoxin). Two other ana-
logues of ouabain were chosen to show that the inhibitory effect on 
Vo2 was a general property of cardiac glycosides, and not a unique 
property of ouabain alone. A further 30-min equilibration time was 
allowed with the new medium. The transition from normal buffer 
to 1 mIs.4 ouabain or 30 i_tM digitoxin containing media resulted in 
small transient effects on Vo 2 and perfusion pressure (PP), which 
were ignored. The transition from normal buffer to 30 jiM digoxin 
was accompanied by the onset of a gradual increase in PP (data not 
shown), which continued for the remainder of the experiment. This 
pressure increase was not blocked by the presence of sodium nitro-
prusside, but did not have any significant effects on Vo 2 . There-
fore, digoxin PP was plotted against a constant moving baseline, to 
compensate for this increase. The study proper commenced when 
Vo2 returned to near basal level (steady state, see Table 1), usually 
within 30-40 min. The data presented are the changes from the 
new steady state. 
Effects of tetrodotoxin on NE- and veratridine-
mediated changes 
In a final series of experiments the effects of the sodium chan-
nel blocker tetrodotoxin (TTX) on NE- and veratridine-mediated 
increases in Vo2 , LE, and PP were assessed. After 50 min equili-
bration with 2% BSA, a constant infusion of either 0.1 p.M NE or 
30 i_tM veratridine was commenced. A period of 30 min was al-
lowed for steady-state stimulation of Vo 2 before TTX infusion 
commenced. TTX dose-response curves against both NE and ve-
ratridine were then conducted, with doses of TTX ranging from 
0.01 to 50 i.tM. 
Statistical analysis 
Repeated measures two-way analysis of variance was used to test 
the hypothesis that there was no difference in oxygen consumption, 
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Fig. 1. Dose-response curves for norepinephrine (NE) on oxygen 
uptake (Vo2), perfusion pressure (PP), and lactate efflux. Both 
hind limbs were perfused at constant flow. Perfusions were 
either control (0), which has been reported previously (Tong 
et al. 1998), or in 1 mM ouabain medium (•). Basal and 
steady-state values are given in Table I. Mean values for 
changes (from basal or steady state) ± SE are shown, where 
n = 5. Significant differences from steady-state stimulation: 
*p < 0.05; ***p < 0.001. 
perfusion pressure, or lactate efflux with each treatment, for 
norepinephrine or veratridine dose-response curves. When a sig-
nificant difference was detected (p < 0.05), pairwise comparisons 
were made with the use of the Student-Newman-Keuls test, and t-
tests to determine the dose of norepinephrine or veratridine at 
which treatments were significantly different. These tests were per-
formed with the use of the SigmaStat statistical program (Jandel 
Software). 
Results 
Effects of cardiac glycosides on basal metabolism 
Equilibration of the perfused rat hind limb for 50 min led 
to steady-state values for Pao2 (647 ± 6.5 mmHg), Vo 2 
(11.35 ± 0.331.tmol.e.h-1 ), and PP (16.7 ± 1.27 mmHg) be-
fore the addition of any agents (n = 30). Lactate efflux was 
also steady within this time, and remained constant for up to 
180 min of perfusion (data not shown). Substitution of the 
perfusion medium with one containing 1 mM ouabain 
caused an increase in perfusion pressure (6 mmHg greater 
than basal values, see Table 1). However, the inclusion of 
0.5 mM sodium nitroprusside (a nitrovasodilator) together 
with ouabain in the perfusion medium abolished this pres-
sure effect. Accordingly, 0.5 rriM sodium nitroprusside was 
included in the perfusion media for all veratridine dose-
response curves. The inclusion of nitroprusside in NE exper-
iments was not possible, since NP would affect the 
vasoconstrictor response to NE (Colquhoun et al. 1990). 
Effects of ouabain on NE-mediated response 
Figure 1 shows the effects of 1 mM ouabain against a NE 
dose-response curve. The NE dose-dependent increase in 
Vo2 was almost completely inhibited by 1 mM ouabain at all 
Fig. 2. Dose-response curves for veratridine (Vera) on oxygen 
uptake (Vo2), perfusion pressure (PP), and lactate efflux. Both 
hind limbs were perfused at constant flow. Perfusions were 
either control, i.e., 0.5 mM nitroprusside (A), which has been 
reported previously (Tong et al. 1998), or with medium 
containing 1 mM ouabain medium with 0.5 mM nitroprusside 
(A), 30 1.1M digoxin with 0.5 InM nitroprusside (•), or 30 1J.M 
digitoxin with 0.5 mM nitroprusside (•). Mean values for 
changes (from basal and steady state) ± . SE are shown, where 
n = 5. Basal or steady-state values for Vo 2 , PP, and lactate efflux 
are given in Table 1. Significant differences of nitroprusside 
alone from cardiac glycoside treated groups: *p < 0.05; 
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doses of NE (0.003 to 0.3 iiM). The greatest inhibition of 
oxygen consumption occurred at the three highest doses of 
NE (0.03, 0.1, and 0.3 jiM, where p < 0.01 for each). 
Lactate efflux was similarly affected, although large varia-
tions in the values meant that blockade by ouabain was sig-
nificant at only one dose of NE (0.1 1.tM). At this dose 
lactate efflux was reduced by 1 mM ouabain from 4.0 ± 0.8 
to 1.4 ± 0.4 grnol.g-1 .11-1 (p < 0.05). Pressure development 
was least affected, with a significant inhibition of 26% at the 
highest NE doses (0.1 and 0.3 i.tM, p < 0.05, Fig. 1). 
Digitoxin (another ouabain analogue) did not significantly 
affect the NE dose-response curves, although an inhibitory 
trend on Vo2 at the highest doses of NE was evident (data 
not shown). Because of the intrinsic pressor effect of 
digoxin, we were unable to test digoxin alone against NE. 
Effects of ouabain and digitoxin and digoxin on 
veratridine-mediated response 
Figure 2 shows the effects of 1 mM ouabain + 0.5 mM 
nitroprusside, 30 1.tM digitoxin + 0.5 mM nitroprusside, and 
30 1.1.M digoxin + 0.5 InM nitroprusside on the dose-
dependent effects of veratridine to stimulate Vo 2 and LE. 
Nitroprusside was included to eliminate any small changes 
in perfusion pressure attributable to veratridine. From previ-
ous studies (Tong et al. 1998), nitroprusside (0.5 mM) was 
found to have no effect on veratridine-mediated increases in 
Vo2 and LE. All three agents (1 ruM ouabain, 30 11M 
digitoxin, and 30 [tM digoxin, each in the presence of 
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Fig. 3. Dose—response curves of TTX against either 100 nM NE 
or 30 [tM veratridine. Both hind limbs were perfused at a 
constant flow rate. Perfusions were either constant infusion of 
NE with TTX dose—response curve (•) or constant infusion of 
veratridine with TTX dose—response curve (•). Values are the 
mean changes from basal ± SE, n = 3 for 50 1.1M TTX and 
n = 5 for all other doses. Significant differences from steady-
state stimulation (no TT'X): **p < 0.01; ***p < 0.001. 
mediated increases in Vo 2 and LE. At doses of veratridine 
greater than and equal to 10 j.tM, inhibition of Vo2 by all 
agents tested was highly significant (p < 0.001, Fig. 2). At 
30 jtM veratridine (the dose having the maximal stimulatory 
effects on Vo2 and LE), the relative percent inhibition of Vo 2 
by ouabain, digoxin, and digitoxin was 69, 89, and 61%, re-
spectively. 
In the presence of nitroprusside, there was no significant 
increase in perfusion pressure above basal due to veratridine. 
In addition, neither ouabain nor digitoxin had any significant 
effect on perfusion pressure in the presence of nitroprusside 
(Fig. 2). However, digoxin produced an intrinsic pressor ef-
fect, even in the presence of nitroprusside. Thus perfusion 
pressure continued to increase throughout the time course of 
the veratridine dose—response curve. Since the increase in 
pressure was independent of veratridine, controls were run 
without veratridine and the data were corrected for the in-
crease in pressure (Fig. 2). The time-dependent increase in 
pressure with digoxin + nitroprusside was without signifi-
cant effect on either oxygen consumption or LE (Table 1). 
Ouabain and its analogues had significant inhibitory ef-
fects on veratridine-stimulated LE at all doses of veratridine 
within the dose range. The inhibitory effects on LE were 
similar to those observed for Vo 2. Maximum inhibition of 
LE occurred at the maximum stimulatory dose of veratridine 
(30 p.M), where all three agents inhibited LE by more than 
82% when compared with control (veratridine + nitro-
prusside) (ouabain, p < 0.0005; digoxin, p < 0.001; and 
digitoxin, p < 0.008). 
Effects of TTX on NE- and veratridine-mediated 
increases in Vo2 
Figure 3 shows the effects of increasing doses of tetro-
dotoxin against a constant infusion of a single dose of either 
NE (0.1 jiM) or veratridine (30 jiM). Infusion of NE alone 
or veratridine alone increased Vo2 above basal by 7.21 ± 1.2  
(p < 0.05; n = 6) and 5.64 ± 0.3 	 (p < 0.05, n 
5), respectively. Stimulation of Vo2 by 0.1gM NE was unaf 
fected by doses of tetrodotoxin in the range of 0.1-50 1.0■, 
(p > 0.05). 
Veratridine (30 1..tM) caused increases . in Vo2 similar ti 
those caused by NE, but this increase in Vo2 was susceptiblo 
to tetrodotoxin. Inhibition by tetrodotoxin was most apparen 
at doses of 0.1 p.M and greater, almost completely reversinj 
the stimulation of Vo 2 due to veratridine (0.1 jtM, 0.3 jtM 
and 1.0 jtM significantly different from veratridine alone 
p < 0.01, p < 0.001, p < 0.001, respectively, Fig. 3). 
Discussion 
The objective of this study was to examine the effects o 
cardiac glycosides and tetrodotoxin on veratridine- and NE 
mediated increases in metabolism of the constant flom 
perfused rat hind limb, with a view to further exploring tin 
mechanism by which NE increases resting muscle metabo-
lism in this preparation. The main findings indicate tha 
ouabain blocks the stimulatory effects . of both NE and verat-
ridine on Vo2, without affecting vasoconstrictor activit) 
(Figs. 1 and 2). The ouabain analogues digoxin and digi-
toxin also significantly inhibited veratridine-mediated in-
creases in Vo2 and LE (Fig. 2). Digitoxin was shown tc 
block NE-mediated increases to a small degree (data noi 
shown), but not as effectively as ouabain. The specific so-
dium channel blocker TTX also blocked the veratridine-
mediated increase in Vo2 but had no effect on NE-induced 
changes (Fig. 3). 
The increased metabolism due to NE over the dose range 
of 0.003 to 0.3 i.tM accompanied by vasoconstriction has 
been regarded by us in the past as having implication for 
facultative thermogenesis in resting skeletal muscle (Col- 
quhoun et al. 1990; Clark et al. 1995; Newman et al. 1996). 
In our most recent report, the mechanism to explain the 
thermogenic action of NE was found to be shared with the 
membrane labilizer veratridine, and to involve Nal - influx 
(Tong et al. 1998). The relevant associated energy dissipa- 
tion process has been suggested to be the result of ATP turn- 
over due to activation of the Nal---K+ ATPase in maintaining 
the plasma membrane potential by pumping the Na+ out of 
the cell (Tong et al. 1998). There are precedents for a close 
association of Na+ inward movement and stimulation of the 
ATPase. Edwards et al. (1989) using turtle brain 
synaptosome preparation demonstrated that oxygen con- 
sumption could be increased by increasing Na+ channel ac- 
tivity with veratridine or inhibiting it with tetrodotoxin, 
respectively. In addition, Cohen and Lechene (1990) using 
isolated rat hepatocytes found that uptake of alanine was fol- 
lowed by an increase in the rate of Na+ entry, an increase in 
intracellular Na+ content, and an increase in ouabain- 
inhibitable rubidium uptake (a measure of Na+—K+ ATPase 
pump rate). Taken together, these and our own findings from 
the present study suggest regulation of the Na+—K+ ATPase 
via intracellular [Nal and concomitant modulation of cellu- 
lar oxygen consumption. Should a mechanism involving 
coupling between Na+ conductance and energy expenditure 
through the Na+—ICE ATPase operate in muscle, it may well 
also provide a mechanism for reduced energy consumption 
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luring hypometabolism. In this respect Hochachka et al. 
J996) have focused attention on reduced membrane con-
luctance as a mechanism for conserving energy during 
hypometabolic states. 
Na+—K+ ATPase is an integral plasma membrane protein 
that transports 3Na+ out and 2K+ into the cytoplasm at the 
expense of ATP turnover. The structure and function of this 
protein has been intensively explored over the years and 
plausible mechanisms have been thoroughly reviewed (De 
Weer et al. 1988; Jorgensen 1992). Activation of this en-
zyme is thought to be voltage dependent due to precedent 
Na+ translocation process (De Weer et al. 1988), and skeletal 
muscle may have sufficient Na+-1(+ ATPase activity to 
match the increases in Vo 2 and LE noted in the present study 
(Clausen et al. 1998). Its expression at the plasma membrane 
is subject to regulation by hormones, long-term exercise, 
and other factors (Clausen 1996a, 1996b). In addition, it has 
been noted that rats injected with thyroid hormone show in-
creases in oxygen consumption in incubated liver slices and 
diaphragm, which is attributed to an increase in Na+—K+ 
ATPase concentration in the tissues (Izmail-Beigi and 
Edelman 1970). It has been demonstrated that thyroid (Lin 
and Akera 1978) or glucocorticoid (Dorup and Clausen 
1997) hormones injected intraperitoneally stimulate in-
creased expression of the enzyme in rat skeletal muscle by 
100 and 50%, respectively. In addition, changes in Na+-1(+ 
ATPase levels occur during early post-natal development in 
skeletal muscle. Starting with low Na+—K+ ATPase concen-
tration at birth, the activity reaches optimal levels at 4 weeks 
of age (increase of 5-fold), then declines to a lower plateau 
in the adult rat (Kjeldsen et al. 1982). Therefore it was inter-
esting to note that in an age comparison between 4 week old 
(70-80 g) and larger (7 weeks old) rats of 180-200 g, the 
NE-mediated increases in hind limb Vo 2 under similar perfu-
sion conditions showed a greater increase in Vo2 in the small 
rats despite a lower perfusion pressure development (Tong et 
al. 1998). 
In the constant flow perfused rat hind limb system, basal 
oxygen consumption is not affected by 1 mM ouabain at 
steady state (Table 1), although a small increase in perfusion 
pressure was evident. This suggests that Na+—K+ ATPase ac-
tivity is not a significant factor in the basal energy consum-
ing process, which is in general agreement with reports that 
the basal energy component due to Na+-1C+ ATPase activity 
in muscle is very low (Clausen et al. 1991). Indeed this rep-
resents approximately 5-7% of basal metabolic rate in iso-
lated intact resting mammalian skeletal muscle when 
measured by microcalorimetric determination (Chinet et al. 
1977; Biron et al. 1979; Fagher et al. 1987) or in a sealed 
oxygen electrode chamber (Wardlaw 1986). Using the rat di-
aphragm muscle, it has been shown that as little as 2% of to-
tal basal energy consumption can be attributed to Nal ---K+ 
ATPase activity (Creese 1968). However, there is one report 
that claims much higher levels of Na+—K+ ATPase involve-
ment in resting skeletal muscle (Gregg and Milligan 1980), 
but this may not be correct as Clausen (Clausen et al. 1991) 
and others (Biron et al. 1979) have shown that the activity 
may be artificially increased due to an effect of using cut or 
nonintact muscle preparations. The absence of a contribution 
of the Na+—K+ ATPase activity to basal state metabolism is  
consistent with the observations that neither high dose 
(±)-propranolol (membrane-stabilizing action) or low extra-
cellular Na+ medium (both of which impede sodium cycling 
activity) also has very little effect on resting metabolic rate 
in the same system (Tong et al. 1998). 
Apart from acting as a potent inhibitor of Na+—K+ ATPase 
activity, as a result of a conformational modulation of the 
extracellular phase of the channel (Caldwell and Keynes 
1959; Hansen 1984; Jorgensen 1992), ouabain and other car-
diac glycosides have been reported to directly stimulate cal-
cium release from cardiac sarcoplasmic reticulum through 
activation of Ca2+ release (McGarry and Williams 1993) and 
to enhance transient inward calcium current of heart 
(Marban and Tsien 1982). Of these, only the two former 
mechanisms are possibilities for skeletal muscle. Since rest-
ing muscle tension does not appear to have changed with ei-
ther veratridine or NE (unpublished observations), it seems 
most likely that effects of the cardiac glycosides on skeletal 
muscle can be attributed to inhibition of the Na+—K+ 
ATPase. Thus our present study confirms the findings of 
Shiota and Masumi (1988) that NE-mediated increases in 
Vo2 and LE in the constant flow perfused rat hind limb are 
blocked by ouabain and involve Na+—K+ ATPase activity. 
We also show that veratridine-mediated increases in Vo 2 and 
LE are blocked by the Na+—K+ ATPase inhibitors (Figs. 1 
and 2), adding further merit to the notion that some aspects 
of the mechanism of action of veratridine and NE might be 
shared (Tong et al. 1998). 
The observation that tetrodotoxin blocks veratridine-
mediated increases in Vo 2 confirms the previous finding of 
others that veratridine acts on a tetrodotoxin-sensitive Na+ 
channel (Lombet et al. 1982). In the present study, NE was 
unaffected by tetrodotoxin even at concentrations of up to 
50 p.M. However, the mechanism by which NE stimulates 
Vo2 is clearly dependent on sodium flux through the cell 
membrane since the .actions of NE are negated by low Na+ 
medium, the membrane stabilizer propranolol (Tong et al. 
1997), and the Nal---K+ ATPase blocker ouabain. This im-
plies that NE is acting on a sodium channel that is tetro-
dotoxin insensitive, even though channels of this kind have 
only been reported in cardiac muscle (Catterall 1992) and 
denervated skeletal muscle of the adult rat (Rogart and 
Regan 1985; Catterall 1992). There are no reports to date of 
tetrodotoxin-insensitive channels in normal innervated skele-
tal muscle, but their presence has not been totally dis-
counted. For example, in primary cultures of fetal rat 
skeletal muscle cells, populations of both tetrodotoxin-
sensitive and -insensitive channels have been shown to co-
exist, with the two subtypes having different developmental 
regulation (Sherman et al. 1983). A further consideration in 
this study is the age of the rats. At 4 weeks of age, rrx-
insensitive channels may still be present. 
It is interesting that in addition to the absence of effect of 
1TX on the NE-mediated increase in Vo 2 , ouabain analogues 
were also poorly effective against NE. This may suggest that 
a complex exists between the specific Na+ channel activated 
by NE and the Na+—K+ ATPase pumps. If so, a different Na 
channel may influence the Na+-1C+ ATPase to such an extent 
that its sensitivity to ouabain analogues is also altered. 
In summary, data from the present study lend additional 
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support to the notion that NE- and veratridine-mediated in-
creases in resting muscle metabolism share a common mecha-
nism, involving Nal- channel activation, and a ouabain-
sensitive step, presumably the Na+-1C+ ATPase. This may 
provide a mechanism for the facultative thermogenesis seen 
in resting skeletal muscle in response to NE demonstrated 
by us (Colquhoun et al. 1990; Clark et al. 1995) and others 
(Jansky and Hart 1963; Grubb and Folk 1977; Richter et al. 
1982; Cote et al. 1985; Shiota and Masumi 1988) in the con-
stant flow perfused muscle preparation. However, there still 
remains uncertainty as to the identity of the tetrodotoxin-
insensitive sodium channel that NE, angiotensin II, and re-
lated vasoconstrictors indirectly activate and the mechanism(s) 
by which this activation occurs. 
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Abstract 
MTT, a positively charged tetrazolium salt, is widely used as an indicator of cell viability 
and metabolism and has potential for histochemical identification of tissue regions of 
hypermetabolism. In the present study, MTT was infused in the constant-flow perfused rat 
hindlimb to assess the effect of various agents and particularly vasoconstrictors that increase 
muscle metabolism. Reduction of MTT to the insoluble formazan in muscles assessed at the 
end of experiments was linear over a 30 min period and production rates were greater in red 
fibre types than white fibre types. The vasoconstrictors, norepinephrine (100 nM) and 
angiotensin (10 nM) decreased MTT formazan production in all muscles but increased 
hindlimb oxygen uptake and lactate efflux. Veratridine, a Na+ channel opener that increases 
hindlimb oxygen uptake and lactate efflux without increases in perfusion pressure, also 
decreased MTT formazan production. Membrane stabilizing doses (100 1.1M) of ( + )-propra-
nolol reversed the inhibitory effects of angiotensin and veratridine on MTT formazan 
production. Muscle contractions elicited by stimulation of the sciatic nerve, reversed the 
norepinephrine-mediated inhibitory effects on MTT formazan production, even though 
oxygen consumption and lactate efflux were further stimulated. Stimulation of hindlimb 
muscle oxygen uptake by pentachlorophenol, a mitochondrial uncoupler, was not associated 
with alterations in MTT formazan production. It is concluded that apart from muscle 
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contractions MTT formazan production does not increase with increased muscle metabolism. 
Since the vasoconstrictors angiotensin and norepinephrine as well as veratridine 
activate Na+ channels and the Na + /K+ pump, energy required for Na± pumping may be 
required for MTT reduction. It is unlikely that vasoconstrictors that stimulate oxygen 
uptake do so by uncoupling respiration. 0 2000 Elsevier Science Ireland Ltd. All rights 
reserved. 
Keywords: Skeletal muscle; Membrane potential; Vasoconstrictors; Sodium channel 
1. Introduction 
Tetrazolium dyes are used widely to assay for growth in cultured cell systems [1], 
particularly in the area of toxicity testing [2]. The mechanism by which tetrazolium 
salts are converted to colored complexes appears to involve reduction by the 
addition of electrons donated by several dehydrogenases, where these may be 
cytosolic enzymes [3] or mitochondria] enzymes of the respiratory chain [1,4]. 
Despite the uncertainty regarding the site(s) of MTT reduction within the cell [1,3], 
it is clear that the MTT reduction rate closely relates to the number of actively 
respiring cells in cell culture [1,2,5]. 
The advantages of some tetrazolium salts (particularly MTT, 3-(4,5-dimethylthia-
zol-2-y1)-2,5-diphenyltetrazolium bromide) in monitoring growth of cell cultures are 
apparent in the use of microplate assays, particularly microculture tetrazolium 
assays [1], where ease of use and avoidance of radioisotopes replaces the use of [41] 
thymidine incorporation and related approaches. MTT also affords another advan-
tage in that the yellow water soluble MTT is converted upon reduction to a lipid 
insoluble purple formazan that becomes trapped within the cell, and particularly 
mitochondria. Having been so successful as an indicator of metabolism in cell 
culture, a questionarises as to whether it is similarly useful for intact tissue 
metabolism and could MTT be used to locate the cells or tissues responsible for 
increases in metabolism. 
Muscle metabolism can be stimulated in the perfused rat hindlimb in a number 
of ways. These include muscle contraction [6], as well as agents such as selected 
vasoconstrictors [7], Na+ channel openers like veratridine [8] and mitochondria] 
uncouplers. Vasoconstrictor effects to stimulate muscle metabolism in the constant-
flow perfused rat hindlimb appear to involve redistribution of flow from non-nutri-
tive connective tissue vessels to the nutritive route probably permitting more 
complete perfusion of muscle capillaries [9]. A histochemical marker of metabolism 
would thus have the potential to confirm this possibility. 
In the present study we have measured MTT formazan production in the calf 
muscles of the constant-flow perfused rat hindlimb to investigate the relationship 
between the increases in muscle metabolism induced in a variety of ways and MTT 
reduction. 




2.1. Hindlimb perfusions 
Flooded Wistar rats were cared for in accordance with the principles of the 
Australian Code of Practice for the Care and Use of Animals for Scientific 
Purposes (1990, Australian Government Printing Service, Canberra). Males (180— 
200 g) were housed at 22°C and a 12/12 h light/dark cycle with free access to water 
and food (commercial rat chow, Gibsons, Hobart, Australia, containing 20.4% 
protein, 4.6% lipid, 69% carbohydrate and 6% crude fibre with added vitamins and 
minerals). Animals were anaesthetized with an intraperitoneal injection of pento-
barbital sodium (6 mg/100 g body wt.). Surgery was essentially as described by 
others [10] with additional details as given previously [11,12]. Flow was controlled 
so as to perfuse exclusively the left limb by ligation of the right common iliac 
artery. Perfusions were performed at 25°C using a modified Krebs-Henseleit buffer 
containing 2% bovine serum albumin (BSA) or 4% Ficoll®, 8.3 mM glucose and 
1.27 mM CaCl2. The buffer reservoir was gassed with 95% 0 2-5% CO2 at 4°C to 
enable full oxygenation. A constant flow rate of 4.0 + 0.2 ml/min or 0.27 + 0.01 
ml/min/g muscle was maintained and venous effluent flowed through a 0.5 ml 
thermostatically controlled chamber containing a Clark-type oxygen electrode to 
measure oxygen content. Comparison of perfusions at 25°C without red blood cells 
and at 37°C with red blood cells indicates that there is very little difference in 
agonist response and energy status of the muscle [7,13]. Perfusion pressure was 
continuously monitored by a pressure transducer fitted into a branch of the arterial 
cannula. After passage through the hindlimb and oxygen electrode, the perfusate 
was then either sampled or discarded. Oxygen uptake was calculated as described 
previously using the appropriate Bunsen coefficient [14]. The mass of muscle 
perfused has been previously determined for rats this size [15]. Details for sciatic 
nerve stimulation were as given previously [6]. 
2.2. Hindlimb reduction of MTT 
Hindlimbs were equilibrated for 30 min prior to infusion of either norepinephrine 
(NE), angiotensin II (All), veratridine (Vera), (± )-propranolol (Prop) or vehicle 
for 50 min. For perfusions involving (± )-propranolol in addition to vasoconstric-
tor or veratridine, the (± )-propranolol was infused 10 min prior to infusion of 
other agonists. Commencement of MTT (10 pg/ml, final) infusion began at 10 min 
after the start of the agonist/vehicle infusion and was maintained for a total of 30 
min. This allowed a washout period of 10 min while still maintaining infusion of the 
agonist. The perfusion was then terminated and the muscle groups excised, freeze-
dried and homogenized in 2 ml of isopropanol. After centrifugation at 1000 x g for 
20 min, the absorbance of the supernatant was measured at 570 nm to determine 
the concentration of reduced MTT (formazan). 
Effluent perfusate concentrations of unconverted MTT and the reduced product 
were monitored at intervals throughout the infusion period. This was conducted to 
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check that the fraction of MTT extracted by the hindlimb remained constant 
( — 40%) and that reduced MTT did not appear ( < 0.1%). 
The extinction coefficient of formazan was determined using diaphorase and 
NADH to completely reduce a known amount of MTT to formazan product. Rates 
of reduction were calculated as mmol formazan formed/h/g dry wt. It was necessary 
to freeze-dry the muscle samples as the water content of the muscle caused turbidity 
of the isopropanol extract. 
3. Statistical analysis 
All data is presented as mean + S.E. Differences in data were analysed either by 
Student's 1-test or by analysis of variance (one-way or two-way ANOVA) with 
pairwise comparison by the Student—Newman—Kuel Test. Statistical significance 
was assumed at P < 0.05. 
4. Results 
4.1. Time course of MTT reduction 
MTT (1-20 pg/m1) when infused during hindlimb perfusion had no vasoconstric-
tor activity, but at the highest doses (10-20 pg/m1) produced a minor vasodilatory 
effect against the pre-constricted hindlimb; that is with angiotensin IT (All) or 
norepinephrine (NE) (data not shown). On this basis a dose of 10 pg/m1 was 
considered a compromise that avoided significant vasoactivity, but permitted 
sufficient MTT for reduction to be determined within a reasonable time frame. 
Fig. 1 shows the amount of MTT converted to its formazan over 10, 20 or 30 
min by the soleus, gastrocnemius and plantaris muscle group of the perfused rat 
hindlimb, respectively. Muscles were combined before analysis to ensure that the 
amount of MTT formazan produced was well above the detection limit of the 
assay. This would have been a problem for some of the individual muscles, 
especially soleus with NE infusion at the 10 and 20 min time intervals. The amounts 
increased linearly over the 30 min interval for both control (no additions) and NE 
(100 nM) infused hindlimbs, but the amount with NE was significantly less than 
that of the control at the 20 and 30 min time intervals, respectively. 
4.2. Effects of vasoconstrictors 
Fig. 2(a) shows that each of the vasoconstrictors, NE (100 nM) and All (10 nM) 
increased perfusion pressure, oxygen uptake and lactate efflux. The metabolic 
effects of NE corresponded to an increase in oxygen uptake of 40.2% from 
7.86 + 0.26 to 11.02 + 0.33 umol/g per h. All produced a similar stimulatory effect 
increasing the rate of oxygen uptake by 35.7%. Lactate efflux was increased from 
8.81 + 0.46 by 5.95 + 0.85 and 7.83 + 0.96 umol/g per h, for NE and All, respec- 
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tively. MTT formazan production in individual muscles is shown in Fig. 2(b). The 
relative order of muscle MTT formazan production under basal (no addition) 
conditions was soleus > gastrocnemius red > extensor digitorum longus > plan-
tans > tibialis > gastrocnemius white. For all muscles both vasoconstrictors de-
creased the rate of MTT formazan production when measured at 30 min (Fig. 2(b)). 
The inhibitory effects of NE were greatest in soleus (49.5%) and gastrocnemius red 
(53.7%). 
Infusion of (± )-propranolol (100 uM) alone caused a slight increase in oxygen 
uptake and perfusion pressure, but had no effect on lactate efflux, or MTT 
formazan production in any of the muscles sampled. When added with All, 
however, it significantly impaired the increase in oxygen uptake and lactate efflux 
due to All without decreasing the perfusion pressure (Fig. 2(a)). The MIT 
formazan production rate was significantly increased compared to All alone (Fig. 
2(b)). Also, (± )-propranolol blocked the inhibition of MIT formazan production 
and stimulation of oxygen uptake and lactate efflux by NE (data not shown). 
4.3. Effects of exercise 
In a separate series of experiments the sciatic nerve in the flank of the perfused 
hindlimb was continuously stimulated during NE and MIT infusion and formazan 
production determined in individual muscles after 30 min. Contraction (n=3) 
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Fig. I. MTT formazan formation by perfused rat hindlimb muscles. Hindlimbs were perfused at 
constant flow and vehicle (0) or 100 nM NE (•) infused for 10 min before, during and for 10 min after 
the infusion of MTT. Muscles of the lower leg comprising the soieus, gastrocnemius and plantaris were 
excised and treated as described in the text for the measurement of formazan formation. Average values 
for the combined muscle group were determined and means + S.E. are shown. *P <0.05 vs. vehicle 
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effects of NE on MTT formazan production in the five muscles, soleus (from 
0.39 + 0.03 to 0.80 + 0.06, P < 0.001), plantaris (from 0.30 + 0.02 to 0.66 + 0.04, 
P < 0.001), gastrocnemius (from 0.24 + 0.02 to 0.56 + 0.07, P < 0.001), tibialis 
(from 0.34 + 0.02 to 0.54 + 0.06, P < 0.01) and extensor digitorum longus (from 
0.45 + 0.03 to 0.75 + 0.05 umol/g dry wt./h, P < 0.001). 
4.4. Effects of veratridine 
Veratridine, unlike NE and All, stimulates oxygen uptake by the hindlimb 
independent of vasoconstriction activity [8]. Accordingly, experiments were con-
ducted to assess whether the rate of MTT reduction was affected. Fig. 3(a) shows 
that veratridine increased both oxygen uptake and lactate efflux without change in 
perfusion pressure. MTT formazan production was significantly inhibited by vera-
tridine in all muscles sampled (Fig. 3(b)). In addition, 100 uM (± )-propranolol, 
which at this dose, acts as a membrane stabilizer, reversed the veratridine-mediated 
changes of metabolism as well as the production of MTT formazan. 
4.5. Effects of uncoupling 
Pentachlorophenol (PCP) is a mitochondrial uncoupler which stimulates respira-
tion without vasoconstrictor activity. Experiments were conducted to determine the 
0.0 
"5 




134 	J.M.B. Newman et al. / Chemico-Biological Interactions 128 (2000) 127-140 
Fig. 3. Effects of 30 !AM veratridine (Vera) and 100 M1V1 propranolol (Prop) on: (a) oxygen uptake, 
lactate efflux and perfusion pressure by perfused hindlimb (during the infusion of MTT); and (b) MTT 
formazan production by individual muscles (at the end of MTT infusion). Experimental details are given 
in the text. Values are means + S.E. (n = 9, 7, 5 and 6 for basal, Vera, Prop and Vera + Prop, 
respectively). *P < 0.05 compared to control, IP < 0.05 compared to veratridine (pairwise comparison 
by Student—Newman—Kuel method after one-way ANOVA). 
effect of 5 AM PCP on MTT formazan production. Ficoll ® was used instead of 
BSA in the perfusion medium for these experiments because PCP is 
highly lipophilic and binds strongly to BSA but not Ficoll ® . Data obtained in the 
presence of Ficoll® is shown in Table I. Using Ficoll ® instead of BSA 
gave a slightly higher basal pressure (P < 0.01), but did not affect the basal 
oxygen uptake or MTT formazan production by the muscles. PCP did not affect 
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5. Discussion 
The main finding emerging from this study was that MTT reduction by muscles 
of the perfused rat hindlimb was not consistently linked to changes in muscle 
metabolism. Thus, apart from muscle contraction in the presence of NE where 
MTT reduction increased in parallel to the increase in muscle metabolism, other 
stimulants of muscle metabolism either inhibited (vasoconstrictors and veratridine), 
or had no effect (uncoupler) on the rate of MTT reduction. Overall," this would 
appear to be contrary to several reports where metabolism is closely linked to the 
rate of MTT reduction [1]. It would also be contrary to the wide spread use of 
MTT in cell toxicity studies where MTT metabolism has been assumed to reflect the 
number of viable respiring cells present [2]. 
For the vasoconstrictors angiotensin and norepinephrine, where metabolism was 
clearly stimulated MTT reduction was inhibited. Thus the use of MTT as an agent 
to locate the cellular sites of extra oxygen consumption stimulated by these 
vasoconstrictors would be inappropriate. Indeed the finding that both veratridine as 
well as NE and All vasoconstrictor effects on metabolism and MTT reduction were 
blocked by membrane stabilizers such as propranolol that inhibit Na+ channels, 
suggest that the energy required for MTT reduction is the same as that required for 
Na± pumping out of the cell, but different to that supporting uncoupled respiration 
induced by pentachlorophenol. 
Fig. 3. (Continued) 
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Table 1 
Effect of Ficoll® and 5 uM pentachlorophenol (PCP) on oxygen uptake, perfusion pressure and MTT 




(n = 4) 
PCP (Ficolln 
(n = 4) 
Oxygen uptake (mmol/h/g) 7.81 + 0.29 8.90 + 0.74 12.50 + 0.09e 
Perfusion pressure (mmHg) 18.1 + 0.9 23.8 + 0.5 b 25.8± 1.8 
MTT formazan production 
(umol/h/g) 
Soleus 0.78 + 0.04 0.89 + 0.11 1.12 + 0.02 
Plantaris 0.56 + 0.04 0.59 + 0.10 0.62 + 0.06 
Gastrocnemius red 0.66 + 0.05 0.62 + 0.10 0.75 + 0.09 
Gastrocnemius white 0.38 + 0.07 0.41 + 0.08 0.42 + 0.05 
Tibialis 0.50 + 0.05 0.51 + 0.09 0.39 + 0.09 
Extensor digitorum longus 0.66 ±0.04 0.76 ±0.12 0.55 + 0.11 
a Experimental details are given in the text. Data are mean + S.E. with n values indicated. Student's 
t-test was used to determine significant differences. 
b P<0.01 compared to basal (BSA). 
P<0.01 compared to basal (Fico11°). 
MTT is a positively charged yellow tetrazolium dye and enters the cell where it 
is reduced to an insoluble purple formazan by cleavage of the tetrazolium ring by 
dehydrogenase enzymes of the cytosol and mitochondria [3]. TPMP+, another 
positively charged molecule is also taken up by viable cells. The accumulation of 
TPMP+ in the mitochondria] matrix is a function of its cytosolic concentration and 
hence is influenced by potential and pH differences across both plasma and 
mitochondrial membrane [16]. However, MIT accumulation in the mitochondria 
may not only be the result of the mitochondria] membrane potential, but also 
formation of an insoluble end product which is effectively removed from further 
reaction. This aspect is highlighted by the linear rate of MTT reduction even at 30 
min whereas the unmetabolised TPMP+ reaches steady state accumulation within 8 
min albeit in another tissue [16]. 
The precise site(s) at which MTT is reduced has been systematically studied [3]. 
They propose that in the bone marrow-derived cell line 32D most of the cellular 
reduction of MIT occurs extra-mitochondrially and probably involves the pyridine 
nucleotide cofactors NADH and NADPH. Other researchers have focused on 
establishing the mitochondrial site at which MIT is reduced and largely ignored the 
possibility that reduction might be occurring outside the mitochondria. If the bulk 
of the MTT reduction does indeed occur on the outer surface of the inner 
mitochondria] membrane [3] then the vasoconstrictor- and veratridine-stimulated 
metabolic events are competing for access to these dehydrogenases and thus 
decreasing MIT reduction. We have previously shown that veratridine increases 
hindlimb oxygen uptake, and this stimulatory effect is opposed by low Na+ or 
propranolol [8] at membrane-stabilizing doses thought to inhibit Na+ channels. 
Similarly, using a turtle brain synaptosome preparation it has been demonstrated 
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that oxygen consumption could be increased or decreased by increasing Na+ 
channel activity with veratridine or closing the Na± channel with tetrodotoxin, 
respectively [17]. 
Changes in plasma membrane potential may alter mitochondrial membrane 
potential [16]. However, the effects on the mitochondrial membrane potential were 
relatively small and a more recent study confirmed this [18]. Using rat liver slices 
they found that while high K± medium decreased the plasma membrane potential 
(as reflected by increased uptake of [ I4C]SCN- ), it had no significant effect on the 
uptake of [41]TPM13 ±. This contrasted with addition of the uncoupler CCCP 
which greatly reduced TPMP± uptake without affecting uptake of [ 14C]SCN - . 
These findings suggest that uptake of cationic dyes such as MTT are likely to be 
more affected by changes in the mitochondrial membrane potential (such as due to 
uncoupling) than to changes in plasma membrane potential as might occur with 
Na+ channel opening. However, in the present study, the addition of the uncoupler 
PCP did not affect the reduction of MTT. This could support the idea that MTT 
is not converted solely within the mitochondria [3]. Obviously this will require 
further study. 
The vasoconstrictors NE and angiotensin II, unlike veratridine, mediate major 
changes in flow distribution within the hindlimb muscles. There is indirect evidence 
that the vasoconstrictors act to diminish non-nutritive flow and in so doing increase 
nutritive flow or muscle capillary surface area in a constant flow preparation. 
Improved perfusion and greater provision of nutrients to the muscle fibres should 
not decrease MTT reduction. It would appear that the increase in nutritive flow is 
not fibre type specific as NE and All decreased MTT formazan production in all 
muscles sampled. Also, the alteration of flow distribution per se does not seem to 
contribute to the overall result since propranolol reversed the inhibitory effects of 
NE and Al!. Previous papers show that propranolol at this concentration (100 1.1.M) 
does not affect the redistribution of flow caused by NE or All [8,19]. 
The involvement of different fibre types during muscle contraction could con-
tribute to the effects seen since it is not known whether the increase in MTT 
formazan production from that of NE with exercise was derived from stimulated or 
unstimulated fibres. Reliable conclusions about the relationship between MTT 
reduction and other metabolic parameters in specific sets of fibres cannot be made 
from the data for muscle contraction. 
It is possible however, that increased competition between oxygen and MTT for 
reducing equivalents results in less MTT reduced. Each molecule of oxygen reduced 
by the respiratory chain requires four electrons. One molecule of MTT requires two 
electrons for reduction. However, the proportion of electrons required for oxygen 
relative to that for MTT under basal perfusion conditions is 31:1. Thus increased 
competition could only occur if oxygen supply was the only change resulting from 
vasoconstrictor action. Analysis of metabolites indicates that vasoconstrictors 
increase glycerol efflux [9] in amounts to suggest that fatty acid availability has 
markedly increased to exceed the amount of reducing equivalents required to 
support the actual increase in oxygen uptake. If so, this would lessen the possibility 
of a competition for reducing equivalents between oxygen and MTT developing. 
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However, some support in favor of a generally diminished reducing equivalent 
availability comes from pyruvate analyses conducted in conjunction with lactate 
determinations (J-M. Ye, PhD thesis, University of Tasmania). These analyses 
indicated that the muscle lactate/pyruvate ratio decreased from 9.2 + 1.1 to 3.1 + 
0.7 as a result of NE infusion into the constant flow perfused rat hindlimb. Using 
the formula: 
K = [Pyruvate][NADH][H+1 
[Lactate][NAD+] 
from [20], the calculated cytosolic 'free NAD+/free NADH' would then have 
increased from 988 to 2909 (assuming K = 1.11 x 10' M and a pH of 7.0). Thus 
it is possible that the vasoconstrictors NE and angiotensin II have depleted the 
reduced pyridine nucleotide pool sufficiently to lower MIT reduction by simply 
increasing oxygen availability or by other unknown mechanisms. 
Tetrazolium dyes have also been extensively used in assays for superoxide and 
superoxide dismutase (SOD). Nitro blue tetrazolium is most commonly used 
[20-23] although other tetrazoliums such as XTT [24] and MTT [25] have been 
employed. In the present study, however, All, NE or veratridine increased oxygen 
uptake of the muscle, which would be expected to increase production of superox-
ide and hence the reduction of MIT. Since All, NE or veratridine caused a 
decrease in the reduction of MIT, the involvement of superoxide is unlikely to be 
a major factor. 
Finally, it is worth noting that muscle contraction elicited by sciatic nerve 
stimulation completely overcame the inhibitory effect of NE on MIT reduction. 
Because oxygen uptake rate is much higher when contraction and NE are combined 
than for NE alone, it would seem unlikely that NE-mediated decrease in MIT 
reduction is the result of competition for reducing equivalents between oxygen and 
MTT. Moreover, the findings also imply that whatever the process responsible, it is 
reversed by muscle contraction induced by nerve stimulation. In this respect nerve 
stimulation would lead to plasma membrane hyperpolarization and the re-establish-
ment of a favorable charge gradient for MTT entry. 
In summary, MTT is reduced at a constant rate by perfused rat hindlimb 
muscles. Although rates generally appear to be greatest in muscles rich in slow 
oxidative and /or fast oxidative glycolytic fibres and are stimulated by muscle 
contractions, MIT reduction does not always correlate with muscle metabolism. 
Uncoupling mitochondria had no effect on MTT reduction whereas vasoconstric-
tors that increase metabolism decrease MTT reduction. 
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Newman, John M. -B., Carla A. Di-Maria, Stephen 
Rattigan, and Michael G. Clark. Nutritive blood flow 
affects microdialysis 0/1 ratio for [ 14Clethanol and 3H20 in 
perfused rat hindlimb. Am J Physiol Heart Circ Physiol 281: 
H000-H000, 2001.-Changes in the microdialysis outflow-
to-inflow (011) ratio for [ 14C]ethanol and 3H20 were deter-
mined in the perfused rat hindlimb after increases and de-
creases in nutritive flow mediated by the vasoconstrictors 
norepinephrine (NE) and serotonin (5-HT), respectively. Mi-
crodialysis probes (containing 10 mM [ 14Clethanol and 3H20 
pumped at 1 or 2 ill/min) were inserted through the calf of the 
rat. Hindlimb perfusion flow rate was varied from 6 to 56 
ml. 
 
min' 100 g -1 in the presence of NE, 5-HT, or saline 
vehicle. The 0/1 ratios for both tracers were determined at 
each perfusion flow rate, as was perfusion pressure, oxygen 
uptake (a surrogate indicator of nutritive flow), and lactate 
release. Both tracers showed a decreased 0/1 ratio as hind-
limb perfusion flow was increased, with [ 4C]ethanol being 
higher than 3H20. NE decreased the 0/I ratio compared with 
vehicle, and 5-HT increased it for both tracers and both 
microdialysis flow rates. We conclude that the microdialysis 
0/1 ratio, while able to detect changes in total flow, is also 
sensitive to changes in nutritive and nonnutritive flow, 
where the latter still extracts tracer, but less than the 
former. 
vasoconstrictors; interstitial fluid; nutritive/nonnutritive 
blood flow; total blood flow; skeletal muscle; outflow-to-inflow 
4 ratio 
MICRODIALYSIS IS A TECHNIQUE used to monitor the con-
centrations of biologically important compounds in the 
interstitial fluid of various organs including the brain, 
skin, adipose tissue, and muscle (for reviews, see Refs. 
3 and 16). The technique is also used to monitor blood 
flow in tissues by the addition of ethanol to the micro-
dialysis solution. As it passes through the probe, eth-
anol diffuses into the tissue and is removed by the 
blood. The ratio of the outflow concentration to inflow 
concentration (011 ratio) of ethanol has been found to 
vary inversely with the total blood flow in skeletal 
muscle (19, 36), which has been mathematically mod-
eled (38). The method has been extended to use 
[14C]ethanol as well as 3H20, both of which have been 
shown to give similar qualitative results (36), with 
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3H20 having a lower 011 ratio, reflecting its ability to 
diffuse more readily across the dialysis membrane and 
through the interstitial fluid. 
Work in this laboratory using the constant flow per-
fused rat hindlimb has followed from a number of 
studies that concluded that there were two vascular 
pathways in skeletal muscle (1, 15, 21, 27, 32) and has 
been recently reviewed (7). It has led to the finding that 
vasoconstrictors can be characterized into two groups 
based on their effects on muscle metabolism (6). These 
vasoconstrictor-mediated changes occur without any 
changes in bulk flow between individual muscles or 
other tissues, as indicated by microsphere embolism 
(7). The first group, type A, to which norepinephrine 
(NE) belongs, increase oxygen uptake (11), aerobic 
muscle contraction (31), and release of lactate (17), 
glycerol (5), uracil, and uric acid (9). Type B vasocon-
strictors, to which serotonin (5-HT) belongs, on the 
other hand, decrease oxygen uptake (12), aerobic mus-
cle contraction (13), insulin-mediated glucose uptake 
(29), and acute release of lactate (6), glycerol (6), uric 
acid, and uracil (6). These effects of vasoconstrictors 
are mediated via the vasculature, because the effects 
on pressure and metabolism can be reversed by the 
addition of vasodilators (10, 11, 17, 29). In addition, the 
stimulatory (or inhibitory) effects of vasoconstrictors 
on contractility or insulin-mediated glucose uptake 
seen in perfused muscle are absent when muscles are 
isolated and incubated (13, 29, 30). Accordingly, we 
proposed that the two types of vasoconstrictors (A and 
B) achieve these effects by redistributing flow at the 
microvascular level, with type A or B increasing or 
decreasing nutritive flow, respectively (7). To add to 
this notion, we have shown that type A vasoconstric-
tors increase blood flow to vessels supplying the muscle 
cells (7, 25), whereas type B vasoconstrictors redirect 
flow away from the muscle cells (7, 25) toward vessels 
of limited exchange capacity probably associated with 
the interfibrillar septa of muscle and with tendon (26). 
An inverse relationship between oxygen uptake and 
tendon vessel flow exists (26), suggesting that, under 
the conditions of the constant-flow perfused hindlimb, 
oxygen uptake is a surrogate indicator of nutritive 
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flow. Further evidence that the nonnutritive route is 
present in the muscle body comes from our most recent 
studies (4, 37) where both nutritive and nonnutritive 
routes were found to be distributed homogeneously in 
muscle. 
The redirection of flow within each muscle of the 
perfused rat hindlimb in the absence of changes in 
total flow may have important implications for the 
microdialysis ethanol technique. The addition of a type 
A vasoconstrictor would be expected to switch flow 
from nonnutritive to nutritive and thereby improve the 
removal of ethanol from the probe, leading to a de-
crease in the 011 ratio. Type B vasoconstrictors would 
have the opposite effect, switching flow from the-nutri-
tive to the nonnutritive, which still extracts tracer, but 
less than nutritive flow; thus the 0/I ratio should 
increase. In this study, the 011 ratio for [ 14C]ethanol 
and 3H20 were determined in the perfused rat hind-
limb over a range of total blood flow rates with and 
without the addition of the vasoconstrictors NE or 
5-HT to alter the proportion of nutritive to nonnutri-
tive flow. 
METHODS 
Animals. Male hooded Wistar rats were cared for in accor-
dance with the principles of the Australian Code of Practice 
for the Care and Use of Animals for Scientific Purposes 
(Australian Government Printing Service; Canberra, Austra-
lia). Experimental procedures were approved by the Commit-
tee on the Ethical Aspects of Research Involving Animals of 
the University of Tasmania. Rats (180-200 g) were housed at 
22°C and were given free access to water and a commercial 
rat chow (Gibsons; Hobart, Australia; containing 20.4% pro-
tein, 4.6% lipid, 69% carbohydrate, and 6% crude fiber with 
added vitamins and minerals). Anesthesia was administered 
by pentobarbitone sodium (6 mg/100 g body wt ip) before all 
surgical procedures. 
Fl 	Microdialysis probes were linear in construction (Fig. 1A). 
The point of a 23-gauge Terumo syringe needle was blunted 
by filing, and the syringe adapter was removed. A short 
length (25 mm) of microdialysis tubing (Bioanalytical Sys-
tems; molecular-weight cutoff, 30 kDa; outer diameter, 320 
AQ: 2 p.m) was inserted into the blunt end of the needle to a depth 
of —5 mm and glued using Araldite. The amount of glue was 
kept to a minimum so that the overall diameter was less than 
the internal diameter of a 16-gauge syringe needle. 
Hindlimb perfusions. Perfusions were conducted in a tem-
perature-controlled cabinet set at 37°C. The perfusion me-
dium was a modified Krebs-Henseleit buffer (118 mM NaC1, 
4.7 mM KCI, 1.2 mM KH2PO4, 1.2 mM MgSO 4, 25 mIVI 
NaHCO3, and 8.3 mM glucose) containing 2.5 mM CaC12, 4% 
bovine serum albumin, and washed bovine erythrocytes (35% 
hematocrit). Fresh bovine erythrocytes were washed three 
times in saline (0.9% NaC1) and twice in Krebs-Henseleit 
buffer and were stored in Krebs-Henseleit buffer at 4°C until 
use (erythrocytes were never >5 days old when used). Per-
fusate was gassed via a Silastic tube oxygenator with 95% 
air-5% CO2 and brought to 37°C by a heat exchanger coil. 
Both the arterial and venous perfusate passed through an 
arteriovenous oxygen difference analyzer (A-VOX Systems), 
which measures the spectral difference of arterial versus 
venous blood at 660 nm (35). Arterial pressure and the 
arteriovenous difference in blood oxygen (in nil 02/100 ml 
blood) were recorded continuously by the data acquisition 
A 
Fig. 1. Microdialysis probe design and positioning in rat hiiadlimb 
muscles. A: the linear probe comprised 25 ram of dialysis tubing (d), 
of which —5 mm was glued inside a 23-gauge syringe needle (n). 
Scale is indicated by the bar. B: positioning in the lower leg muscles 
required a 18-gauge syringe needle to be carefully inserted through 
the muscle, right to left. The steel end of the probe was inserted into 
the emergent end of the 18-gauge needle, which was then slowly 
withdrawn, leaving only the microdialysis tubing in contact with the 
muscle. Other details are given in the text. 
program Windaq. The arterial and venous perfusate were 
periodically sampled for the determination of lactate concen-
tration on a Yellow Springs Instrument glucose/lactate ana-
lyzer. 
Hindlimb surgery was essentially as described in Ref. 34 
with modifications as given in Ref. 11. Flow was restricted to 
the left hindlimb by ligation of the right common iliac artery 
and vein. Also during the surgery, a small area of skin over 
the gastrocnemius and tibialis muscles was removed. One or 
two microdialysis probes were inserted into the muscle with 
the aid of an 18-gauge syringe needle. This was achieved by 
initially inserting the 18-gauge steel needle through the 
muscle at the site where the probe was to be positioned. The 
steel 23-gauge needle end of the probe was then inserted into 
the emergent end of the 18-gauge needle, which was then 
slowly withdrawn. Care was taken to ensure that the probe 
remained snugly within the 18-gauge needle. Withdrawal 
was continued until 10 mm of the dialysis tubing was posi-
tioned within the muscle (Fig. 1B). The 18-gauge needle was 
discarded, and the needle end of the microdialysis probe was 
attached to a syringe pump. During equilibration of the 
hindlimb preparation, the microdialysis probes were flushed 
with 200 p.1 saline (0.9% NaC1) containing 10 mM [ 14Cletha-
nol (100 nCi/m1) and 3H20 (500 nCi/m1). For the remainder of 
the experiment, the syringe pumps were set at 1 or 2111/min. 
The hindlimb preparation was allowed to equilibrate for 20 
min at 4 ml/min of hindlimb perfusate flow before the addi-
tion of either 70 nM NE, 300 nM 5-HT, or saline vehicle into 
the arterial perfusate. After equilibration, the hindlimb per-
fusion flow rate was changed at 30-min intervals in a step-
wise manner to 1, 2, 4, 6, and 9 ml/min. To minimixe evapo-
rative loss, microdialysate samples were collected into 
narrow preweighed microfuge tubes (diameter, 12 )( 4 mm), 
which were uncapped. Samples were collected in the last 10 






17; 717, 	60 
o.,.. • 
c 43 o 	40 C 
X 3- o 	20 
40 
L — 30 
E 11.1 
'C 	20 
E 03 =. 10 
o
o 
    
2 	4 6 	8 10 
Perfusion flow rate (ml.min' l ) 
Fig. 2. Effect of vehicle, norepinephrine (NE), or serotonin (5-HT) on 
perfusion pressure (A), oxygen uptake (B), and lactate efflux (C) in 
the perfused rat hindlimb at varying total flow rates. The conditions 
were: 0, vehicle; II, NE; and a, 5-HT; n = 6 for all conditions at flow 
rates of 1 and 2 ml/min and n = 10 for the higher flow rates. 
Statistical significant was assessed by two-way repeated-measures 
ANOVA, with comparisons using the Student-Newman-Kuels' mul-
tiple-comparison procedure. Data were compared with 1 ml/min 
within each condition (§P < 0.05) or to vehicle values at correspond-
ing perfusion flow rates (*P < 0.05). 
Increasing perfusion flow rate led to decreasing 011 
ratios for 3H20 under all three conditions (shown by a 
significant difference compared with values at 1 ml/ 
min). NE significantly decreased the 0/I ratio for 3H20 
at all perfusion flow rates for both probe flow rates 
compared with vehicle. 5-HT significantly increased 
the 011 ratio compared with basal at all perfusion flow 
rates except 1 ml/min for probes set at 1 p.1/rain (Fig. 
4A) and perfusion flow rates of 4-9 ml/min for probes 
set at 2 p.1/rain (Fig. 4B). 
Figure 5 shows the effect of the vasodilator NP as Fs 
well as NE and 5-HT on the oxygen uptake, perfusion 
pressure, and 0/1 ratios for [14Clethanol and H2O.3  NP 
blocked all of the increase in pressure due to NE or 
5-HT. There was a slight dilation below basal, although 
this was not significant. The effect of NP on oxygen 
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rain with either one 10-rain sample for probes set at 1 pl/min 
or two 5-rain samples for probes set at 2 1.1.1/min. The volume 
of sample collected was then determined by reweighing the 
tubes, which were then put into 5-ml vials containing 3 ml of 
scintillant. Prior testing indicated that the volume of the 
collected dialysate was as expected from the perfusion rate 
and time of collection; the consecutive 5-rain samples at 2 
1.LI/min were averaged because they were not significantly 
different. A known volume of the inflow solution was also put 
into a vial containing 3 ml of scintillant. Vials were then 
counted for 'AC and 3H in a Beckman counter (LS 6500), and 
the 0/I ratios for both PAClethanol and 31120 were deter-
mined. 
A separate set of experiments was conducted to assess the 
effect of-a vabudilator on the 0/I ratio of [ 14C] ethanol and 
3H20. Perfusions were equilibrated with a single probe in the 
calf muscle set at 2 ill/min and the perfusion flow rate at 4 
ml/min for 40 min. Subsequently, either saline vehicle, 0.5 
mM nitroprusside (NP), 70 nM NE, 70 nM NE + 0.5 mM NP, 
300 nM 5-HT, or 300 nM 5-HT + 0.5 mM NP were infused for 
40 rain. During the last 10 rain of the equilibration and 
treatment periods, two 5-rain samples of microdialysate were 
collected. The 01I ratios for [14C]ethanol and 3H20 were 
—determined in the same way as the previous set of experi-
ments. 
Statistics. One-way or two-way repeated-measures 
ANOVA was performed using SigmaStat (SPSS Science; Chi-
cago, IL), with comparisons made between conditions using 
the Student-Newman-Kuels' post hoc test. Significance was 
assumed at the level of P < 0.05. Data are presented as 
means -± SE; if error bars are not visible, they are within the 
symbol. 
RESULTS 
Figure 2 shows changes in hindlimb perfusion pres-
sure, oxygen uptake, and lactate efflux of the perfused 
hindlimb in response to increasing total flow. At the 
doses chosen, NE and 5-HT produced similar increases 
in pressure, which were significantly above that of the 
vehicle (Fig. 2A). Figure 2.8 shows that NE signifi-
cantly increased oxygen uptake compared with vehicle 
at all flow rates except 1 ml/min, whereas 5-HT signif-
icantly decreased oxygen uptake at the higher three 
flow rates. Lactate efflux was significantly different to 
vehicle in the presence of NE at the three higher flow 
rates but was unaffected by 5-HT (Fig. 2C). 
The effect of increasing hindlimb perfusion flow 
rates on the 011 ratio for [14Clethanol is shown in Fig. 
F3. 3. Figure 3A shows data from probes set at 1 I.LI/min, 
and Fig. 3B shows data from probes set at 2 p.1/min. 
Increasing the perfusion flow rate decreased the 0/I 
ratio for [14C]ethanol under all three conditions, as 
indicated by a significant difference compared with 
values at 1 ml/min. NE significantly decreased the 0/1 
ratio compared with vehicle at perfusion flow rates of 2, 
6, and 9 ml/min for probes set at 1 p.1/min (Fig. 3A) and 
at all perfusion flow rates for probes set at 2 p.1/min 
(Fig. 3B). 5-HT, on the other hand, significantly in-
creased the 011 ratio at perfusion flow rates of 4, 6, and 
9 ml/min for probes set at 1 p.1/min (Fig. 3A) and at 6 
and 9 ml/min for probes set at 2 ul/min (Fig. 3B). 
The effect of increasing hindlimb perfusion flow 
F4 rates on the 0/1 ratio for 3H20 is shown in Fig. 4. 
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Perfusion flow rate (ml.min' l) 
Fig. 3. Effect of vehicle, NE, or 5-HT on the outflow-to-inflow (0/I) 
ratio of r*Clethanol in the perfused rat hindlimb. Microdialysis 
probes were set at 1 p.1/min (A) or 2 pl/min (B). Conditions and 
symbols were the same as in Fig. 2; n = 8 for all conditions at all 
perfusion flow rates in A and the same as for Fig. 2 in B. Data were 
compared with 1 ml/min within each condition (§P < 0.05) or to 
vehicle values at corresponding perfusion flow rates (5P < 0.05). 
uptake was inhibitory and4. so did not block the 5-HT-
mediated decrease in oxygen uptake. NP, however, was 
able to block the increase in oxygen uptake due to NE. 
NP entirely blocked the change in the 011 ratios for 
both tracers due to NE and 5-HT. A tendency for NP to 
increase the 01I ratio under basal conditions was not 
significant. 
DISCUSSION 
The major finding arising from this study is that, 
whereas the 0/1 ratio of [14C]ethanol and 31120 is 
inversely related to the total flow in the perfused rat 
hindlimb, the ratio can also be affected by the addition 
of the vasoconstrictors NE and 5-HT. The inverse re-
lationship between the 0/1 ratio and total flow supports 
data by other researchers (19, 36). The important new 
data are that two vasoconstrictors that have similar 
effects on pressure, but opposing effects on muscle 
oxygen uptake and hence nutritive flow, can also have 
opposing effects on the 0/1 ratios of PAgethanol and 
3H20. This is despite the proportion of total flow to 
individual muscles and muscle as a whole, as indicated  
by microsphere entrapment being unchanged by NE or 
5-HT (5). 
Explanations for this must, therefore, concentrate on 
how NE and 5-HT can affect the removal of ["C]etha-
nol and 31120 from the microdialysis probe. For the 
tracers to be removed from the system, they must first 
diffuse into the interstitial fluid and from there into the 
capillaries to be carried away by the blood flow. Diffu-
sion into the capillaries can be affected by two things: 
one is the blood flow rate through capillaries with 
direct access to the interstitial fluid and the other is the 
number of capillaries through which the blood flow is 
passing at any time. The total blood flow, as assessed 
by 15-p.m microsphere distribution, to individual mus-
cles was unaffected by NE or 5-HT (5). It is thus the 
second component which the vasoconstrictors are 
likely to have altered. That is, we would envisage that 
NE and 5-HT have changed the effective tissue blood 
flow at a level of vessels smaller than 15 p.m that are in 
contact with the interstitial fluid around the probe. 
Therefore, because NE decreased the 0/1 ratio, it is 
Perfusion flow rate (ml.min -1 ) 
Fig. 4. Effect of vehicle, NE, or 5-HT on the On ratio of 3H20 in the 
perfused rat hindlimb. Microclialysis probes were set at 1 u.1/min (A) 
or 2 Allraia (B). Conditions and symbols were the same as in Figs. 2 
and 3; n = 8 for all conditions at all perfusion flow rates in A and the 
same as for Fig. 2 in B. Data were compared with 1 ml/min within 
each condition (§13 < 0.05) or to vehicle values at corresponding 
perfusion flow rates (*P < 0.05). 
AJP-Heart Circ Physiol • VOL 281 • DECEMBER 2001 • www.ajpheartorg 
PIPP1,-.7...x.x. am 
MNIMI=11 
tapraid4/h4-ahea/h4-ahea/h41201/h41200d01a I sweigart t S=6 I 9/5101 I 13:16 I MS: H0335-1 I Int 12e/kmp I Input-OCT-al 













• 100 c 
50 0 













Fig. 5. Effect of vehicle, nitroprusside (NP), NE, and 5-HT on per-
fusion pressure (A), oxygen uptake (B), 0/1 ratio for [' 4C] ethanol (C), 
and 0/1 ratio for 3H20 (D). Perfusion flow rate was 4 ml/min and 
probe flow rate was 2 1.1.1/nain. Data are shown as a percentage of the 
corresponding basal for each condition: vehicle (open bars; n = 5), 0.5 
mM NP (solid bars; n = 4), 70 riM NE (hatched bars; is = 5), 70 nM 
NE + 0.5 mM NP (crosshatched bars; is = 4), 300 nM 5-HT (hori-
zontally lined bars; is = 4), and 300 nM 5-HT + 0.5 mM NP 
(horizontally and vertically lined bars; is = 4). Statistical significance 
was assessed by two-way repeated-measures ANOVA, with compar-
ison using the Student-Newman-Kuels' multiple-comparison test. 
Data were compared with their corresponding basal values (§P < 
0.05) or to corresponding data without NP < 0.05). 
likely to have increased the local tissue blood flow 
adjacent to the probe by increasing the number of 
capillaries and/or the flow rate through the capillaries 
near the probe. Because total flow to each muscle 
remained constant, the increase in flow around the 
probe must come at the expense of flow to another part 
of the muscle. The concept of increased number of 
capillaries being perfused is consistent with previous 
studies showing that NE accesses a new vascular space 
in muscle (25) at the expense of flow in the nonnutri-
tive route, which may located nearby in muscle (4) or in 
connective tissue (26). 
5-HT, on the other hand, probably decreased the 
number of capillaries and/or the flow rate through  
capillaries in contact with interstitial fluid around the 
probe. In a complementary fashion to NE, 5-HT is 
likely to have increased flow through vessels smaller 
than 15 p.m that are less involved with nutrient ex-
change but still within the muscle for the total flow to 
the muscle to remain constant. Again, this is consistent 
with previous studies, where 5-HT was found to deny 
access to a vascular space (25), increase nonnutritive 
flow (4), and increase connective tissue vessel flow (26). 
It is important to note that the effects of either NE or 
5-HT to change the 0/I ratios were blocked by the 
nitrovasodilator sodium NP in association with block-
ade of the pressure increases. This confirms that the 
effects of NE and 5-HT are the result of the vasocon-
strictor activity and are not the result of receptor-
mediated metabolic effects in the skeletal muscle. Be-
cause the perfused rat hindlimb is essentially fully 
dilated under basal conditions, NP has no significant 
pressure-lowering effect unless the hindlimb vascula-
ture is preconstricted by either NE or 5-HT (Fig. 5A). 
Thus NP prevents flow redistribution by relaxing the 
sites constricted by either agonist. 
At present, there are no methods that allow a quan-
titative assessment of the proportion of nutritive to 
nonnutritive flow either under basal conditions (no 
additions) or after NE or 5-HT addition. Thus the 
interventions serve simply to alter the proportion of 
flow, and, at best, only approximations can be made. 
For example, Fig. 4A shows that 5-HT addition at the 
total flow rate of 9 ml/min increased the 011 ratio of 
3H20 to a value of nutritive flow comparable with that 
of NE at 1 mllmin. From that, the nutritive flow after 
5-HT is approximately one-ninth the total flow, provid-
ing NE has fully recruited nutritive flow at 1 ml/min. 
However, the precise proportion is unknown, and the 
extent of change induced by each agonist is dependent 
on dose and bulk perfusion flow rate. While this may 
account for the similar 0/I ratios, such absolute values 
for relative flow in the two routes must be treated with 
caution. 
The 0/I ratio for ethanol has been used in animals to 
monitor blood flow changes during insulin infusion (14, 
20, 22) as well as in humans during hyperinsulinemia 
(33), glucose ingestion (23), or exercise (18). A recent 
study (28) on exercising humans showed that exercise, 
which increased femoral blood flow, decreased the 0/I 
ratio of ethanol but that the 0/1 ratio was unaffected by 
the subsequent infusion of adenosine despite further 
increases in femoral blood flow. The authors concluded AQ: 3 
that the 0/1 ratio of ethanol was due to changes in the 
probe recovery during exercise rather than the in-
crease in flow to the muscles. This apparent discrep-
ancy between flow and 0/I ratio may be explained by 
the notion of two vascular routes through muscle. The 
infusion of vasodilators such as adenosine, while in-
creasing total blood flow, would not necessarily in-
crease the flow to capillaries in intimate contact with 
muscle cells. This has indeed been shown to be the case 
for isoproterenol, which specifically dilates the trans-
verse arterioles of the rabbit tenuissimus muscle to 
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flow to muscle (2). Data from this study also suggest 
that the vasodilator NP does not enhance nutritive flow 
in that it decreased oxygen uptake and had a tendency 
to increase the 0/I ratio for both [14C]ethanol and 3H20 
under basal (vehicle only) conditions (Fig. 5). 
The use of the microdialysis 0/I ratio as a putative 
indicator of total blood flow in skeletal muscle would 
seem to be of use only if the proportion of nutritive to 
nonnutritive flow remains constant. The presence of 
two vascular pathways in muscle may have also led to 
discrepancies between total flow and laser Doppler 
flowmetry (LDF). A study (24) using LDF on rat skel-
etal muscle during ganglionic blockade found that 
changes in LDF signal were dissociated with changes 
in total muscle blood flow, as measured by micro-
spheres during the infusion of vasoactive drugs. In a 
recent study (4) from our laboratory, the LDF signal 
from implantable microprobes inserted into muscles of 
the perfused rat hindlimb was investigated. The data 
showed there were three characteristic responses to 
the infusion of NE and 5-HT indicative of discrete 
regions of nutritive and nonnutritive flow in muscle. 
Larger surface probes showed only one type of re-
sponse, that of increasing nutritive flow in response to 
NE (4). 
This study therefore provides further evidence for 
the existence of two flow pathways within muscle, the 
nutritive and nonnutritive vessels (7, 8). The nonnu-
tritive vessels, which are probably distributed through-
out the muscle in the interfibrillar septa, are readily 
visible in the tendon region (26). They would probably 
be of short length and larger diameter, but still be 
capillary in nature and therefore unable to pass 15-p.m 
microspheres and with a low capacity for nutrient 
exchange. The model most likely is one where there are 
both nutritive and nonnutritive routes in the immedi-
ate vicinity of the probe, so that the two vasoconstric-
tors have simply acted by switching flow from the 
nutritive route, which ean pick up the 3H20 or 
[14C]ethanol, to the nonnutritive route, which still ex-
tracts tracer but less than nutritive flow. Given that 
the probe is 320 p.m in diameter, the region within the 
muscle tissue sensed by the probe is likely to be a 
cylinder of 640-1,120 p.m [i.e., 2- to 3.5-fold the diam-
eter of the probe (38)]. If this is so, then the region of 
sensing would contain both nutritive and nonnutritive 
routes, as recently detected using a randomly placed 
260-p.m-diameter LDF microprobe (4) and predicted by 
the findings of Vincent et al. (37) 
The 0/I ratio of ethanol in skeletal muscle has been 
mathematically modeled (38). The model described 
how the 0/1 ratio changed as the flow rate through the 
microdialysis probe and the blood flow rate changed. A 
further study (19) showed consistency between the 
model and experimental data. However, there was no 
contingency for the distribution of flow within muscle. 
Clearly, this requires a reconsideration of the model 
(38) particularly in view of our present findings and the 
presence of two alternative flow routes in muscle. 
It is assumed that the vasoconstrictors do not affect 
the metabolism of ethanol, which would then affect the  
011 ratio. Metabolism of ethanol would seem very un-
likely because the 0/I ratios of both tracers, [ 14C]etha-
nol and 3H20, show very similar patterns (Figs. 3 and 
4) and muscle does not appreciably metabolize ethanol 
because it contains no alcohol dehydrogenase. Meta-
bolic effects of the vasoconstrictors are also unlikely 
because the addition of the vasodilator NP blocked the 
effect of NE and 5-HT on the 011 ratios. 
There appears to be little advantage between either 
of the tracers used in this study due to the similarity of 
the results gained by them. It may be, however, that 
31120 is a more useful tracer because it is more freely 
diffusable. Also, ethanol is more prone to evaporation 
in the collection tube than water and thus can lead to 
greater errors in measurement. Indeed, if a proportion 
of the ethanol evaporated, this would not make an 
appreciable difference to the volume collected but 
would mean that the actual concentration of [14C]etha-
nol was underestimated. In the case of 3H20, any loss 
by evaporation would be matched by a loss of total 
volume without a net effect on tracer concentration. 
This may be reflected in the fact that, whereas the Oa 
ratio of PACIethanol was above that for 31120, the 
difference is not as great as has been reported previ-
ously (36). 
In conclusion, the current study demonstrates that 
the 0/1 ratios of [14C]ethanol and 3H20 reflect both the 
total flow to muscle and the distribution of flow in 
pathways within muscle. Therefore, the distribution of 
flow within muscle, specifically the proportion of total 
flow that is nutritive, must be taken into account in the 
interpretation of data obtained with this method. The 
findings reinforce the notion that the nonnutritive 
route carries flow but is unavailable for nutrient as 
well as [14Clethanol and 3H20 exchange. Finally, pro-
viding bulk blood flow to muscle remains constant, 
microdialysis using the 0/1 ratio of [ 14C]ethanol or 
3H20 has the potential to be a qualitative measure of 
the proportion of nutritive to nonnutritive flow. 
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Abstract 
Resting muscle thermogenesis as controlled by vasocontrictors was compared in rat hindlimb and cardiac muscle. An 
a-adrenergic agonist combination of phenylephrine atenolol increased oxygen uptake and perfusion pressure in the 
constant flow hindlimb and neither increase was blocked by 10 uM tetrodotoxin. The same adrenergic combination also 
increased oxygen uptake and perfusion pressure in the perfused heart but the former along with beating was completely 
blocked by tetrodotoxin. Vasoconstriction by phenylephrine occurs in the heart but is not linked to thermogenie 
increases as in hindlimb, implying that all metabolic energy in heart is conserved for contractile activity. The findings 
highlight a fundamental difference between skeletal and cardiac muscle. C 2002 Elsevier Science Ltd. All rights reserved. 
Keywords: Resting muscle thermogenesis; Vascular control of muscle metabolism; Vascular effects in heart; Na + channel 
I. Introduction 
Not all homeotherms possess functional brown 
adipose tissue and are instead reliant on thermogenesis 
from other tissues to combat the threat of cold or to 
compensate from over-eating. There is substantial 
evidence that skeletal muscle contributes to heat 
production through shivering but there is also some 
evidence that the muscle possesses non-shivering me-
chanisms (Jansky, 1995). This has been demonstrated in 
a number of species by infusing norepinephrine or 
related adrenergic agonists in vivo (Jansky, 1995). 
However, the mechanisms that could account for resting 
muscle thermogenesis are uncertain with proposed 
contributions from increases in total blood flow to 
muscle (Simonsen et al., 1999), mitochondrial proton 
leakage (Rolfe and Brand, 1996; Rolfe et al., 1999), 
mitochondrial uncoupling due to UCP-3 (Clapham et al., 
2000) and Na + ion cycling (Tong et al., 1999). 
*Corresponding author. Tel.: +61-3-6226-2672; fax: +61-3-
6226-2703. 
E-mail address: michael.clark@utas.edu.au (M .G. Clark). 
Involvement of metabolic futile cycles is also a 
possibility (Newsholme and Crabtree, 1976) and there 
is evidence from malignant hyperpyrexia in mammals 
(MacLennan and Phillips, 1992) and heat-producing 
muscles in certain fish (Block, 1994) that Ca 2+ cycling 
between sarcoplasmic reticulum and myoplasm is a 
pronounced thermogenic process. Attempts to study 
resting muscle thermogenesis in vivo have met with 
mixed success and thus many workers have instead used 
in vitro muscle preparations. But this too has proved 
problematic. Indeed, a number of workers have shown 
that perfused, but neither incubated nor perifused, 
hindlimb muscle responds to a variety of vasomodula-
tors, including norepinephrine and various a-(but not 
/3) adrenergic agonists, angiotensin II, and vasopressin 
by rapidly increasing the rate of oxygen consumption 
and lactate release (see review Clark et al., (1995), and 
references therein). Owing to the magnitude of the 
response in perfused muscle, which is often 50% or more 
over basal for oxygen uptake and lactate release, and the 
increased release of a number of other metabolites, 
including glycerol, fatty acids and breakdown products 
of nucleotides, this has been interpreted as an increase in 
0306-4565/02/$-see front matter 	2002 Elsevier Science Ltd. All rights reserved. 
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resting muscle thermogenesis (Jansky, 1995). Vasocon-
striction appears to be essential for the thermogenic 
response on two grounds. Firstly, as indicated above, 
only perfused muscle preparations respond. Thus, an 
effect of the vasoconstrictors to directly stimulate 
oxygen uptake or lactate release when added to isolated 
incubated (therefore non-perfused) muscles does not 
occur (Dubois-Ferriere and Chinet, 1981; Hettiarachchi 
et al., 1992). Secondly, blockade of the pressor effect 
with various types of vasodilators also blocks the 
increases in metabolism (Colquhoun et al., 1990). More 
recent studies suggest that a major change in blood flow 
pattern within the muscle is a key component of the 
vasoconstrictor-mediated increase in metabolism. Thus, 
there is evidence for redistribution of flow to nutritive 
capillary networks (Newman et al., 1996) at the expense 
of flow from a non-nutritive, possibly connective tissue 
route (Newman et al., 1997). 
Although the detailed mechanism for vasoconstrictor-
mediated thermogenesis in resting muscle is still 
unknown, there is fragmentary evidence to suggest that 
cation cycling may be involved. Thus, the vasoconstric-
tor-mediated oxygen uptake in perfused rat hindlimb 
muscle can be blocked by membrane stabilizers such as 
propranolol (or quinidine) or by inhibition of the 
Na ± /K ATPase without inhibition of the increase in 
perfusion pressure and thus, the redistribution of flow 
(Tong et al., 1997, 1998). In addition, in the perfused rat 
hindlimb, oxygen uptake without vasoconstriction can 
be stimulated by the Na + channel activator, veratridine, 
and this stimulation is inhibited by propranolol (or 
quinidine) or by inhibition of the Na + /K ATPase. 
Taken together, this suggests the involvement of Na 
channels in the vascular thermogenesis of the resting 
muscle (Tong et al., 1998, 1999). 
In the present study, the presence of vascular 
thermogenesis was investigated in perfused non-con-
tracting cardiac muscle and compared to skeletal 
muscle. To do this, we have used doses of an 
a-adrenergic combination of phenylephrine and ateno-
lol, sufficient to cause vasoconstriction in each system 
and tetrodotoxin (10 pM) to arrest beating in the heart. 
Tetrodotoxin has no effect on the vascular thermogen-
esis elicited by vasoconstrictors in the hindlimb muscles 
(Tong et al., 1999). Veratridine was used to demonstrate 
that, in both skeletal hindlimb muscles and cardiac 
muscle, the increased thermogenesis was due to the Na + 
channel opening. 
2. Materials and methods 
2.1. Animals 
Male rats (l80-230g body weight) of the Hooded-
Wistar strain, maintained ad libitum on a standard  
commercial laboratory chow (Gibson's Hobart, Aus-
tralia) at 22°C in a 12 h light : 12 h dark cycle were used 
for these experiments. Rats were anaesthetized with 
pentobarbital sodium (7-8 mg/100 g body weight, 
intraperitoneally) before removal of their hearts for 
perfusion. All aspects of animal handling were in 
accordance with the recommendations of the Animal 
Welfare Committee of the National Health and Medical 
Research Council (in Australian code of practice for the 
care and use of animals for scientific purposes, 1990). 
Experimental procedures were approved by the Com-
mittee on the ethical aspects of research involving 
animals of the University of Tasmania. 
2.2. Hindlimb perfusions 
Hindlimbs were perfused in a constant flow non-
recirculating mode, as described elsewhere (Colquhoun 
et al., 1988) using essentially the technique of Ruderman 
and colleagues (Ruderman et al., 1971). The perfusion 
medium was Krebs-Henseleit bicarbonate buffer con-
taining (in mM) 118 NaC1, 4.8 KCI, 1.2 MgSO4 , 1.2 
KH 2PO4 , 25 NaHCO 3 , 2.5 CaCk, 5 glucose and 4% 
(w/v) bovine serum albumin. The medium was equili-
brated with 0 2/CO2 (19 :1), and the perfusion tempera-
ture was 37°C. Atenolol (0.3 mM) was present in the 
perfusion medium when phenylephrine was infused to 
prevent activation of /3-adrenoceptors and at this dose, is 
without effect on basal or agonist-stimulated oxygen 
uptake (Tong et al., 1997). The flow rate was 
14 ml min-I (0.87 mlniin g wet wt - I ). Oxygen concen-
tration in the venous perfusate was constantly measured 
at 37°C with a Clark-type 0 2 electrode calibrated with 
air and 02 gas. Arterial P0 2 was measured before and 
after each perfusion and oxygen uptake calculated from 
arterial-venous difference, as described previously, using 
the appropriate Bunsen coefficient (Dora et al., 1992). 
Perfusion pressure was continuously recorded with a 
pressure transducer fitted in the arterial line. When 
present, tetrodotoxin and veratridine were each infused 
at 10 pM. Phenylephrine was present at 1 pM. For the 
veratridine perfusions, 0.5 mM sodium nitroprusside 
(SNP) was included in the perfusion media to block 
any vasoconstriction due to the Na + channel opening in 
vascular smooth muscle and thus, any subsequent 
redistribution of flow that might occur. 
2.3. Heart perfusions 
Hearts were perfused in the Laneendorff manner 
using a system based on that of Williamson (1964). 
The perfusion medium was Krebs-Henseleit bicarbo-
nate buffer, as described above, which contained 
0.05 mM EDTA, 5 mM pyruvate, and 5 mM glucose, 
and was equilibrated with 0 2/CO 2 (19 :1); the perfusion 
temperature was 37°C. The perfusion medium also 
PHE 
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contained 0.3 mM atenolol when phenylephrine 
was infused. Each heart was perfused at constant 
flow (6.79 +0.12 ml min -1 , equivalent to 8.94± 
0.25 ml g wet wt heart -I (mean + SE, n = 18)). 
Oxygen concentration in the venous perfusate was 
constantly measured at 37°C with an in-line Clark-type 
02 electrode calibrated with air and 0 2 gas and uptake 
calculated, as described above. The cannulated heart 
was contained within a sealed chamber to prevent 
exchange of 0 2-0O2 between effluent perfusate and the 
atmosphere (chamber volume 10 ml) and in this system, 
drift in measurement was less than 2% h (Richards 
et al., 1993). Aortic pressure was continuously recorded 
with a CFP blood pressure monitor (Model 8138). 
Contracting hearts were arrested by infusion into the 
perfusate line just prior to the heart of either tetrodo-
toxin (TTX) or KCI to give a final concentration of 
1011M and 40 mM, respectively. KC1 was used in place 
of TTX to arrest the heart for veratridine infusion 
experiments as TTX is an inhibitor of veratridine-
mediated oxygen uptake in perfused hindlimb (Tong 
et al., 1999) and likely to be so in heart. As indicated, 
phenylephrine or veratridine solutions (in isotonic 
saline) were infused to give final concentrations of 50 
and 10 pM, respectively. The total infusion rate of 
agents did not exceed 1: 50 of the perfusate flow rate. 
2.4. Statistics 
Statistical testing was performed using the Sigma 
Statr" statistical program (Jandel Software Corp.) and 
significant differences were recognized at P<0.05. 
3. Results 
3.1. Perfused hindlimb 
Fig. I shows a typical trace of oxygen uptake and 
perfusion pressure obtained during 1 1iM phenylephrine 
infusion with and without 10 p.M tetrodotoxin. Mean 
values with standard errors for a total of five experi-
ments are shown in Fig. 2. Phenylephrine in the presence 
of the fl-adrenergic antagonist, 0.3 mM atenolol, sig-
nificantly increased both the oxygen uptake and perfu-
sion pressure. Mean basal values (before phenylephrine) 
for oxygen uptake and perfusion pressure were 
31.5 + 1.0 pmol 1 -1 - I g - I and 40 + 5 mm Hg, respectively, 
and 	these 	increased 	to 	39.1 +1.4 pmol 
(P<0.001) and 53+5 mm Hg (P<0.001), when pheny-
lephrine was infused. Infusion of 10 pM tetrodotoxin for 
10 min before and during phenylephrine had no effect on 
the magnitude of the changes in oxygen uptake or 
pressure due to phenylephrine 
Fig. 3 shows the effects of veratridine on oxygen 














Fig. I. Time course for the effect of phenylephrine (PH E, I 1.1M) 
on oxygen uptake and perfusion pressure by the perfused rat 
hindlimb with and without 1011M tetrodotoxin (TTX). The 
perfusion buffer contained 0.3 mM atenolol and perfusions 
were conducted at constant flow. A representative trace is 
shown. 
sodium nitroprusside (SNP). 10 pM veratridine signifi-
cantly increased oxygen uptake from 26.1+0.4 to 
38.1 + 0.9 pmol h -1 (P< 0.001) representing an in-
crease over basal of approx. 45%. Perfusion pressure 
was only marginally increased by veratridine from 
41.3 +1.7 to 43.4 +2.3 mm Hg, but this was not 
significant (P> 0.05). 
3.2. Perfused heart 
Hearts were allowed to equilibrate for 20-30min until 
steady state levels of oxygen uptake and perfusion 
pressure were obtained. Preliminary experiments were 
conducted to determine a dose of the a-adrenergic 
agonist combination of phenylephrine + 0.3 mM ateno-
lol that would reproducibly increase both oxygen uptake 
and perfusion pressure at constant flow. These pre-
liminary experiments showed that the heart was 
considerably less sensitive to phenylephrine and a dose 
of 50 gM was considered optimal. 
Fig. 4 shows a typical trace of oxygen uptake and 
perfusion pressure obtained during a 7-10 min infusion 
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Fig. 2. Effects of phenylephrine (1 pM), tetrodotoxin (10 pM) 
and a combination of the two on oxygen uptake and perfusion 
pressure of the constant-flow perfused rat hindlimb. Other 
details were as for Fig. I. Values are means +SE for n = 5; *, 
significantly different from basal; #, significantly different from 
TTX treatment tested by repeated one-way analysis of variance 
and pair-wise comparisons using the Student—Newman—Kuels 
test. 
Fig. 3. Effects of veratridine (Vera, 10 pM) in the presence of 
0.5mM sodium nitroprusside (SNP) on oxygen uptake and 
perfusion pressure of the constant-flow perfused rat hindlimb. 
Values are means+SE for n = 5; ***, significantly different 
from basal. 
of 50 jiM phenylephrine + 0.3 mM atenolol, while the 
heart was contracting. After 15-20 min from the 
cessation of phenylephrine infusion, when oxygen and 
pressure values had returned to pre-infusion levels, 
infusion of TTX was commenced. Contraction rapidly 
declined within 2 min after TTX infusion and no 
contraction was observed for the remainder of the 
experiment (data not shown). When oxygen uptake and 
perfusion pressure had again stabilized, infusion of 
phenylephrine was re-commenced at the same rate as 
prior to arrest. For some of the hearts, there was a 
transient stimulation of oxygen uptake coinciding with 
the commencement of phenylephrine infusion, but this 
was transient and overall, there was no sustained 
increase in oxygen uptake (Fig. 4) despite a marked 
increase in perfusion pressure (Fig. 5). Atenolol 
(0.3 mM) alone did not affect basal oxygen uptake or 
perfusion pressure (compare Figs. 5 and 7). 
Fig. 5 shows the meanvalues+ SE (from 10 experi-
ments) for oxygen uptake and perfusion pressure, 
recorded just prior to the first phenylephrine infusion 
(Basal) and TTX infusion, and at the end of both 
phenylephrine infusions, as conducted in the protocol of 
Fig. 4. Repeated one-way analysis of variance and pair-
wise comparisons using the Student—Newman—Kuels 
test demonstrated that phenylephrine caused a signifi-
cant (P<0.05) increase in oxygen uptake (70.4%) when 
infused in contracting hearts, but no change in TTX-
arrested hearts. However, perfusion pressure was 
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Fig. 4. Time course for the effect phenylephrine (50 1.1M) on 
oxygen uptake and perfusion pressure by the perfused rat heart 
with and without l0M tetrodotoxin. The perfusion buffer 
contained 0.3 mM atenolol and perfusions were conducted at 
constant flow. A representative trace is shown; means of all 
experiments are shown in Fig. 5. 
Fig. 5. Effects of phenylephrine (50 )IM), tetrodotoxin (1011M) 
and a combination of the two, on oxygen uptake and perfusion 
pressure of the constant-flow perfused rat heart. Other details 
were as for Fig. 4. Values are means +SE for n =8; *, 
significantly different to TTX treatment. 
both contracting (32.7%) and TTX-arrested (51.4%) 
hearts. TTX-arrest of contracting hearts resulted in a 
significant (P <0.05) decrease in oxygen uptake (52.5%) 
but no significant change in perfusion pressure. 
Fig. 6 shows a typical trace of oxygen uptake and 
perfusion pressure obtained during veratridine experi-
ments. Hearts were allowed to equilibrate for 20-30 min 
until steady state levels of oxygen uptake and perfusion 
pressure were obtained. Infusion of 40 mM KCI was 
then commenced to arrest contraction. Contraction 
ceased within 2 min and no contraction was observed 
for the remainder of the KCI infusion (data not shown). 
Shortly after commencing KC1 infusion, there were 
initial transient changes in oxygen uptake and perfusion 
pressure (Fig. 6). After 15 min, when oxygen uptake and 
perfusion pressure had stabilized, veratridine (10 gM) 
infusion was commenced. Oxygen uptake was stimu-
lated by veratridine after a delay of approximately 3 min 
(Fig. 6). This delay was similar to that seen with the 
perfused hindlimb (Tong et al., 1998). 
Fig. 7 shows the mean +SE values (from eight 
experiments) of oxygen uptake and perfusion pressure, 
determined just prior to KCI (Basal), veratridine 
infusions, and after 10 min of veratridine plus KC1 
infusion. Repeated one-way analysis of variance and 
pair-wise comparisons using the Student—Newman-
Kuels test demonstrated that KC1 arrest caused a 
significant (P < 0.05) decrease (32.7%) in oxygen uptake 
and increase (165%) in perfusion pressure, while 
veratridine infusion resulted in a significant (P <0.05) 
increase (55.6%) in arrested-heart oxygen uptake and a 
further small rise (12.8%) in perfusion pressure. 
4. Discussion 
The main finding emerging from this study is that 
vasoconstrictor-mediated thermogenesis is absent from 
heart. Thus, the constant-flow perfused heart, when 
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Fig. 6. Time course for the effect of veratridine (Vera, 10 ttM) 
on oxygen uptake and perfusion pressure of the KCI (40 mM)- 
arrested rat heart. A representative trace is shown; means of all 
experiments are shown in Fig. 7. 
combination of phenylephrine atenolol in terms of 
increased oxygen uptake, despite a rise in perfusion 
pressure. This contrasts with the constant-flow perfused 
hindlimb which, at rest, showed a marked increase in 
oxygen uptake with pressure rise, in response to the 
same a-adrenergic agonist combination (Fig. 1). The 
finding is also in contrast to the result when pheny-
lephrine was applied to the beating heart. Since, under 
these conditions, there was both an increase in pressure 
and oxygen uptake, it would seem likely that energy 
expenditure by the heart is closely coupled to supporting 
myocyte contractility. Thus, the increase in oxygen 
consumption by phenylephrine during beating is the 
result of the well-established a-adrenergic inotropic 
effect of this and other catecholamines (Aass et al., 
1983; Benfey, 1982; Schumann et al., 1974). 
The absence of a vasoconstrictor-mediated thermo-
genesis in heart, may reflect the absence of either a flow 
redistribution process, or a specific thermogenic me-
chanism that responds to flow redistribution. There is 
Fig. 7. Effects of veratridine (10 nM), KC1 (40mM) and a 
combination of the two on oxygen uptake and perfusion 
pressure of the constant-flow perfused rat heart. Values are 
means+SE for n =8; *, significantly different from KCI 
treatment. 
compelling evidence for two vascular routes in skeletal 
muscle, both from older (Barlow et al., 1961; Grant and 
Wright, 1970; Pappenheimer, 1941) and more recent 
studies (Clark et al., 1995). Perfusion flow can thus be 
distributed between a nutritive route which is in intimate 
contact with the muscle fibres, or a non-nutritive route 
which has poor delivery of nutrients and which may be 
located in nearby connective tissues. Implications are 
that, for skeletal muscle at rest, blood flow is hetero-
geneous with a considerable proportion of the total flow 
entering muscle not actually in contact with muscle 
fibres for its passage through the tissue. Absence 
of a thermogenic response to the vasoconstrictor, 
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phenylephrine, by the heart, may reflect homogeneous 
flow in this tissue and the absence of a non-nutritive 
route. It is also possible that heart lacks the signalling 
system that we have previously proposed for the skeletal 
muscle where the re-direction of flow, mediated by the 
vasoconstrictors, activates a thermogenic mechanism in 
the striated muscle cells (Clark et al., 1995). 
Comparison of heart and skeletal muscle in terms of 
putative thermogenic mechanism involving Na ÷ cycling 
revealed no major difference. Both the tissues responded 
positively to the sodium channel opener, veratridine 
(10 jtM), although beating of the heart had to be 
prevented by high IC and some constriction of the 
myocardial vasculature resulted. 
In a previous publication (Tong et al., 1998), we have 
described the similarities between vasoconstrictor-
mediated increases in metabolism and those produced 
by veratridine in the perfused hindlimb. Veratridine, 
like norepinephrine, increased oxygen uptake and 
lactate release. Each was blocked by low Na l- medium 
(Tong et al., 1998), by the membrane-stabilizer, ( + )- 
propranolol (Tong et al., 1998) or by the Na ± /K + 
ATPase inhibitor, ouabain (Tong et al., 1999). 
Veratridine-mediated increases in metabolism are not 
associated with changes in perfusion pressure, are 
unaffected by agents such as sodium nitroprusside 
(Tong et al., 1998), and therefore unlikely to involve 
redistribution of flow between non-nutritive and 
nutritive routes. 
We have previously reported that vasoconstrictor-
mediated increases in metabolism were insensitive to 
tetrodotoxin (5-501AM), but those of veratridine were 
completely abolished at 1 jtM (Tong et al., 1999). With 
the added knowledge that tetrodotoxin at these doses 
completely prevents beating of' the heart and opportu-
nity presented itself, where we could investigate 
the presence or otherwise of the tetrodotoxin-insensitive 
vascular thermogenesis in the arrested heart. In the 
present study, it is clear that the response to veratridine 
(in terms of increased oxygen uptake) is present even 
in the arrested heart, suggesting that the mechanism 
is present. However, it cannot be entirely ruled out 
that the lack of response to phenylephrine in TTX-
exposed hearts reflects the absence of the specific 
tetrodotoxin-insensitive process that exists in the skeletal 
muscle. 
In summary, the heart differs from skeletal muscle in 
its response to the a-adrenergic agonist, phenylephrine. 
In skeletal muscle, vasoconstriction is associated with an 
increase in oxygen uptake. For the arrested heart, there 
is no response. This is likely to be the result of the 
absence of heterogeneity of flow, or differences in the 
expression of early mechanisms linking vasoconstriction 
to Na ± movement. Down-stream processes appear to be 
similar as veratridine stimulates oxygen uptake in both 
heart and skeletal muscle. 
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